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Abstract 
Chronic mechanical load variation triggers a wide range of responses in the heart, a 
part of which includes cellular remodelling. Over the past 15 years, evidence has 
amassed that a part of this remodelling process involves changes to a sophisticated 
structure in the cell membrane, called the transverse (t)-tubule system. The t-tubules 
are a series of regular membrane invaginations, which contain a high density of ion 
channels responsible for local Ca2+ induced Ca2+ release (CICR). 
 
This thesis addresses the question of whether the t-tubule system can be said to be 
specifically load sensitive, the nature of that load sensitivity and its molecular 
regulators. Using surgical models, the influence of mechanical load variation of 
different durations, degrees and settings are studied. Local CICR and t-tubule 
structure are investigated. 
 
First, it was found that prolonged mechanical unloading induces subtle changes to the 
t-tubule system, which functionally uncouples the Ryanodine receptors (RyR) and L-
type Ca2+ channels (LTCC) and induces a loss of whole cell Ca2+ release synchrony. 
 
Second, heart failure was found to be associated with loss of t-tubule structure and 
Ca2+ handling abnormalities. Following mechanical unloading, the t-tubule system 
recovered with enhanced LTCC-RyR uncoupling, resulting in improved Ca2+ 
handling. 
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Third, the t-tubules were found to be unchanged initially during graded mechanical 
load variation. Prolonged myocardial unloading or overloading impaired t-tubule 
structure, with loss of normal CICR. 
 
Telethonin (Tcap), a member of the cardiomyocyte stretch sensing complex, is a 
candidate regulator of the t-tubules. In a Tcap knock-out (KO), cardiomyocytes show 
a primary t-tubule defect, which becomes more pronounced following mechanical 
overload. 
 
These results support the notion that the t-tubule system is dynamically regulated by 
mechanical overload and unloading, via a molecular pathway including Tcap. 
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“CASUALLY CONSIDERED, the heart is merely a pump. 
In fact, it is a sophisticated organ. Comprised of four valves, two holding chambers, 
two pumping chambers, a spiderweb of vessels to nourish it, and an intricate network 
of nerves to control it, the heart must harmoniously propel blood through 
approximately sixty thousand miles of arteries, capillaries, and veins – two thousand 
gallons of blood through the average-size person each and every day. 
 
It does not pump autonomously. The heart must properly respond to sometimes 
severe, sometimes subtle changes in temperature, exertion, emotion, and stress. It 
should last a normal lifetime: some two and a half billion beats over the course of 
seventy-five years. Evolution has confirmed the heart’s importance by protecting it 
with bone. The brain and bone marrow, foundation of the immune system, are among 
the few other parts of the body so honoured. 
 
Congenital disease can warp the heart with great variety. Valves can be sealed tight, 
missing parts – or absent altogether. Major vessels can be misplaced, narrowed, or 
blocked completely. A chamber can be too small or missing, a wall too thick or thin. 
The heart’s electrical system – its nerves – may go haywire. The muscle can be weak. 
Holes may occur almost anywhere, in almost any size. Studying heart pathology, one 
is reminded that the genetic symphony that produces a normal baby is indeed a 
wondrous and delicate one” 
 
-King of Hearts 
The True Story of the Maverick Who Pioneered Open Heart Surgery 
[Dr Walt Lillehei] 
GW Miller 
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Chapter 1 
General Introduction 
1.1 Myocardial Load Variation 
The heart is characterised by its ability to adapt its structure and function to external 
stressors (Catalucci et al., 2008). Acute mechanical load variation has a major impact 
on cardiac contractility, with changes in cardiac preload resulting in altered cardiac 
contractility, termed Starling’s Law of the Heart (Patterson and Starling, 1914) 
(Figure I-1). These early experiments proved a number of important concepts, which 
can be observed in the relationship between load (in this case, changes to cardiac 
preload in the form of altered end-diastolic volume (EDV)) and contractility (in this 
case, cardiac output, (CO)) (Figure I-1).  First, they show that increased stretch causes 
increased contractility i.e. that the heart is able to adapt acutely to changes in load. 
Second, such adaptations are normally reversible, in that as soon as the stimulus is 
reduced (reduced EDV), contractility will fall. Third, that beyond a certain stage, 
further stretch is no longer accompanied by increased contractility, so-called failure. 
Further work showed that the augmentation of cardiac contractility under increased 
loading conditions is mediated by a number of mechanisms including increased 
myofilament sensitivity to Ca2+, decreased myofilament lattice spacing and others 
(reviewed in (Shiels and White, 2008)). This demonstrates the important role of Ca2+ 
in regulating the myocardial response to altered mechanical load. 
! 24!
 
FIGURE I-1: STARLING’S LAW OF THE HEART 
Acutely, CO is enhanced by increased EDV within a physiological range. 
 
 
Chronic mechanical overload and unloading trigger adaptive responses, which cause 
the heart to undergo physiological remodelling as a part of a wider response to meet 
increased or reduced demand (Ellison et al., 2012). Causes of mechanical load 
variation are listed in Table I-1. 
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TABLE I-1 CAUSES OF MYOCARDIAL MECHANICAL LOAD VARIATION 
*These may cause overloading or unloading depending on the prevailing conditions of the circulation. 
 
Chronically elevated demand causes depletion of the adaptive reserve and leads to 
heart failure (HF) (Heineke and Molkentin, 2006). A central concept is the notion of 
physiological versus pathological change. Physiological changes allow the 
myocardium to meet the increased demand placed by altered loading conditions. 
These include cardiomyocyte hypertrophy, augmentation of the Ca2+ transient and 
altered contractility amongst many other factors (Ellison et al., 2012). These 
Mechanical Overloading Mechanical Unloading 
Increased Afterload 
-Aortic Stenosis 
-Hypertension 
-Atherosclerosis 
-Coarctation of the aorta 
-Renal Artery Stenosis 
 
Pressure unloading 
-Ventricular Assist Devices 
-Septal Defects* 
-Mitral Valve Regurgitation* 
-Bed Rest 
-Possibly space flight 
-Aortic Valve Bypass 
Increased Preload 
-Mitral Valve Regurgitation* 
-Septal Defects* 
-Renal Failure 
-Ischaemic Heart Disease 
-Increased circulating volume (e.g. 
 pregnancy) 
-Arrhythmia 
 
Volume Unloading 
-Ventricular Assist Devices 
-Diuresis 
-Mitral Valve Regurgitation 
-Heterotopic, “piggy-back” 
 Transplantation 
-Fontan Circulation* 
-Any cause of prolonged venodilatation 
e.g. sepsis. 
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physiological responses are so-called because they are reversible upon removal of the 
stimulus that triggered them. Pathological changes are thought to begin as 
physiological, adaptive changes. This pathophysiological pathway is termed 
remodelling and has been defined as (Table I-2): 
 
“The molecular, cellular, interstitial and genomic changes which are manifested 
clinically as changes in size, shape and function of the heart following cardiac injury.” 
-(Pfeffer and Braunwald, 1990) 
 
!
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TABLE I-2: THE SPECTRUM OF REMODELLING 
 
 
Systems 
- Neuroendocrine changes that coordinate skeletal, cardiac and smooth muscle 
structure, function and metabolic activity 
Organ 
-Ventricular wall hypertrophy or atrophy and changes in cavity size and shape 
-Changes in heart rate which alter preload 
Tissue 
-Changes to electrophysiological properties of conduction 
-Changes to extracellular matrix 
Cellular 
-Cardiomyocyte: 
-Hypertrophy/atrophy 
-Changes to activity and expression of ion channels 
-Changes to the membrane structure 
-Changes to sarcomere size and biochemistry 
-Fibroblasts 
-Changes in number 
-Changes in secretory function 
-Possible changes in myocyte:fibroblast coupling 
-Immune and other cellular changes 
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The defining difference between physiological and pathological remodelling is 
thought to be its reversibility. This is shown in an elegant study of chronic aortic 
banding in rats for a period of time followed by removal of the band (Derumeaux et 
al., 2002) (Figure I-2). If the band remains in place for two months, removal of the 
band leads to recovery of cardiac contractility (measured as the systolic mean velocity 
gradient (sMVG), recorded using echocardiography). However, if the band remains in 
place for nine months, removal of the band does not induce reversal of the phenotype, 
with chronically blunted contractility. This shows that one essential determinant of the 
transition between physiological and pathological remodelling is the duration of 
mechanical overload. 
 
 
FIGURE I-2: PHYSIOLOGICAL REMODELLING VERSUS PATHOLOGICAL 
REMODELLING 
sMVG is slowed after chronic mechanical overloading (induced by aortic banding), presumably to 
reduce the energetic cost of increased contractile force. If debanding is performed after two months, 
sMVG recovers, indicating physiological, reversible remodelling. If debanding is performed at nine 
months, such remodelling is irreversible. Figure from (Derumeaux et al., 2002). Y axis shows 
myocardial velocity gradient before, 5, 30, 60 minutes and 24 hours following debanding. 
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1.2 Clinical Entity Of Heart Failure 
HF is defined as the inability of the heart to meet the demands of the metabolising 
tissues (Jessup and Brozena, 2003). HF may involve the right, left or both ventricles 
(the role of the atria in HF is complex, understudied and is emerging (Corradi et al., 
2011)). When right-sided, symptoms and signs include peripheral oedema, 
hepatomegaly, with the attendant symptoms of bruising (coagulopathy) and lethargy 
among others. When left-sided, pulmonary oedema occurs, resulting in chronic 
breathlessness and marked anxiety. The end organs are under-perfused resulting in 
neuroendocrine derangement, skeletal muscle cachexia and severe lethargy. Two 
symptoms may be said to be pathognomonic of HF – paroxysmal nocturnal dyspnoea 
(a distressing attack of night-time breathlessness that wakes the patient) and 
orthopnoea (breathlessness on lying flat). These two symptoms describe a state where 
the ventricles are unable to drive sufficient flow to prevent pulmonary oedema in the 
supine position. A failing left or right ventricle can cause failure of both ventricles, 
congestive cardiac failure. 
 
HF is progressive and its impact on function can be described according to the New 
York Heart Association (NYHA) class system1. Class I describes those patients who 
have no functional restriction and whose symptoms do not impact on their ability to 
perform any activity. Class II describes those patients in whom normal levels of daily 
physical activity are possible, but induce symptoms of HF including shortness of 
breath. Class III describes those patients who experience significant functional 
limitations but are generally comfortable at rest. These patients show a specific 
feature which is that they can start but not finish normal daily activity. Class IV 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!1!The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis 
of Diseases of the Heart and Blood Vessels. Boston: Little Brown, 1964. !
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describes those patients who are not able to conduct any physical activity without 
discomfort and who are symptomatic at rest. 
 
HF is associated with more morbidity and a lower quality of life than other multi-
system diseases (Hobbs et al., 2002). In terms of prognosis, up to 40% of patients die 
within one year of diagnosis (Rector and Cohn, 1994). The cause of death is either 
pump failure or arrhythmia, which each account for approximately 50% of deaths due 
to HF. 
 
The scale of the HF problem is substantial2. In the United Kingdom, there are 63000 
new diagnoses of HF every year, with a total patient population of over 800000. One 
million inpatient bed days (2%) are occupied by HF, and this is projected to double 
over the next 25-years. HF has an annual cost to the NHS of approximately £625 
million. Therefore, HF, which is the end-result of chronic mechanical overload, is a 
disease that is common, debilitating and often rapidly lethal. 
 
1.3 Current Therapy For Heart Failure 
The therapeutic rationale for HF has changed substantially in the last few decades 
(Eichhorn and Bristow, 1996). In the pre-clinical trial era of the 1950s, treatment was 
aimed at improving symptoms using digitalis (to enhance cardiac contractility, and 
improve symptoms by reducing breathlessness), diuretics (to reduce the circulating 
volume and reduce peripheral and pulmonary oedema) and prolonged bed rest (to 
reduce cardiac work). In the 1960-1980s, focus shifted to thinking of HF as a 
cardiovascular disease, based on pathological preload, afterload and contractility. !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 British Heart Foundation. Heart Failure Supplement. http://www.bhf.org.uk/publications/view-
publication.aspx?ps=1001402 
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Treatment was still aimed at relieving symptoms, using vasodilators (to reduce pre- 
and afterload) and inotropes. In the 1980s-90s, clinical trials showed that these 
strategies for improving symptoms had no benefit on survival (Cohn et al., 1986, 
Packer et al., 1991). From the 1980s, clinical trials showed that angiotensin-
converting enzyme inhibitors (ACEi) and β-adrenergic blockers, which do not 
enhance short-term cardiac performance, improve mortality (Currie et al., 1984, 
Ikram and Fitzpatrick, 1981). These agents have become the mainstay of treatment for 
prognostic benefit. Thus in fifty years, treatment has changed from positive inotropes 
to negative inotropes, from rest to exercise training (Belardinelli et al., 1995) and 
from vasodilators to ACEi. Today the mainstay of therapy is ACEi, diuretics and β-
adrenergic blockers. 
 
1.4 Left Ventricular Assist Devices 
Left Ventricular assist devices (LVADs) provide relief from HF by supporting the 
circulation 
(Terracciano et al., 2010). The inflow cannula removes blood from the left ventricle 
(LV), via a tract made in the apex of the LV and pumps this blood into the ascending 
aorta. This induces pressure and volume mechanical unloading of the LV. 
 
The first ventricular assist devices were essentially extensions of the cardiopulmonary 
bypass machine and were entirely extracorporeal (Terracciano et al., 2010). Later 
pulsatile ‘paracorporeal’ ventricular assist devices allowed some mobility. A major 
breakthrough was the development of totally implantable devices, powered by 
batteries carried in a holster by the patient. After internalisation, the next major step 
was achieved by the HeartMate pump (Thoratec Laboratories Corp., Pleasanton, CA), 
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which abolished the need for warfarin (which is a major source of complications) due 
to the development of anticoagulant surfaces. Second generation, axial, continuous 
flow pumps then emerged, which use grooves to drive rotational blood flow (Figure I-
3). They are smaller, safer, and more durable and can provide up to six litres of flow. 
The third, and current, generation devices are small and centrifugal pumps which lack 
ball bearings and in which the rotor is magnetically (or mechanically) suspended. 
Some of these devices can be implanted totally within the pericardial space. Newer 
devices are emerging which provide “partial” mechanical support and can be 
implanted without median sternotomy (Meyns et al., 2011). 
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FIGURE I-3: VARIOUS TYPES OF VENTRICULAR ASSIST DEVICE 
(a, b) Examples of first-generation pulsatile VAD (HeartMate® I, Thoratec Corp., left) and second-
generation continuous-flow (HeartMate II®, Thoratec Corp., right) (from http://www.thoratec.com). 
(c, d) A second-generation LVAD (Jarvik 2000, Jarvik Heart®) with intraventricular implantation 
(http://www.jarvikheart.com). (e, f) A third-generation centrifugal VAD (HVAD®, HeartWare, 
http://www. heartware.com.au), with small dimension and hydrodynamically suspended impeller. 
Figure from (Terracciano et al., 2010). 
 
Apart from their role as permanent circulatory support (“destination therapy”) and as 
bridges to transplantation, their most interesting use is to induce substantial reverse 
remodelling of myocardial structure and function (Yacoub, 2001) termed “Bridge to 
Recovery” (BTR). BTR is clinically defined as explantation of the device without 
needing cardiac transplantation. 
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The seminal discovery of BTR was accidental when devices had to be removed due to 
complications (Frazier et al., 1996). The rate of recovery initially observed appeared 
to be very small (1-10%) (Mann and Willerson, 1998, Mancini et al., 1998, Maybaum 
et al., 2007). In some studies, the rate of recovery could be substantially increased by 
combining LVAD treatment with pharmacological therapy (up to 70%) (Birks et al., 
2011, Birks et al., 2006). There are many unanswered questions with respect to BTR 
including which is the optimal device, in what mode of operation and, especially, for 
which patients. The indications for BTR are still evolving. To date, BTR has been 
offered mainly to patients with severe HF due to non-ischemic dilated 
cardiomyopathy (DCM), whether idiopathic, post-viral, familial, postpartum or post-
chemotherapy, regardless of age, sex or duration of HF (Yacoub and Miller, 2008). 
Their use in ischaemic and other cardiomyopathies is expanding. 
 
One important issue in the clinical use of LVADs is the decision about the timing of 
application, with some advocating increased use of LVADs in less sick patients 
(Miller, 2011). Timing of LVAD intervention can have an important influence on 
outcome, in both the short and long term. Virtually all patients recruited for BTR are 
from the larger pool of bridge-to-transplantation patients, and therefore by 
definition have an extremely advanced grade of HF (Kirklin et al., 2008). This can 
have an adverse effect on early mortality, which is usually caused by multi-organ 
damage. 
 
Rapid progress in the field has resulted in the development of several types of 
implantable LVAD (Figure I-3) with different performance characteristics, which can 
influence both the mode and degree of interaction with the native heart (Terracciano 
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et al., 2010). Although the pulsatile devices such as Heart Mate I are thought to 
provide better unloading of the LV, which could enhance recovery, their use has 
declined due to their much bigger size and higher incidence of complications. Recent 
series utilising the continuous flow Heart Mate II reported results similar to those 
obtained by Heart Mate I (Birks et al., 2011). Further definition of the haemodynamic 
interaction between the device and the native heart should help in optimising the 
choice of device. 
 
Although the process of reverse remodelling starts within a very short time after the 
onset of unloading, it continues for many weeks or months and varies in different 
types of animal models and from patterns observed in humans (Maybaum et al., 2007, 
Oriyanhan et al., 2007) with relatively wide variations between individuals. Tests for 
cardiac recovery in patients are problematic and clear protocols are not established. 
The tests to monitor recovery are usually started four weeks after leaving intensive 
care, when the patient is fully ambulant, with no evidence of infection or any other 
complication.  Measuring LV size and ejection fraction (EF) during LVAD 
support provides a rough estimate of the degree of recovery (Dalby et al., 
2003).  However, accurate evaluation of cardiac function requires discontinuing the 
contribution to cardiac output by the device. This can be achieved by switching the 
device off in pulsatile pumps or by reducing the pump speed in continuous flow 
pumps. This should be performed after full heparinisation, with close monitoring of 
haemodynamic and echocardiographic parameters. If the patient tolerates this period, 
a six-minute walk test followed by repeating echocardiography to test for inotropic 
reserve is performed. These tests are repeated at two-weekly intervals, and continued 
for up to 18 months so long as there is any degree of improvement in the parameters 
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measured. Additional tests in the form of measuring exercise capacity with gas 
exchange and cardiac catheterisation are performed at the appropriate stage to confirm 
recovery (Birks et al., 2006). 
 
There are currently no specific biological markers of recovery and assessment is 
based on clinical parameters alone. The development of such markers is predicated on 
our understanding of the molecular mechanisms of cardiac recovery. 
 
1.5 Biological Remodelling in Heart Failure And Its Regression 
Following LVAD Therapy 
Since the phenomenon of cardiac recovery was discovered at the clinical level, efforts 
in the laboratory have attempted to define its mechanisms. Patients treated with 
LVADs offer the unprecedented opportunity to study myocardial structure and 
biology at two time points in the same patient:  before treatment (tissue taken during 
device implantation) and after treatment (tissue taken at explantation or 
transplantation). Given the limited amount of tissue available at explantation in BTR 
patients, most of the studies have been performed on bridge to transplantation 
samples, and it is therefore difficult to correlate the relationship between the changes 
observed and clinical consequences. In addition, a large body of information has 
amassed from studies using animal models of mechanical unloading. The array of 
LVAD-induced reverse remodelling has been reviewed extensively (Hall et al., 2007, 
Terracciano et al., 2010, Baba et al., 2000, Wohlschlaeger et al., 2010), and in this 
section, a brief summary of the most interesting and relevant changes is given. The 
physiology and pathophysiology of cellular electrophysiology is discussed in detail in 
the following sections. 
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1.5.1 System And Organ Effects Of LVADs 
There are a number of effects of LVAD therapy. First, they induce major volume and 
pressure unloading of the LV, reducing myocardial wall tension and normalising CO. 
The enhanced CO improves brain (with improved neuroendocrine function (Klotz et 
al., 2009)), kidney (with diminished anaemia, and adequate circulatory volume 
management), liver (with enhanced immune and metabolic function), gut (with 
enhanced metabolic and immune function) and other end-organ perfusion. 
Importantly, enhanced coronary blood flow is a major effect of the enhanced cardiac 
output. This can improve cardiac function independently.  Cardiac improvements are 
listed in Table I-3.  Within the heart, the main players are the cardiomyocytes, the 
extracellular matrix, immune and other cells. 
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TABLE I-3: CHANGES AFTER LVAD THERAPY 
 
 
 
 
CChanges after LVAD therapy Study 
Decreased neurohormones (Klotz et al., 
2005) 
Decreased Cytokines (Thompson 
et al., 2005) 
Decreased Apoptosis (Hattori, 
2003) 
Decreased whole heart dimensions (Levin et al., 
1995) 
Improves LV geometry and CO (Mancini et 
al., 1998) 
Reduces Cell size (Terracciano 
et al., 2004) 
Normalisizes beta-adrenergic pathways (Klotz et al., 
2005) 
Alters collagen pattern [or fibrosis, varied reports] (Bruggink et 
al., 2006) 
Normalisation of the cytoskeleton (Birks et al., 
2005) 
Improved cellular Ca2+ handling Figure I-4 
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1.5.2 Metabolic Impact Of LVAD Therapy 
The metabolic derangements of the failing heart, partly mediated by dysfunctional 
mitochondrial performance, has led to the failing heart being characterised as an 
engine out of fuel (Neubauer, 2007). LVADs, apart from reducing cardiac workload, 
also induce improvement of metabolic and mitochondrial function in HF. This is 
mediated in part by restored respiratory capacity of mitochondria, and by enhanced 
endogenous nitric oxide regulation of mitochondrial function (Mital et al., 2000). 
 
1.5.3 Impact Of LVAD Therapy On Fibrosis 
LVAD therapy increases fibrosis in some studies (Klotz et al., 2005), and decreases 
fibrosis in other studies (Bruckner et al., 2004). Klotz et al showed that collagen 
cross-linking increased after LVAD therapy with consequent increase in myocardial 
stiffness, which could impact on ventricular filling properties (Klotz et al., 2008).  
Bruggink et al demonstrated a biphasic response with an initial increase in fibrosis 
followed by a subsequent regression with prolonged LVAD therapy (Bruggink et al., 
2006). 
 
1.5.4 Effect Of LVAD Therapy On Tissue And Cell Electrophysiology 
Possibly related to altered extracellular matrix conditions, reverse 
electrophysiological remodelling occurs at the myocardial level during LVAD 
therapy, demonstrated by reduction of the QT interval (Harding et al., 2001, Drakos et 
al., 2011). Cellular electrophysiology is discussed in detail in section 1.6. Briefly, the 
depolarisation of the cell membrane in the form of the action potential (AP) opens the 
voltage-gated L-type Ca2+ channels (LTCC). These allow a small amount of Ca2+ to 
enter the cell, which triggers the opening of the Ryanodine receptors (RyR) which 
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allow the release of the intracellular Ca2+ stores from the sarcoplasmic reticulum 
(SR), resulting in in contraction. The whole cell Ca2+ transient is then terminated by 
extrusion of Ca2+ via the Na+/Ca2+ Exchanger (NCX) and sarcoplasmic reticulum 
ATPase 2a (SERCA2a) (Bers, 2001). 
 
Multiple elements of this system are affected by LVAD therapy (Figure I-4). LVAD 
therapy induces a regression of the pathologically prolonged AP duration occurs with 
possible improvements to depressed L-type Ca2+ current (ICa,L) (Terracciano et al., 
2004). SR Ca2+ release function is possibly improved after LVAD therapy (Marx et 
al., 2000), with an increase in SR Ca2+ content (Terracciano et al., 2004). These 
mechanisms could partly explain the observed increase in the Ca2+ transient amplitude 
(Dipla et al., 1998) and therefore also the enhanced cellular contractility. Removal of 
diastolic Ca2+ is also improved by LVAD therapy, through increased SR Ca2+ uptake 
(Frazier et al., 1996), presumably because of an increase in the amount of SERCA2a 
protein (Heerdt et al., 2006). Therefore, the whole of local CICR appears to undergo 
some degree of local CICR reverse remodelling (Figure I-4). These mechanisms play 
some role in the enhanced whole heart function observed after LVAD use, which 
leads to clinical recovery. 
 
1.5.5 Cardiomyocyte Contractility 
Both basal cellular contractility and the contractile response to β-adrenergic 
stimulation (Dipla et al., 1998) are improved after LVAD therapy. There is also 
evidence that LVAD therapy enhances EF in a number of clinical studies (Maybaum 
et al., 2007), suggesting improved whole heart function. 
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FIGURE I-4: REVERSE REMODELLING OF LOCAL CICR AFTER LVAD THERAPY 
Multiple elements of the excitation-contraction coupling system undergo reverse remodeling after 
LVAD therapy. 
 
1.5.6 Regression Of Cellular Hypertrophy 
The cardiomyocytes form approximately 35% of myocardial cells by number, but 
almost 75% of the ventricular volume (Nag, 1980). These cells are linked to one 
another through intercalated disks, which provide a low resistance route for 
excitation. As such, the cardiomyocytes form an electric and mechanical syncytium. 
The cardiomyocytes are the sole force generators in the heart and the mechanisms that 
regulate their contractility will be discussed below. The hypertrophic cellular response 
to mechanical overload and HF has been described by a number of investigators (Del 
Monte et al., 2002). Regression of cardiomyocyte hypertrophy has been documented 
after LVAD therapy (Zafeiridis et al., 1998). It is widely assumed that regression of 
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hypertrophy improves clinical prognosis (and possibly cellular function), partly 
because of LVAD studies that show both regression of cellular hypertrophy and 
improvements in functional features such as cellular contractility (Dipla et al., 1998). 
In a study comparing cardiomyocyte Ca2+ handling and cell size in patients who 
recovered clinically and those who did not, regression of hypertrophy was found to be 
common to both patient groups. Clinical recovery occurred in patients whose SR Ca2+ 
content recovered (Terracciano et al., 2004). 
 
1.5.7 LVADs Alter Cardiomyocyte Cell Cycle Regulation 
HF is associated with increased apoptosis, which reduces cell number further, leading 
to increased stretch and dysfunction in the remaining cells. There is some evidence 
that the enhanced cell death of HF is reduced by LVAD support; LVAD therapy 
increases the expression of anti-apoptotic proteins (Bartling et al., 1999) and 
decreases markers of cellular apoptosis (Baba et al., 2000). 
 
Cardiomyocyte division may occur in response to cardiac injury, but is clearly limited 
given the overt failure of neomyogenesis in the failing heart. The favourable 
environment during LVAD support, which improves the neuroendocrine environment 
by reducing plasma adrenaline, noradrenaline (NA), renin, aldosterone and 
vasopressin (Klotz et al., 2009), as well as atrial and brain-type natriuretic peptide 
plasma levels (Thompson et al., 2005), could promote conditions for cardiac 
regeneration. Wohlschlaeger et al recently showed a dramatic halving of mean 
cardiomyocyte DNA and a doubling in number of diploid cardiomyocytes, together 
with a significant decrease in the number of polyploid cardiomyocytes 
(Wohlschlaeger et al., 2010).  These results may imply that LVAD therapy promotes 
cardiomyocyte cell division. 
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1.5.8 Cardiomyocyte Cytoskeletal Structure 
LVAD therapy alters the expression of multiple sarcomere, cytoskeletal and linker 
proteins within the cardiomyocyte, suggesting some role for internal cardiomyocyte 
reorganization of the cell (Margulies et al., 2005, Vatta et al., 2002, Latif et al., 2007). 
De Jonge et al demonstrated that the disrupted cytoskeletal architecture observed in 
HF is improved after LVAD therapy (involving a number of proteins including actin, 
tropomyosin, troponin T and troponin C) (de Jonge et al., 2002). Among cytoskeletal 
proteins, the integrin family of proteins span the membrane and link the extracellular 
matrix with the cytoskeleton. As such, they play an important role in 
mechanosensation and cell signalling. LVADs could induce recovery at multiple 
levels in the integrin pathway, which is dysfunctional in HF (Hall et al., 2007). 
Whether this molecular recovery restores mechanosensation and the diverse actions of 
integrins is not yet known. 
 
1.5.9 β-Adrenergic Subcellular Signalling 
One of the major regulators of cellular and myocardial contractility is the β-adrenergic 
system, which is altered in HF. The domains of different β-adrenergic signalling 
pathways within the single cell, which are normally spatially segregated, have 
recently been shown to be more globalised in failing cells compared to healthy cells in 
an animal model of post-ischaemic HF (Nikolaev et al., 2010). In addition, LVADs 
enhance the β-adrenergic response of the myocardium, both by increased receptor 
density (Ogletree-Hughes et al., 2001) and by improved localization of β-receptors 
(Bick et al., 2005). 
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1.5.10 Nature Of LVAD- Induced Gene Expression Changes 
 
LVAD therapy alters the expression of a large number of proteins and their post-
transcriptional regulation. MicroRNAs are small RNA sequences, which do not code 
for protein directly, but can alter patterns of translation by binding with coding RNA 
sequences and by influencing the pattern of protein expression. Patterns of microRNA 
expression appear to be normalized by LVAD therapy and could be a more sensitive 
marker for reverse remodelling than changes in gene expression (Matkovich et al., 
2009). 
 
1.6 Physiological And Pathological Excitation-Contraction Coupling 
And The Transverse-Tubule System 
The ventricular ability to contract resides in the function of the single cardiomyocytes. 
This contractility is triggered and regulated by a series of messengers (Bers, 2002), 
which were introduced briefly above. The cell membrane messenger in this case is 
electrical depolarisation of the cell membrane in the form of the morphologically 
complex AP. Depolarisation of the cell membrane opens voltage-gated LTCC (also 
termed dihydropyridine receptors, DHPR), which allows some entry of Ca2+ into the 
cytoplasm, in the form of the ICa,L. Through a positive feedback mechanism, this 
Ca2+  triggers the opening of the RyRs, which control the release of Ca2+  from the SR. 
This Ca2+ then bathes the myofilaments, triggering contraction. Ca2+ is then rapidly 
removed and re-uptaken into the SR (by SERCA2a) and out of the cell (via NCX) 
terminating contraction. These coordinated events can be observed in the whole cell 
Ca2+ transient, which precedes cellular contraction. Each of these components will be 
discussed below. 
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1.6.1 The Action Potential 
The AP was first described by Hodgkin and Huxley in 1952 using giant squid axon 
(Hodgkin and Huxley, 1952). The AP describes a voltage waveform (as the 
consequence of the activity of different ion channels (DiFrancesco and Noble, 1985)), 
which is generated along the membrane of excitable cells, altering the membrane 
potential (Em). APs are all-or-nothing (Noble, 1962), meaning that (i) their size is not 
affected by the original stimulus size because when triggered the amplitude is 
constant at any further point; this is because of the positive feedback mechanism 
which regulates the voltage-gated Na+ channel; (ii) they are not triggered if the 
stimulus is below a certain threshold voltage. This threshold is set by the interaction 
between the negative feedback of voltage-gated K+ channels (which tend to repolarise 
the cell and are dominant near the resting potential) and the positive feedback of 
voltage-gated Na+ channels (which tend to depolarize the cell  and as more Na+ enters 
the cell, the greater the depolarization, and so on) (Noble and Hall, 1963). There is a 
voltage at which the positive feedback overcomes the negative feedback, a threshold. 
So, for a stimulus sufficient to tip the balance toward the positive feedback of Na+, the 
AP will be generated and, if there are no conduction defects, will regeneratively pass 
through the electrical syncytium. 
 
The AP is different in morphology in different cardiac tissues (pacemaker, atrium and 
ventricle) due to the presence of different types of ion channels, which open in a 
different manner when depolarised (Nerbonne, 2000). The cardiac ventricular AP has 
a plateau phase due to the balance achieved by ICa,L and outward currents such as the 
delayed rectifier current (Charpentier et al., 2010). In conjunction with the 
electrochemical gradient, this plateau allows inward Ca2+ flow through open LTCC. 
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Therefore changes in AP duration can have a major impact on the inward flow of 
Ca2+. 
 
1.6.2 The Long Lasting Type Ca2+ Current 
In 1967, Reuter described the Long-lasting type Ca2+ current (Reuter, 1967). LTCCs 
are a type of voltage gated Ca2+ channel which persist in an open state, in contrast to 
the transient (T)-type Ca2+ channels which have a far smaller role in cardiac 
ventricular excitation-contraction coupling. Dihydropyridines stabilize the closed state 
of LTCC, and due to their ability to inhibit Ca2+ influx, have a wide therapeutic use 
for the management of angina and hypertension through their effects on smooth and 
cardiac muscle (Elliott and Ram, 2011). 
 
The LTCC opens in response to membrane depolarisation at a voltage threshold that 
depends on physical parameters like temperature and [Ca2+], but under physiological 
conditions, it is approximately -40mV. Between -40mV and +10 mV, ICa,L reaches a 
peak in 2-3 ms (Rosenberg et al., 1986). 
 
The inactivation of ICa,L depends on [Ca2+ ]i, membrane potential, and time (Lee et 
al., 1985) and generally occurs over 60-200 ms. The Ca2+-dependent inactivation of 
ICa,L is demonstrated by the fact that use of Ca2+ free extracellular solutions (using 
Ba2+ for example) lead to a prolongation of ICa,L (Hofer et al., 1997, Grandi et al., 
2010). Such Ca2+-dependent inactivation provides a mechanism for limiting the 
amount of Ca2+ entering the cell during the AP. Moreover, this effect is observed even 
when the extracellular Ca2+ is highly buffered with the use of extracellular Ca2+ 
chelators, suggesting that Ca2+  local to LTCC can have an effect on ICa,L inactivation 
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(Hofer et al., 1997). Sipido et al. showed that SR Ca2+ release could also inhibit the 
ICa,L, providing one method for regulating Ca2+ influx (Sipido et al., 1998). 
 
The LTCC are present throughout the membrane, but are concentrated in the t-tubules 
(Gu et al., 2002). Their close interaction with RyR has a number of implications for 
their function, which is discussed later. 
 
1.6.3 Ca2+ - Induced Ca2+ Release 
Ca2+ entering through the LTCC is insufficient to activate the myofilaments, both 
because of the amount of Ca2+ and also because of Ca2+ buffering (Fabiato, 1983). 
Approximately 60-70 µmol/L cytosolic Ca2+ is required to activate a normal 
ventricular twitch (40% maximal force at 25-30 °C). This means that the diastolic 
[Ca2+] of ~150nM needs to rise to 600nM (Puglisi et al., 1999). The amount of Ca2+ 
entering through the LTCC is approximately 14µmol per litre of cytosol (under 
voltage-clamp conditions using an AP waveform) (Yuan and Bers, 1994), which is 
not sufficient alone to activate ventricular contraction. 
 
In skinned canine Purkinje fibres (which lack t-tubules), Fabiato (Fabiato, 1985a, 
Fabiato, 1985b, Fabiato, 1985c) showed that 1ms exposure of Ca2+  (simulating the 
LTCC) could lead to SR Ca2+ release, in a process termed Ca2+ -induced Ca2+  release 
(CICR). In other words, the Ca2+ signal was amplified. In ventricular cardiomyocytes, 
portions of expanded SR, termed junctional SR, reside close to the t-tubule’s zone of 
concentrated LTCC, and would be exposed to ICa,L very quickly. This unit is a dyad, 
which has been defined as the “structural complex and functional unit of muscle 
excitation-contraction coupling. Anatomic elements include the LTCC or voltage 
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sensors, the Ca2+ release units (RyR), and the subspace between them” (Cheng and 
Lederer, 2008). This provides a structural basis for that amplification, through a 
mechanism of positive feedback. This amplification must be regulated such that the 
amount of SR Ca2+ release is graded to the ICa,L. Fabiato showed that the amount of 
SR Ca2+ release depends on the trigger [Ca2+] and the time taken to reach that [Ca2+ ]. 
Interestingly, SR Ca2+ release shows a refractory period where further addition of Ca2+ 
is unable to trigger SR release. SR Ca2+ depletion cannot explain this because caffeine 
addition does result in further SR Ca2+ release. Fabiato described a model involving 
SR activation sites with a high on-rate but low affinity and other inactivating sites 
with a higher affinity, but a slower activation constant (Fabiato, 1983). When rapid 
increases in [Ca2+] occur, SR Ca2+ release occurs, and the inactivation site binds Ca2+ 
more slowly to terminate Ca2+ release. This theory has been replaced with others 
(stochastic attrition, luminal SR Ca2+ release) described later. 
 
Initially, it was uncertain whether Ca2+ or voltage were the essential steps of Ca2+ 
release. The evidence presented so far is consistent with either voltage-dependent or 
Ca2+-dependent Ca2+ release. Nabauer et al (Nabauer et al., 1989) presented evidence 
in rat ventricular cardiomyocytes showing that during a stimulus wave, a typical 
ICa,L trace is observed as well as a Ca2+  transient. In the presence of ethylene glycol 
tetraacetic acid (a Ca2+ chelating agent), the extracellular [Ca2+] is reduced to 
submicromolar levels and the current flow consists mainly of Na+. Under these 
conditions, no Ca2+ transient is observed. This is despite the fact that caffeine is able 
to produce a large Ca2+ release. Therefore, SR Ca2+ release appears to be dependent 
upon Ca2+, indicating that Ca2+ dependent not voltage-dependent SR Ca2+ release is 
occurring. Niggli and Lederer (Niggli and Lederer, 1990) showed that the application 
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of Ca2+ (using caged photo-dependent release) is able to produce SR Ca2+  release 
under voltage clamp. In addition, CICR was the same irrespective of the Em. 
 
Although these experiments provide a great deal of information related to the general 
regulation of CICR at the level of the whole cell, it has become apparent that SR Ca2+ 
release occurs in localized regions, visualized first by Cheng et al as Ca2+ sparks 
(Cheng et al., 1993). Ca2+ sparks initiate along z-lines, raise local [Ca2+] by ~200nM, 
rise in 10ms, fall with time constant of ~25ms and a spatial spread of approximately 
2µm (Bers, 2001). Importantly, the scale of optical measures of Ca2+ sparks is 100 
times the depth of the junctional complex, so they do not resolve the true structure of 
the dyadic Ca2+ handling. During resting states in cardiomyocytes, the frequency of 
Ca2+ sparks is typically very low, approximately 100/s. Activation of ICa,L by the AP 
leads to simultaneous activation of thousands of sparks to give rise to the whole cell 
Ca2+ transient (Cheng and Lederer, 2008). 
 
In the local control theory of CICR initially proposed by Stern (Stern, 1992), SR Ca2+ 
release is effectively all-or-none within a cluster of RyRs. However, the physical 
separation between clusters, and the high local [Ca2+] required to activate a cluster 
means that activation cannot spread between clusters. Parker et al (Parker et al., 1996) 
showed that occasionally one Ca2+ spark could activate another in the lateral direction 
along the z-line (~0.76µm away), but could never extend to a second z-line (~1.8µm 
away). This implies that in order to obtain gradation of CICR, recruitment of a 
variable number of RyR clusters is required. 
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In rat cardiomyocytes, approximately 55% of SR Ca2+ is released during a normal 
twitch for SR Ca2+ contents of approximately 100 µmol per litre of cytosol (Delbridge 
et al., 1997). The SR Ca2+ released varies with the ICa,L amplitude (Bassani et al., 
1995a, Bassani et al., 1995b). When SR Ca2+ load is halved, fractional release is zero, 
indicating that ICa,L cannot trigger such low amounts of SR Ca2+  load. This could be 
due to an altered RyR sensitivity by changes to SR luminal [Ca2+]. Ca2+ spark 
frequency increases as SR Ca2+ content rises, possibly because sensitisation of RyR 
means that even diastolic [Ca2+] is able to trigger Ca2+ sparks. 
 
The intrinsic positive feedback which drives the amplification of SR Ca2+ release 
requires a termination mechanism to regulate it. Three mechanisms have been 
suggested including local luminal depletion of SR Ca2+, RyR inactivation and 
stochastic attrition. Stochastic attrition requires that all LTCC and RyR involved in a 
cluster close at the same time, therefore terminating SR Ca2+ release. If the dyad 
involved a single LTCC and single RyR, then stochastic release would be a feasible 
mechanism for Ca2+ release termination, but as there are multiple channels this 
mechanism appears unlikely. SR Ca2+ depletion is also unlikely given that the 
application of caffeine can produce Ca2+ sparks which are much longer than those 
normally observed (>200 ms) (Cheng and Lederer, 2008). Importantly during these 
extremely long releases, Ca2+ spark amplitude does not fall, indicating that SR Ca2+ 
content does not fall. However, Satoh et al showed that the Ca2+ sparks may be 
regulated in some way by SR Ca2+ content, because as described above, ICa,L cannot 
trigger Ca2+ release when SR Ca2+ content is severely reduced (Satoh et al., 1997). 
This is likely to be mediated by reduced RyR sensitivity. Therefore reduced RyR 
sensitivity may play some role in Ca2+ spark termination under normal conditions. 
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Sham et al used Ca2+ spike measurements to understand the mechanisms mediating 
Ca2+ spark termination (Sham et al., 1998). Early LTCC opening produced Ca2+ 
sparks, but prolonged opening did not. This indicates that some mechanism within the 
SR leads to the Ca2+ spark termination, likely including an element of intrinsic RyR 
inactivation. The mechanisms mediating this are not understood. 
 
Ca2+ sparks offer the most practical direct assessment of the function of the RyR 
clusters and SR Ca2+ release. However, although Ca2+ spark imaging can reveal many 
details of SR Ca2+ release function, it does not provide the real biophysical 
characteristics of Ca2+ sparks. Imaged Ca2+ spark amplitude is a representation of true 
Ca2+ spark amplitude, which depends on the optical slice and line scan selected. 
Imaged, representative Ca2+ spark amplitude underestimates true spark amplitude 
(Cheng and Lederer, 2008). Importantly, the F/Fo value (fluorescence peak over 
fluorescence of the baseline background) depends heavily on the [Ca2+ ] at Fo, which 
likely varies between cells. Ca2+ sparks, even from the same RyR clusters, show 
morphologic heterogeneity (Lipp and Niggli, 1993). 
 
Ca2+ spark width (reported as the full width at half-maximal, FWHM) depends on 
Ca2+ diffusion properties and reaction. Ca2+ sparks approximately measure 2.0µm 
FWHM when measured at the time of the peak signal, which appears to be more than 
twice the value obtained by mathematical models of Ca2+  spark formation (Cheng and 
Lederer, 2008). This Ca2+ spark width paradox could be related to non-Fickian 
diffusion properties of Ca2+ sparks, the biological mechanisms of which are uncertain. 
The total duration of a Ca2+ spark is approximately 30ms. This extremely brief 
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duration underpins the tight spatial localisation of Ca2+ spark signalling. Luminal 
transfer of Ca2+ within the SR, and regulated Ca2+ release linked to [Ca2+ ]SR 
occasionally allow for very long sparks (Bers, 2002). 
 
Despite the fact that Ca2+ sparks from the same RyR cluster can be morphologically 
different, Ca2+ sparks are autonomous. That is, Ca2+ sparks caused by ICa,L or 
spontaneous sparks are essentially similar in morphology. Despite large changes in 
ICa,L the individual Ca2+ sparks remain constant. Once activated, Ca2+ spark 
amplitude and duration are autonomous of ICa,L. This is not to say that ICa,L does 
not modulate Ca2+ sparks at all. Indeed, more sparks are evoked at negative rather 
than positive voltages for a given amount of ICa,L supporting the idea that the 
microscopic properties of ICa,L are also important determinants of SR Ca2+ release 
function (Santana et al., 1996). Understanding Ca2+ spark function is a crucial element 
of dissecting the changes underlying the Ca2+ transient. Underpinning the relationship 
between ICa,L and Ca2+ release is the tight spatial proximity between LTCC and 
RyRs. These two channels are brought into tight spatial contact by the t-tubules. 
 
1.6.4 Termination Of The Ca2+ Transient Via NCX And SERCA2a 
To terminate the whole cell Ca2+ transient, the raised [Ca2+]i must be lowered via Ca2+ 
extrusion. This occurs via two routes, NCX and SERCA2a. NCX, which is 
concentrated in the t-tubules (Despa et al., 2003), is the major Ca2+ extrusion pathway 
from the cell under normal conditions (Noble et al., 1991). NCX can also modulate 
both local Ca2+ release (Sher et al., 2008) and the AP (Armoundas et al., 2003). Under 
the conditions of AP prolongation and raised [Na+]i in HF, NCX may contribute a 
significant amount of Ca2+, augmenting the weakened Ca2+ transient (Despa et al., 
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2002).  Enhanced NCX activity in HF may have multiple effects on the AP depending 
on the intracellular [Na+]. When [Na+]i is high, NCX may contribute to AP 
repolarisation but when [Na+]i is low, NCX may prolong the AP (Armoundas et al., 
2003).  
 
SERCA2a is responsible for the uptake of Ca2+ into the SR; SERCA2a protein 
expression is depressed in HF, which partially explains the loss of contractile 
performance and SR Ca2+ reuptake (Hasenfuss et al., 1994). Replenishment of 
SERCA2a, using gene therapy, results in restoration of cardiac performance, cellular 
contractility and augments SR Ca2+ content (Lipskaia et al., 2010, Lyon et al., 2011). 
Recent evidence shows that SERCA2a is powerfully regulated by post-translational 
modification in health and disease; restoration of normal levels of small ubiquitin-
related modifier-1 (SUMO-1) restores SERCA2a protein levels in a mouse HF model 
and rescues SR Ca2+ content and Ca2+ transient dynamics (Kho et al., 2011). Although 
the relative contribution of NCX and SERCA2a in lowering [Ca2+]i differs by species, 
SERCA2a typically accounts for 70-80% of Ca2+ removal from the cytoplasm under 
normal conditions in adult mammalian cardiomyocytes (Bassani et al., 1994, Bassani 
and Bassani, 2002, Bassani et al., 1992, Fowler et al., 2005, Bers and Bridge, 1989, 
Bers et al., 1989, Hryshko et al., 1989). NCX accounts for the removal of the vast 
majority of the remaining systolic Ca2+, with the rest (approximately 1%) extruded by 
slow pathways involving the plasma membrane Ca2+-ATPase and mitochondrial Ca2+ 
uniporter.  
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1.7 The Transverse Tubules 
The t-tubules are invaginations of the external membrane of skeletal and cardiac 
muscle cells (Figure I-4 and I-5), which are rich in ion channels important for 
excitation-contraction coupling (Brette and Orchard, 2003) (Figure I-6). The 
transverse t-tubule network of mammalian ventricular cardiomyocytes was first 
discovered by Linder, using electron microscopy (EM) in 1956 (Lindner, 1957). The 
first report of axial t-tubules was in 1971 (Sperelakis and Rubio, 1971). 
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FIGURE I-5: TWO-PHOTON IMAGING OF THE T-TUBULE NETWORK IN RAT 
VENTRICULAR CARDIOMYOCYTES 
The t-tubule network runs deep into the cell and extends in multiple directions, with a diameter varying 
from 20 to 450 nm. Figure from (Soeller and Cannell, 1999). 
 
 
EM studies (Franzini-Armstrong and Porter, 1964, Porter and Palade, 1957) 
confirmed that the t-tubules were invaginations of the sarcolemma, and described 
their transverse and axial radiations, which paralleled findings in skeletal muscle 
cells. These studies described in ventricular cells a less regular but much larger t-
tubule system. The finding that the external membrane regularly penetrated the cell 
centre was used to explain the earlier finding that it took less than 40ms for excitation 
to travel from the external membrane to the centre of the cell, a distance of 
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approximately 50µm (Hill, 1949). This also explained the observation that cells with 
well demarcated invaginations (t-tubules) contracted more rapidly than those without 
such structures (Peachey and Huxley, 1962). 
 
Soeller and Cannell’s two-photon live-imaging study elaborated the complexity of the 
t-tubule system (Figure I-5), which runs deep into cardiomyocytes and varies in its 
diameter (Soeller and Cannell, 1999). Recent work has reconstructed a three-
dimensional model of the network and provided a new level of detail using 
computational approaches (Savio-Galimberti et al., 2008). It confirms that the cardiac 
t-tubules are not transverse only, but have protrusions in many directions and a 
diameter that varies from 20 to 450nm. Skeletal muscle t-tubules are much smaller, 
with a diameter between 20 and 40nm (Franzini-Armstrong et al., 1975). 
 
 
The scheme of CICR described earlier relies heavily on the juxtaposition of 
sarcolemmal LTCCs and RyR to form a dyad (Figure I-4) (Franzini-Armstrong et al., 
1999). This close association (approximately 12nm) is critically dependent on normal 
t-tubule structure and guarantees that the Ca2+ trigger results in adequate Ca2+ release 
from the intracellular stores. This process of CICR is most effective in ventricular 
cells where the t-tubules ensure that Ca2+ is released in close proximity to all 
sarcomeres, regardless of how deep they lie within the cell (Brette and Orchard, 
2003). The t-tubule network is responsible for just one third of the capacitance of the 
membrane, but most of the influx of Ca2+ which triggers the release of intracellular SR 
Ca2+ enters across the t-tubular membrane fraction (Kawai et al., 1999). This is 
because there is a different complement of ion channels in the surface and t-tubular 
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fractions, with a three to nine fold higher number of LTCCs in the t-tubule fraction 
than in the surface sarcolemma (Scriven et al., 2000, Brette and Orchard, 2003) 
(Figure I-6). 
 
The myofilaments represent 45-60% of the cardiomyocyte volume. These contractile 
complexes are organised into sarcomeres with only a minority of these units close to 
the surface sarcolemma. In cells without t-tubules, the wave of Ca2+ propagates from 
the periphery of the cell into the centre (Huser et al., 1996) either by simple diffusion 
or by a wave of propagated CICR (Figure I-7). Such a system would first activate the 
peripheral sarcomeres, and then the deeper sarcomeres, resulting in sub-maximal 
force production. A system where current is simultaneously relayed to the core of the 
cell.would mean a larger instantaneous force is produced which is more equally 
shared between sarcomeres. The t-tubules make this possible by triggering SR Ca2+ 
release near to all sarcomeres simultaneously. 
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FIGURE I-6: CA2+ CHANNELS ARE CONCENTRATED AT THE T-TUBULE 
(A) Variation of the density of chloride and LTCCs at different positions on the cell surface (B) 
Functional schematic of the sarcomeric unit showing clustering and colocalisation of chloride and Ca2+  
channels on the cell surface. From (Gu et al., 2002). 
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FIGURE I-7: EFFECT OF T-TUBULE NETWORK ON SR CA2+ RELEASE EFFICACY 
Confocal line scans of isolated cardiomyocytes from (left to right), human atrial, normal rat ventricular 
and failing rat ventricular tissue labelled with the Ca2+ sensitive dye, Fluo-4-AM. In atrial cells, the t-
tubular density is reportedly very low, and this results in non-synchronous release of Ca2+, with the cell 
exterior (edges of trace) activated before the centre of the cell (middle of trace). Normal rat ventricular 
cardiomyocytes show normal dense t-tubules and this allows synchronous activation of Ca2+ release 
throughout the cell. However, in failing ventricular cells the t-tubular membrane shows defects and this 
results in a loss of Ca2+ release synchronicity. The traces show two stimulated activations, the lower of 
which has been outlined by the dotted line for clarity. Each trace is shown at a different magnification 
for clarity, and the white scale bar represents 50µm. (Original figure obtained using isolated cells 
labelled with Fluo-4-AM, and imaged using a confocal microscope). 
 
This role for t-tubules in cardiac muscle is, to a certain extent, supported by 
comparative biology studies. Although there is little evidence that differences in t-
tubule density are related to cell size, there appears to be a correlation with species 
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(which reveals a possible association with heart rate). For example, the mouse, which 
has a heart rate of approximately 600-800 beats per minute (bpm) at rest, has a denser 
t-tubule network than the pig, whose heart rate is less than 100 bpm (Heinzel et al., 
2002). This trend suggests the t-tubules are more important in hearts where the rapid 
cycling of Ca2+ is necessary in order to cope with high heart rates. 
 
The t-tubules restrict diffusion of the extracellular fluid, creating a microdomain of 
ions of a concentration that is relatively stable in comparison to the wider 
extracellular space. This may be a mechanism to prevent rapid changes in the 
extracellular fluid from adversely affecting CICR. However, investigators have 
argued that it is theoretically possible that as more Ca2+ is drawn out of the t-tubule 
cleft, it may become Ca2+ depleted (Orchard et al., 2009). Savio-Galimberti et al. have 
visualised single t-tubules at very high resolution and their analysis suggests that as 
the cardiomyocyte contracts, the t-tubules are squeezed and this ‘pumps’ the micro-
domain contents into the extracellular space (Savio-Galimberti et al., 2008). It is not 
yet clear whether such a mechanism is quantitatively important in replenishing the 
contents of the t-tubular microdomain, and more studies are needed. However, recent 
computational studies which have modelled the t-tubular microdomain as containing 
ion concentrations either fixed at those of the extracellular space or altering by 
diffusion, suggest that the accumulation and depletion of ions in the t-tubule may have 
a significant effect on membrane currents (Pasek et al., 2008a, Pasek et al., 2008b). 
Whether this scenario is prevented by t-tubule pumping or other mechanisms (e.g. 
Ca2+ extrusion at the t-tubules by NCX (Despa et al., 2003)) is a matter to be 
established by experimental approaches. 
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The density of LTCCs is higher in t-tubules than in the surface sarcolemma (Gu et al., 
2002) (Figure I-7). Brette et al estimate that approximately 75-80% of ICa,L flows 
across the t-tubules, indicating they are the main source of the Ca2+ trigger (Brette et 
al., 2006). The Ca2+ current of the t-tubules is more readily inactivated by Ca2+ flow 
than the same current at the surface, indicating that Ca2+ released from the SR may 
have a greater autoregulatory role on the Ca2+ current in the t-tubules, further 
supporting their special role in CICR (Brette et al., 2004b). 
 
The t-tubules are not only a site for Ca2+ influx, but also for Ca2+ extrusion. NCX also 
appears more highly concentrated in the t-tubule (Despa et al., 2003). T-tubular NCX 
appears to have privileged access to the Ca2+ released from the SR (Trafford et al., 
1995) and may occur in a specialised zone in the t-tubule. SERCA2a is preferentially 
expressed close to the t-tubules (Greene et al., 2000), indicating that the major Ca2+ 
extrusion pathways are near to the influx pathways at the t-tubule. Recent evidence 
suggests that Ca2+ efflux through SERCA2a occurs only in the t-tubule, and Ca2+ 
efflux through NCX occurs predominantly through the t-tubule. Just as the major 
influx pathways in the t-tubules allow rapid contraction throughout the cell (Chase 
and Orchard, 2011), so the extrusion pathways allow rapid relaxation throughout the 
cell and further implicate the t-tubule in Ca2+ homeostasis. These data suggest the 
hypothesis that the t-tubules may have a specialised role in the extrusion of 
intracellular Ca2+ but this requires further experimental studies. 
 
1.7.1 Signalling Functions 
The β-adrenergic system is known to modulate the function of a number of key Ca2+ 
channels and contractile proteins. Indeed, a number of key proteins in this signalling 
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pathway (e.g. stimulatory G-protein, Gs) are localised at the t-tubule (Laflamme and 
Becker, 1999). Reports suggest that the β2-adrenoceptor (AR) system is more tightly 
coupled to the modulation of the ICa,L at the t-tubule than at the surface sarcolemma 
(Jurevicius and Fischmeister, 1996), as β-adrenergic stimulation causes a greater 
increase in the Ca2+ current in normal cells compared to detubulated cells (Brette et 
al., 2004a). This may have a structural basis, as a subpopulation of LTCCs resides in 
caveolae associated with the t-tubule network, and may play signalling functions 
(Davare et al., 2001, Balijepalli et al., 2006). These LTCCs colocalise with a β2-
AR/G-protein macromolecular signalling complex, raising the possibility that they 
process small Ca2+ signals which could be important in inducing hypertrophy and 
controlling contractility. There are conflicting reports as to the effect of caveolae 
disruption on β2-AR stimulation of the ICa,L, with some reports that caveolae are 
necessary (Balijepalli et al., 2006) and some to the contrary (Calaghan and White, 
2006); however, it is clear that caveolae-based signalling complexes modulate Ca2+ 
signalling in cardiomyocytes. Caveolin-3 is the major structural protein of caveolae. 
Interestingly, it is known that caveolin-3 deficient mice develop HF (Woodman et al., 
2002). 
 
βAR localisation is critical to the functional signalling properties of the intracellular 
signalling molecule cAMP (Nikolaev et al., 2010) (Figure I-8). In normal cells, β1-
ARs appear to be functionally homologous across the external and the t-tubule 
membrane, and are not spatially localised to any specific site. However, the β2-ARs 
are spatially localised to the t-tubule in normal cells. In HF, this spatial localisation is 
lost, with a relative redistribution to the cell surface. The normally tight spatial 
localisation of the β2-AR response depends on its colocalisation with protein kinase A 
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(PKA), which limits the spread of the cAMP response. The normally striated pattern 
of PKA is lost in HF. This ‘globalisation’ of the β2-AR response may partly mediate 
the loss of its cardioprotective effects and its role in driving the disease process in HF. 
The full implications of this remain to be tested. 
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FIGURE I-8: Β-ADRENERGIC RECEPTOR DISTRIBUTION IS ALTERED IN HEART 
FAILURE 
The left panel shows the cell surface structure (top) and β2-AR distribution in healthy cells. Normally, 
β2-AR are concentrated in the t-tubules, whereas β1-AR are spread across both membrane fractions. In 
HF, t-tubule abnormalities are associated with a reversal of normal β2-AR distribution. Adapted from 
(Nikolaev et al., 2010). 
 
1.7.2 T-Tubule Regulation 
The t-tubule network is extremely dynamic; it appears after birth (e.g. (Haddock et 
al., 1999)), when the ventricular pressures rise, and disappears when cardiomyocytes 
are placed in culture (Mitcheson et al., 1996), or in HF (see later). T-tubules are also 
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absent in stem cells and in neonatal cardiomyocytes. The exact mechanisms 
responsible for these changes remain unknown. However, they appear to be regulated 
by both biochemical (Table I-4) and biophysical factors (e.g. load and heart rate). 
Both these factors appear to interact under both physiological and disease conditions 
and govern the t-tubule’s structure and function. 
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TABLE I-4: MOLECULES INVOLVED IN T-TUBULE REGULATION 
Protein Major finding  
B
IN
1 
Involved in tubule formation. Mutations in BIN1 in skeletal muscle myopathies. 
Shuttles LTCCs to the t-tubule. 
(Fugier et al., 2011, 
Hong et al., 2012, 
Hong et al., 2010, Lee 
et al., 2002) 
M
yo
tu
bu
la
ri
n 
Mutations are associated with x-linked myotubular myopathy, and result in severe structural 
and functional disruption to the t-tubules. There is a possible common amphiphysin-
myotubularin pathway regulating t-tubule biogenesis. Overexpression causes accumulation 
of membrane saccules. May also directly modulate RyR function and alters the expression of 
DHPR and RyR. 
(Al-Qusairi et al., 
2009, Buj-Bello et al., 
2008, Dowling et al., 
2009) 
T
ro
po
m
yo
si
n Absence of certain isoforms of tropomyosin (an actin binding protein) disrupts t-tubules, 
suggesting the myofilaments may be involved in maintenance of T-tubule system. 
 
(Vlahovich et al., 2009) 
T
el
et
ho
ni
n 
Mutations cause muscular dystrophy-like phenotype with associated t-tubule disruption. 
Forms part of stretch sensitive centre, which is defective in some cardiomyopathies eg 
HOCM. 
(Knoll et al., 2011, 
Zhang et al., 2009) 
Ju
nc
to
ph
ili
n 
Critical for accurate association of T-tubule and SR membrane. Downregulated in HF. 
Knockdown in culture causes disrupted t-tubule structure. 
(Ito et al., 2001, 
Komazaki et al., 2002, 
Komazaki et al., 2003, 
van Oort et al., 2011, 
Wei et al., 2010) 
M
its
ug
um
in
 
Mice lacking mitsugumin-29 display significant ultrastructural abnormalities to the t-tubule 
membranes but only have limited myopathy. This indicates some of these genetic 
abnormalities may be partly due to alterations in the function of the constituent ion channels 
as well as structural changes. 
(Nishi et al., 1999) 
T
ri
ad
in
 
Triadins are structural proteins which bind RyR. Triadin null mice have normal life spans 
and preserved contractility despite a significant reduction in the amplitude of evoked Ca2+ 
release and disrupted t-tubule structure in skeletal muscle. 
(Shen et al., 2007) 
O
bs
cu
ri
n Depletions in zebrafish cause profound disruption to the t-tubules as well as many other 
structural and functional features of both skeletal and cardiomyocytes. 
(Raeker et al., 2006) 
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Among the biochemical factors, amphyphysin 2 (BIN1) has a fundamental role in t-
tubule formation (Lee et al., 2002). When ectopically expressed in non-muscle cells, 
it results in tubular formation, and is concentrated at the sites of developing 
membrane striations in muscle (Lee et al., 2002). It is also essential for the trafficking 
of LTCC to the t-tubule membrane, along microtubules (Hong et al., 2010). Total 
knockdown of BIN1 is lethal in perinatal life, with a DCM phenotype. Hong et al 
showed that BIN1 expression is reduced in the failing human heart and that while 
total protein expression of LTCC is unchanged, in failing cardiomyocytes LTCCs are 
not concentrated at the t-tubule (Hong et al., 2012, Hong et al., 2010). Lentiviral 
knockdown and replenishment of BIN1 are able to modulate the surface expression of 
LTCCs, with a major impact on the whole cell ICa,L. Thus, reduced BIN1 expression 
in the failing heart could result in a failure to direct LTCC to the membrane. The 
major consequence of detubulation in diseased cardiomyocytes is a loss or uncoupling 
of LTCCs, and changes to BIN1 expression may play a role in mediating changes to 
both gross t-tubule structure and correct protein localisation. 
 
Junctophillin-2 (JPH2) has been suggested to have an important role in promoting 
junction formation between the sarcoplasmic membrane and the t-tubule (Takeshima 
et al., 2000). It has recently been reported to be downregulated proportionally during 
the progression from hypertrophy to HF (Wei et al., 2010). This may partly mediate 
the uncoupling observed between the t-tubule and SR in cardiac muscle during 
pathological remodelling. JPH2 has emerged as a candidate molecule because of work 
that shows it is a membrane-linking protein and is reduced in expression in HF (Wei 
et al., 2010). JPH2 germline knock-out (KO) results in perinatal death with a HF 
phenotype (Ito et al., 2001). This initially hindered understanding its mode of action. 
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Van Oort and colleagues show that loss of JPH2 in the adult mouse hearts leads to 
DCM without gross remodelling (van Oort et al., 2011), with pronounced early 
mortality. Surviving mice have cardiomyocytes with reduced CICR gain due to 
reduced colocalisation of LTCC and RyR without changes in amount of protein 
expression. They also document dyadic remodelling and increased SR Ca2+ leak. The 
authors also show that these defects are not present when JPH2 over-expressing 
animals are crossed with conditional short-hairpin RNA animals (which reduce JHP2 
expression), demonstrating that the effects are specifically associated with loss of 
JPH2, rather than an unknown secondary effect. Thus JPH2 has a role in mediating 
pathological remodelling at the level of local CICR. 
 
Telethonin (Tcap) was identified as a part of the stretch-sensitive complex in 
myocardium in previous studies (Hayashi et al., 2004). The effect of Tcap mutations 
on t-tubule structure in cardiac muscle is unknown; disruption of Tcap in zebrafish 
produces a form of muscular dystrophy, suggesting that it is important in force 
production (Zhang et al., 2009). Lack of Tcap is associated with disrupted t-tubule 
development and abnormal muscle function. Tcap expression is increased by stretch 
and appears to correlate with the level of t-tubule development, suggesting the novel 
possibility that Tcap promotes t-tubule formation in response to increased stretch. 
Tcap mutations can cause DCM or hypertrophic cardiomyopathy (HOCM) which 
could be related to the differential response of the myocardium to stretch (Hayashi et 
al., 2004). In a small group of patients with DCM or HOCM, Hayashi et al found that 
DCM-associated Tcap mutations impaired the interaction of Tcap with its partners in 
the stretch-signalling complex, whereas HOCM-associated mutations promoted the 
interaction of these molecules (Hayashi et al., 2004). They suggest that these different 
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Tcap mutations were consistent with an impaired stretch-response in DCM patients, 
and a hyper-reactive stretch response in HOCM patients, possibly affecting the 
clinical manifestation of the cardiomyopathy. The findings from zebrafish discussed 
above raise the possibility of a role for Tcap in t-tubule structural disruption in the 
mechanisms of this subset of rare cardiomyopathies, but this remains to be tested. 
Importantly, Tcap binds minK (K+ channels which reside in the t-tubule) (Furukawa 
et al., 2001). This provides a possible link between the stretch-sensing complex of the 
cardiomyocyte and the t-tubule membrane. Recent work using a Tcap KO shows that 
under basal conditions, there is no spontaneous cardiac dysfunction, but when 
subjected to mechanical overload, cardiac failure develops rapidly (Knoll et al., 
2011). In this setting, there is marked apoptosis and fibrosis. Tcap expression was 
recently found to be depressed in HF and enhanced following SERCA2a gene 
therapy, which recovered the t-tubule network and many elements of myocardial 
structure and function (Lyon et al., 2012). 
 
 
1.7.3 T-Tubule Dysregulation In Heart Failure 
1.7.3.1 Animal Models 
The presence of t-tubular changes in HF has been demonstrated in both human studies 
and animal models (e.g. (He et al., 2001, Benitah et al., 2002, Louch et al., 2004, 
Louch et al., 2006, Balijepalli et al., 2003). In animal models, HF is associated with t-
tubule disarray which appears to be caused by a number of myocardial insults 
including sustained tachycardia (Benitah et al., 2002), chronic mechanical overload 
(Wei et al., 2010) and myocardial infarction (Heinzel et al., 2008). T-tubule changes 
appear to occur early in the transition from hypertrophy to HF (Wei et al., 2010), 
suggesting they could be driving the pathogenic mechanism. T-tubule density loss 
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appears to be the major mechanism in larger species, with loss of t-tubule regularity in 
smaller species. 
 
Work using a pig post-ischaemic cardiomyopathy model suggests that t-tubule 
dysfunction is causally related to the contractile dysfunction of the failing heart 
(Heinzel et al., 2008). The impaired contractility of the failing heart was associated 
with a reduced Ca2+ release synchronicity, a delayed Ca2+ release and a smaller Ca2+ 
transient. The authors of this study documented a significant reduction in t-tubule 
density, while the ICa,L and SR Ca2+ content were not deleteriously affected. They 
therefore suggest that the flaw is in the gain of the CICR process, which implicates 
the structural dysregulation of the t-tubules in the pathophysiology of the failing 
cardiomyocyte. Failing rat cardiomyocytes have an increased Ca2+ spark frequency, 
which is consistent with an uncoupling of the Ca2+ release machinery mediated by 
structural disruption to the t-tubules. The mechanisms mediating this increased Ca2+ 
spark frequency are likely to be multifaceted, including changes to the regulation of 
the RyR. Further work suggests that the level of detubulation correlates with the 
degree of HF, and regions of delayed Ca2+ release are spatially localised to regions of 
disrupted t-tubular structure (Heinzel et al., 2008). Structural uncoupling of the Ca2+ 
release machinery may be a final common pathway in HF, as it appears to be a 
mechanism common to diabetic cardiomyopathy (Stolen et al., 2009), hypertensive 
cardiomyopathy (Song et al., 2006) and ischaemic HF (Louch et al., 2006). 
 
The possible causal role of t-tubule dysregulation in the impaired contractility of HF 
is supported by evidence from experiments where the t-tubules are artificially 
disrupted (discussed in detail below). Artificial detubulation (Brette et al., 2002) 
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mimics some of the changes in Ca2+ handling observed in HF, with a reduced Ca2+ 
transient synchronicity leading to a slow Ca2+ transient, associated with diminished 
but prolonged contraction (Brette et al., 2004a, Brette et al., 2004b). Isoproterenol 
activation can improve the Ca2+ transient dynamics and amplitude of detubulated cells 
(Brette et al., 2004a). In these circumstances, wave-like propagation of the Ca2+ 
transient from the sarcolemma to the interior is observed. In culture, Louch et al 
showed that Ca2+ transient propagation is initially triggered at t-tubules and 
propagates to detubulated regions (Louch et al., 2004). Litwin et al first showed that 
failing cardiomyocytes had dysynchronous Ca2+ release (Litwin et al., 2000), and this 
was shown to be related to detubulation (Louch et al., 2006).  Double staining with 
Ca2+-sensitive and membrane-binding dyes shows that areas of dysynchronous Ca2+ 
release correspond to gaps in the t-tubule network (Louch et al., 2006). Such 
dysynchronous Ca2+ transients results in overall broadening and slowing of the Ca2+ 
transient. 
 
The notion of reduced CICR gain (i.e. less SR Ca2+ release for the same ICa,L) during 
detubulation was first shown by Gomez et al  and later shown to be related to 
detubulation (Gomez et al., 1997). Detubulation leads to orphaned RyRs, 
unstimulated by ICa,L (Song et al., 2006). Other changes may also be important 
including LTCC activity or number, RyR number, organisation or functional status. 
Prolongation of the AP in failing cells reduces the driving force for Ca2+ entry, which 
can reduce ICa,L (Mork et al., 2009). Switching the AP stimulus morphology from 
normal to failing results in loss of Ca2+ transient synchrony. Such Ca2+ transient 
dysynchrony is different to the dysynchrony found after detubulation because it is 
highly variable beat to beat, whereas that found after detubulation is consistent over 
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multiple beats (Harris et al., 2005). 
 
In failing cells which show t-tubule loss, the upstroke of the Ca2+ transients shows a 
pronounced lag after the upstroke of the AP, and this may correspond to expansion of 
the dyadic cleft (Louch et al., 2006).  Importantly, such changes may be obtained by 
relatively minor changes to the t-tubules, which could expand the dyadic cleft 
sufficiently to slow LTCC-RyR signalling. Xu et al showed that the response of RyR 
to the opening of a single LTCC is delayed, which is consistent with dyadic expansion 
(Xu et al., 2007). 
 
Most investigators report unchanged ICa,L density in HF (Bers, 2006a), due to a 
combination of reduced LTCC number but increased activity (Schroder et al., 1998). 
The mechanisms mediating this could include phosphorylation of LTCC by PKA or 
Ca2+/calmodulin-dependent protein kinases II (CAMKII) (Chen et al., 2002). Brette et 
al 2004 showed that detubulation with formamide (discussed later) reduced ICa,L 
(Brette et al., 2004b). Whether LTCC redistribute and the precise mechanisms of their 
regulation in the failing heart is not yet known. 
 
There is also substantial evidence that RyR function is altered in HF. In isolated 
bilayer experiments, Marx et al showed that RyR had greater activity and suggested 
that such increased activity could deplete the SR (Marx et al., 2000). Marx suggested 
that hyperphoshorylation of RyR by PKA causes dissociation of the regulatory 
element FKBP12.6 (FK506 binding protein) and this enhances RyR activity, 
destabilising it and causing uncoupling of neighbouring RyR. This could lead to 
increased diastolic activity and also to loss of synchrony. Other groups have been 
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unable to demonstrate FKBP12.6 dissociation from RyR (Xiao et al., 2005). RyR 
activation may arise from phosphorylation by CaMKII (Ai et al., 2005) or other 
changes to RyR regulatory proteins (Kubalova et al., 2005). Increased SR leak, apart 
from reducing SR content and therefore blunting contractility, may also be pro-
arrhythmic because NCX-mediated extrusion can trigger extra APs (Bers, 2006a).  
The issue of the nature, conditions, mechanisms and implications of RyR 
phosphorylation are contentious and unresolved (Bers, 2012). RyR phosphorylation-
mediated Ca2+ leak is a feature of the failing heart, and  may be more important than 
PKA in modulating RyR open probability. 
 
Whether these RyR changes are due to generic changes in the cell including general 
shifts in phosphorylation patterns or localised changes to the dyad, or are more 
specific is uncertain. Meethal et al showed that increased Ca2+ spark frequency 
occurred at gaps in the t-tubules where diastolic Ca2+ levels were higher (Meethal et 
al., 2007). This suggests that orphaned RyR show increased activity than coupled 
dyads, possibly pointing to a direct effect of detubulation on local RyR activity. 
 
The degree of t-tubules loss that can be tolerated without functional changes is not 
clear. APs may access a similar portion of the cell via an axial or transverse t-tubule, 
possibly providing a safety mechanism. Normally, APs of the surface and t-tubule 
network are identical (Bu et al., 2009). This tight electrical coupling appears to fail 
when the t-tubules are disrupted in HF, as AP propagation does not access the t-
tubules and spontaneous electrical activity takes hold (Sacconi et al., 2012). Other 
compensatory mechanisms may initially mitigate the loss of t-tubules, including an 
increased SR Ca2+ content. 
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SERCA2a depletion is commonly reported in HF (reviewed in (Louch et al., 2010c)). 
Recent studies of SERCA2a gene therapy in a rodent model of HF show that the t-
tubule membrane and many elements of local CICR recover after gene therapy (Lyon 
et al., 2012). In addition, a study using SERCA2a gene KO animals shows that the t-
tubule network grows in response to impaired SR Ca2+ release, with the appearance of 
longitudinal t-tubules which allow NCX-mediated SR Ca2+ release to partially 
compensate for impaired SR Ca2+ release (Swift et al., 2012). 
 
1.7.3.2 Artificial Detubulation 
While the detubulation following myocardial insults has provided a great deal of 
information on t-tubule biology, the interpretation of such studies is complicated by 
the sophisticated response to myocardial stressors, which impinges upon multiple 
aspects of cardiovascular biology. Artificial detubulation allows a more direct 
examination of the effects of t-tubule loss alone, enabling an examination of their 
physiological functions. Artificial detubulation is achieved using the detubulating 
agent, formamide, which results in osmotic shock, sealing off the t-tubule 
compartment and disrupting t-tubule structure within the cell. 
 
Detubulation reduces cell capacitance by 30% and ICa,L by approximately 80% 
(Kawai et al., 1999). There is more ICa,L concentrated in the t-tubule than data from 
immunocytochemistry experiments would predict, suggesting that the channels in the 
t-tubule are more active as well as more numerous than those in the surface 
sarcolemma (Brette and Orchard, 2003). Detubulation reduces transmembrane Ca2+ 
entry by 60% (Brette et al., 2006). The percentage reduction in transmembrane Ca2+ 
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entry corresponds to the percentage of NCX localised in the t-tubule (Despa et al., 
2003). Other currents, such as the Na+ and K+ currents, are equally distributed across 
the surface and t-tubule membrane fractions (Komukai et al., 2002, Yang et al., 2002). 
 
Interestingly, inactivation of ICa,L is slower in detubulated cells, although not in the 
presence of Ryanodine (i.e. when SR Ca2+ release is diminished) (Brette et al., 2005). 
This suggests that SR Ca2+ release inactivates ICa,L in the t-tubules more than ICa,L 
in the surface sarcolemma (Brette et al., 2004a, Brette et al., 2004b, Brette et al., 
2006).  As noted by Orchard, this has a number of implications (Orchard and Brette, 
2008). First, that the t-tubules contain a large and rapidly inactivating ICa,L, ideal for 
acting as a Ca2+ release trigger. Second, that the more slowly inactivating ICa,L 
arising from the surface sarcolemma may function as an SR Ca2+ loading mechanism 
(Brette et al., 2005). The differential inactivation of ICa,L in the surface sarcolemma 
and the t-tubules adds weight to the notion of the t-tubule as a specialised site for Ca2+ 
release. 
 
Detubulation studies also shed light on the regulation of Ca2+ sparks. Detubulated 
cells show Ca2+ sparks mainly within 2µm of the cell edge (Brette et al., 2005). This 
does not appear to be due to ICa,L, as inhibition of ICa,L does not affect Ca2+ spark 
frequency in control or detubulated cardiomyocytes (Brette et al., 2005). It has been 
suggested that detubulation makes the t-tubules less organised and disrupts dyads 
associated with t-tubules, which reduces Ca2+ sparks. These results imply that the 
structural integrity of the dyad influences SR Ca2+ release. The effect of dyadic 
disruption on Ca2+ sparks is addressed in the subsequent Chapters. 
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1.7.3.3 Human Studies 
Loss of and disruptions to the regularity of t-tubules occur in human cardiac cells 
from patients with HF, irrespective of the aetiology (Lyon et al., 2009). 
Cardiomyocytes from patients with HOCM, DCM and ischaemic HF all show 
profound t-tubule damage, with a reduction in the t-tubule density and parameters of 
cell surface regularity (Figure I-9). This mirrors the findings of t-tubule disruption in 
animal models of HF from an ischaemic, hypertensive or tachycardic phenotype 
described above and suggests that t-tubule disruption is a common pathway in HF. 
Failing human cardiomyocytes have t-tubules that run more on the longitudinal axis 
and are often dilated and bifurcated rather than aligned normally along the radial axis 
of the cardiomyocyte (Cannell et al., 2006). Recent work has described the detailed 
structural remodelling of the t-tubules that occurs in human HF (Crossman et al., 
2011). 
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FIGURE I-9: HEART FAILURE, REGARDLESS OF THE AETIOLOGY, DISRUPTS THE T-
TUBULE NETWORK 
Scanning Ion Conductance Microscope images from the surface of cardiomyocytes isolated from 
nonfailing (A) and failing (B) human hearts. The black dotted line represents a linear trace presented as 
a 1-dimensional surface contour map from nonfailing (C) and failing (E) human cardiomyocytes. 
Confocal images after staining with Di-8-ANNEPPS in nonfailing (D) and failing cardiomyocytes (F). 
T-tubule (G) and z-groove (H) ratios in cardiomyocytes isolated from patients with DCM, HF 
secondary to Ischaemic Heart Disease (IHD), or HOCM and non-failing, NF. (I) (from left) Prolonged 
time to peak and decline times (R50 and R90) in human failing cardiomyocytes (solid bars, n = 12) 
compared with nonfailing human cardiomyocytes (open bars, n = 6). **, P < 0.01 vs. nonfailing. From 
(Lyon et al., 2009). 
 
1.7.4 T-Tubule Dysregulation In Atrial Fibrillation 
Although atrial cells lack the complex t-tubule structure of ventricular cells, some 
reports suggest that there is a functional uncoupling of the LTCC and RyR leading to 
asynchronous, chaotic Ca2+ release, which may be implicated in the poor contractility 
and arrhythmia of experimental models of AF (Bootman et al., 2006). In larger 
animals, a more extensive t-tubule network has been reported with evidence that the t-
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tubules of atrial cells are disrupted in models of HF (Dibb et al., 2009). The loss of 
the network of t-tubules in atrial versus ventricular cardiomyocytes appears to have 
different effects on Ca2+ handling (Smyrnias et al., 2010). Detubulation of atrial 
cardiomyocytes appears to have significantly less effect on cellular Ca2+ handling than 
in ventricular cells. Nevertheless, in atrial cells where t-tubules are present, they have 
a major impact on the Ca2+ transient morphology. Whether t-tubular changes play a 
major role in the pathological remodelling of atrial cardiomyocytes, given their 
paucity under physiological conditions, is a major question for future work. 
1.7.5 Non LTCC-RyR Proteins 
NCX expression and activity is increased in HF. Activity of NCX is enhanced by AP 
prolongation and increased [Na+]i  (Bers et al., 2006).  Greater NCX-mediated Ca2+ 
influx could stimulate Ca2+ release in HF, in the setting of reduced ICa,L. For this to 
be a major effect, NCX would need to be close to RyR. Importantly, Fowler shows 
that when cells were devoid of t-tubules, increased [Na+]i did not enhance the SR Ca2+ 
load (Fowler et al., 2004). This could be due to loss of concentrated NCX zones in the 
t-tubule. 
 
Reduced Na+-K+-ATPase appear to be important in increasing intracellular Ca2+ 
(Swift et al., 2008, Louch et al., 2010b). The α-2 isoform is localised to the t-tubules, 
which when disrupted could impair NCX and Na+-K+-ATPase cross-talk, resulting in 
increased local [Ca2+]i (Swift et al., 2008). Other factors thought to contribute to 
elevated cytosolic [Ca2+] in HF include enhanced late Na+ current and higher activity 
of the Na+-H+ exchanger (Valdivia et al., 2005). T-type Ca2+ channels are normally 
expressed at low levels, and some studies have shown increased density in 
hypertrophy and HF, with a Ca2+ influx reaching one third of the ICa,L (Jaleel et al., 
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2008). The role of these channels in disease is poorly understood, but they are 
unlikely to be localised at the t-tubule. The Plasma Membrane Ca2+ ATPase (PMCA) 
was thought to possibly compensate for reduced NCX expression in HF but recent 
studies suggest that PMCA is reduced in HF (Mackiewicz et al., 2009).  Inositol 
trisphosphate receptors are upregulated in HF at the junctional SR and have been 
shown to augment SR Ca2+ release (Zima and Blatter, 2004). Their interaction with 
NCX, the t-tubule and other dyadic proteins is an important topic for future studies. 
 
The t-tubule is thus a highly concentrated zone of electrophysiological activity and 
changes in all of the elements described could contribute to the changes observed 
during cardiomyocyte remodelling after alterations in mechanical loading. The t-
tubule creates a “neighbourbood” of local, compartmentalised Ca2+ signalling. 
 
1.7.6 Reversibility of T-tubule Dysregulation 
A recent report by Stolen et al using an animal model of diabetic cardiomyopathy 
demonstrated disrupted t-tubular structure in cardiomyocytes and that interval training 
can induce improvements to the t-tubule network, contractility and CICR (Stolen et 
al., 2009). This is an important first report of changes to the t-tubule network that are 
associated with improved function. Little is known of the exact biophysical regulators 
of the t-tubule system and this is a missing gap in the knowledge required to attempt 
reversal of t-tubule dysfunction. A second report recently documented the effect of 
pulmonary hypertension in inducing progressive t-tubular dysfunction in the heart, 
using recordings taken at the whole heart level (Xie et al., 2012). Pulmonary 
hypertension results in increased afterload of the right heart, and t-tubule dysfunction 
appears to be an early change in the cellular remodelling process. Interestingly, the 
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use of sildenafil (a phosphodiesterase-5 inhibitor), a drug which acts to reduce 
pulmonary hypertension, induces reversal of t-tubule dysfunction (Xie et al., 2012). 
This indicates that modulation of mechanical overload can regulate t-tubule structure, 
and that normalisation of mechanical overload is able to induce recovery of the t-
tubule system. The administration of β-adrenergic blockade shortly after myocardial 
infarction in rats largely prevented t-tubule disruption many weeks later (Chen et al., 
2012). Importantly, the investigators observed maintenance of JPH2 expression, 
possibly providing a mechanism for preserved t-tubule structure. The biophysical 
effects of β-blockade could be numerous, including effects on blood pressure (and 
therefore loading of the ventricles), adrenergic stimulation (driving remodelling), and 
heart rate. Because of the widespread use of β-blockade clinically, this study would 
merit further investigation. 
 
SERCA2a gene therapy has been associated with reversal of remodelling of the t-
tubule network as discussed earlier (Lyon et al., 2012). One of the emerging therapies 
for clinical HF is cardiac resynchronisation therapy (CRT), thought to act by 
promoting synchronous contraction. This has a number of effects, including 
improving cardiac output and reducing wall stress, and could be said to induce 
mechanical unloading. A recent study shows that CRT can induce reversal of t-tubule 
structure and Ca2+ handling (Sachse et al., 2012). 
 
All these studies show that the t-tubule network is a highly plastic system, which is 
regulated by cross-talk between multiple elements of local CICR as well as in 
response to altered haemodynamic conditions. 
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1.8 Hypothesis 
The evidence presented above suggests that the t-tubule system is a labile network, 
sensitive to alterations in a number of biophysical properties, including mechanical 
load (Figure I-10). Alterations in the t-tubule network have a major impact on Ca2+ 
handling. In addition, the growing role of LVAD therapy makes the dissection of the 
mechanisms mediating the myocardial response to mechanical unloading a priority. 
Whether the functional benefit of mechanical unloading is mediated by reversal of 
damage to the t-tubule network is untested. 
 
This thesis addresses the hypothesis that mechanical load affects t-tubule structure 
and function in a graded and reversible manner via specific molecular mechanisms. 
In particular, the following specific hypotheses were tested. 
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FIGURE I-10: T-TUBULE STRUCTURE IS SENSITIVE TO MECHANICAL LOAD 
VARIATION 
Chronic mechanical overload results in t-tubule loss and irregularities, which uncouple the LTCC and 
RyR, which are normally tightly coupled. Mechanical unloading could also induce changes to t-tubule 
structure. If so, this raises the possibility that normalisation of mechanical load could normalise the t-
tubule structure. 
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1. The t-tubule network of LV cardiomyocytes is altered by prolonged mechanical 
unloading, with consequences for CICR. This hypothesis was tested using a model of 
prolonged mechanical unloading using heterotopic abdominal heart transplantation 
(HAHT) in rats. Cells were isolated and studied for cellular and t-tubule structure, and 
local CICR (Chapter 4). 
 
2. Mechanical unloading of chronically overloaded hearts can restore t-tubule 
structure with important consequences for local CICR. This hypothesis was tested 
using a model of mechanical unloading using HAHT following chronic coronary 
artery ligation (CAL). Cells were isolated and studied for cellular and t-tubule 
structure, and local CICR in the setting of control, failing and failing hearts following 
HAHT (Chapter 5). 
 
3. The t-tubule network and local CICR is sensitive to graded variations in the degree 
and duration of mechanical load. This hypothesis was tested using a model of 
moderate mechanical unloading using heterotopic abdominal heart-lung 
transplantation (HAHLT) or following a model of mechanical overload, thoracic 
aortic constriction (TAC). Results from HAHT were compared to HAHLT. Cells 
were isolated and studied for cellular and t-tubule structure, and local CICR in the 
setting of control, HAHT, HAHLT and TAC at different time points (Chapter 6). 
 
4. The molecular mechanisms governing t-tubule structure are not understood. In 
particular, the molecules that mediate the load-sensitivity of the t-tubules are not 
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known. Tcap is a member of the stretch-sensitive complex of the cardiomyocyte, 
binds the t-tubule membrane and its expression is load-sensitive and correlates with 
the appearance of the t-tubule network, and it was therefore hypothesised that Tcap is 
a regulator of t-tubule structure, which is especially important during mechanical 
overload. This was tested using cardiomyocytes from a mouse KO model of Tcap, 
under spontaneous conditions and following chronic mechanical overload (Chapter 7). 
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Chapter 2 
General Methods 
 
This thesis involves the use of rat and mouse models of human disease and models of 
clinical interventions. Single cells were isolated from the whole heart at defined time 
periods following surgery. An array of single cell electrophysiological techniques was 
used to assess local CICR and t-tubule structure. All solutions are described in detail 
at the end of this Chapter. 
 
2.1 Animal Models 
Four animal models were used throughout the course of this project. One was 
performed by Mr Manoraj Navaratnarajah (HAHT) and three were performed by 
myself (HAHLT, CAL, and TAC (mouse TAC surgery in Chapter 7 was performed 
by Dr Mutsuo Harada)). All animals were supplied by Harlan Laboratories, 
Blackthorn, UK. 
 
2.1.1 Species 
A number of previous studies showed that mechanical unloading in rats produced 
measurable effects at the level of Ca2+ handling after four weeks (Soppa et al., 
2008b). The use of a syngeneic strain (inbred Lewis rats) allows transplantation 
without the need for immunosuppression (Forbes and Guttmann, 1984).  The isolation 
of cardiomyocytes is reproducible and provides living cardiomyocytes, which can be 
assessed in terms of local CICR (Siedlecka et al., 2008). Rat cardiomyocyte 
electrophysiology is somewhat different to human electrophysiology (Bers, 2001). 
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Examples of such differences include different t-tubule density, AP morphology, 
complement of ion channels, and heart rate (Bers, 2001). KO mice (described below) 
were used to assess the role of Tcap. 
 
2.1.2 Surgical Procedures 
Pre-operative preparation of the animals was similar irrespective of the operation to 
be performed. All operations were performed under licence by the UK Home Office 
and according to their guidelines for the ethical and humane treatment of animals. The 
use of animal models is of great use in furthering our understanding of disease, for the 
advancement of human and animal health. However, it is right to acknowledge that it 
raises significant ethical questions, and is contentious. All animals were treated with 
respect, with the aim of minimising suffering and discomfort. 
 
Animals were kept in normal rodent cages in groups of up to five and had free access 
to food and water.  Animals were sedated with 5% Isoflurane in an anaesthetic 
chamber and then weighed and shaved, leaving a generous border surrounding the 
incision area. The animals were then returned to the anaesthetic chamber for further 
light sedation. 1.5% Isoflurane was used throughout the surgical procedures to enable 
humane surgery but maintain adequate tissue perfusion and enable rapid post-
operative recovery. The animals were then placed supine on the operating table and 
were breathing spontaneously, under Isoflurane delivered by a nose cone, when the 
chest was not to be opened. If a thoracotomy was to be performed, an endotracheal 
tube was used and the animal mechanically ventilated. The endotracheal tube was a 
modified 20-gauge adult peripheral venous cannula (NHS Supply Chain, UK). Using 
a standard paediatric laryngoscope, the larynx was visualised from the mouth, and the 
tongue displaced upwards using forceps. A light was used to visualise the opening of 
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the vocal chords, and the modified endotracheal tube was placed, as described 
previously for mice (Tarnavski et al., 2004). Prior to ventilation, correct placement 
was confirmed by checking for exhaled condensation through the cannula, using a 
scalpel blade. Ventilation was provided by a Model 683 Rodent Ventilator (Harvard 
Apparatus Ltd, UK), attached to a standard gas anaesthetic rig with medical oxygen 
and Isoflurane (National Veterinary Services, UK). Mechanical ventilation was set to 
85 breaths per minute with a tidal volume of 1.5ml. All animals received 10-15mg/kg 
amoxycillin trihydrate (Clamoxyl LA®, Pfizer, USA) as antibiotic prophylaxis and 
10-20µg/kg buprenorphine hydrochloride (Vetergesic®, Reckitt & Colman, UK) for 
pain prevention. An iodine-containing solution (10% Povidone-iodine, NHS Supply 
Chain, UK) was applied to the skin. To maintain hydration, a bolus dose of 3ml warm 
saline was given subcutaneously, at the start of the operation. 
 
All techniques were performed solo using sterile technique. Operations were 
performed under 3.5X magnifying loupes (Designs for Vision, London, UK). 
 
2.1.3 Permanent Coronary Artery Ligation (CAL) 
Permanent occlusion of the left anterior descending artery produces a model of acute 
myocardial infarction and can progress to chronic HF. This model has a number of 
important anatomical, physiologic and clinical considerations. 
 
2.1.3.1 Anatomical Considerations 
Coronary artery anatomy is highly variable in humans and rats. Bloor et al analysed 
4500 rat coronary trees and found large variations which are consistent with 
polygenetic and environmental determination (Bloor et al., 1967). The basic coronary 
anatomy of the rat is as follows: a left coronary originates from the left sinus of 
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Valsalva and passes to the anterior surface of the LV. Before descending toward the 
apex of the heart, it branches to supply the lateral border of the LV. The point at 
which it branches is variable as indicated by the variable pattern of blanching 
observed during coronary artery occlusion. This is the single biggest practical 
consideration when attempting CAL, as the presence of a variable branch point also 
means that a different amount of the LV will be affected after CAL. Another 
important consideration concerns the presence and quality of an anastomosis between 
the posterior descending artery and the left anterior descending artery at the apex of 
the heart. In the presence of a widely patent apical anastomosis, ligation of the 
anterior descending artery results in infarction of less myocardium, as there is more 
overlap in vessel supply territory. These factors increase the heterogeneity of the 
animal model. Therefore, echocardiography to select failing hearts is mandatory. 
 
2.1.3.2 Physiological Considerations 
CAL leads to the rapid death of the dependent myocardium due to ischaemia. The 
subsequent necrosis sets in motion a cascade of pathological sequelae including 
inflammation and ultimately leads to the replacement of cardiomyocytes with scar 
tissue. Since cardiac preload and afterload are not chronically reduced, the remaining 
myocardium must increase its work to maintain the CO. Adaptive mechanisms 
promote a hypertrophy in the remaining cardiomyocytes, which initially results in 
maintained CO. Chronic overloading of this healthy myocardium depletes the 
adaptive reserve and results in pathological remodelling and HF (Anversa et al., 
1986). 
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2.1.3.3 Clinical Considerations 
CAL is typically described as being a model of ischaemic cardiomyopathy. In 
principle, it is similar to clinical ischaemic cardiomyopathy in that a coronary 
insufficiency leads to death of the dependent myocardium. However, it has a number 
of important differences. First, the natural history of coronary artery disease is gradual 
and involves the whole coronary tree to a greater or lesser degree. This results in some 
damage to the total extent of the myocardium and not an isolated region. Second, after 
clinical myocardial infarction, the remaining myocardium which must compensate for 
the loss of cell number is diseased. Therefore, the sudden, isolated loss of 
myocardium obtained by coronary ligation is different to clinical myocardial 
infarction in important respects. CAL models may be said to achieve volume and 
pressure overload of healthy surviving myocardium, due to an ischaemic trigger. 
 
2.1.3.4 Operative Technique. 
After anesthesia and intubation, draping and preparing the skin, a left lateral 
thoracotomy was started by incising the skin overlying the left 4th intercostal space 
using a number 22 scalpel (NHS Supply Chain, UK). Blunt dissection of Pectoralis 
major allowed its retraction from the operative field using a stay suture or retracting 
clip. Latissimus dorsi was dissected from the chest wall and retracted away from the 
operative field. The intercostal space to be targeted was confirmed and a needle was 
introduced into the thoracic cavity and a cut extended with a number 22 or number 11 
blade along the intercostal space away from the sternum. The cut must not extend too 
medially, otherwise the internal thoracic artery can be torn which results in potentially 
life-threatening bleeding. Needle holders were used to widen the thoracotomy further 
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and the incision was held open using a rodent thoracotomy retractor (World Precision 
Instruments, UK). 
 
The heart was now visible inside the pericardium, which may be divided using 
forceps to expose the anterior surface of the LV. In order to access the proximal 
portion of the left anterior descending artery, a small swab was placed over the left 
atrium, which was thus retracted laterally. Once the outline of the left coronary artery 
was visible, a 6-0 Prolene suture was placed around it at the level of the lower border 
of the left atrium and permanently tied. Adequate bite size was needed to ensure that 
the suture does not tear the myocardium while tying down. Blanching to the level of 
the apex was seen, which was usually blue or white in colour and associated with 
akinesia of the anterior LV wall. If no blanching was observed a second suture, taking 
a wider bite of the myocardium was taken. The suture was cut and the chest was 
closed with a single wide 4-0 Prolene mattress suture. The lung was re-expanded by 
increasing end-expiratory pressure by clamping the expiration line of the ventilator. 
The muscles were replaced and a saline-iodine wash of the chest was performed prior 
to closing the skin. The skin was closed with straight running suture using 2-0 or 3-0 
silk. The animal was ventilated until it roused and then extubated. The animals were 
allowed to recover in a quiet, well-oxygenated and warm environment. Close 
observation is required to ensure smooth post-operative recovery. Monitoring 
thereafter consists of weekly weighing, clinical examination (respiratory rate, absence 
of piloerection, examination of the scar) and echocardiography. 
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2.1.4 Permanent TAC 
Placing a band to induce a stenosis of the ascending aorta produces myocardial 
pressure overload, by increasing cardiac afterload. Greater LV pressures are needed to 
drive blood past the stenosis, therefore increasing wall stress and myocardial 
workload. This technique has a number of anatomical, physiological and clinical 
considerations. 
 
2.1.4.1 Anatomical Considerations 
This technique provides much more consistent anatomical targets than coronary 
ligation, but involves a much riskier operative pathway.  This technique has two 
major variants, depending on whether the band was placed distal to, or proximal to the 
brachiocephalic artery. Placing the band distal to the brachiocephalic artery provides 
normal brain perfusion but less afterload increase. Placing the band proximal to the 
brachiocephalic artery produces severe overload but likely induces some cerebral 
hypoperfusion. This was the approach used here because of the marked increase in 
afterload. 
 
2.1.4.2 Physiological considerations 
In order to generate consistent cardiac remodelling, two factors must be kept constant: 
the size of the stenosis and the size of the aorta. In this way, the relative reduction in 
aortic diameter will be constant. In order to produce a fixed size of the aorta, a needle 
of 0.9mm external diameter was used. In order to attempt to use animals of constant 
aortic diameter, animals of weights of 200-300g only were used. 
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2.1.4.3 Clinical Considerations 
TAC is often compared to clinical aortic stenosis, but there are a number of important 
differences. The cardinal difference is that clinical aortic stenosis (at the level of the 
aortic valve) involves reduced coronary perfusion, mediating part of the dysfunction, 
as flow is reduced prior to the pulse wave passing the coronary ostia. Therefore, TAC 
provides a model of chronically raised afterload alone without ischemia. 
2.1.4.4 Operative Technique 
In rats, an approach via the right thoracotomy was found to provide better exposure of 
the ascending aorta. Preparation and access was as for CAL, except on the right. Once 
the chest was opened, the thymus lobes were divided to provide a view of the 
ascending aorta. The superior vena cava (SVC) and surrounding structures were 
bluntly dissected from the ascending aorta. Curved forceps were passed under the 
aorta, followed by a 3-0 silk tie. The tie was constricted around the needle overlying 
the aorta. Further ties were rapidly laid down, and the needle removed. End-
expiratory pressure was increased to reinflate the lungs and reduce any pulmonary 
oedema, by increasing alveolar pressure. The chest and skin were closed routinely. 
 
For the Tcap experiments, in mice, a similar approach was taken except that the 
second rib was partially excised and the loop was placed between the brachiocephalic 
and left subclavian arteries. The loop was tied around a 26 gauge needle using 7-0 
Prolene. Otherwise, all elements of the procedure were identical. 
 
2.1.5 Heterotopic Abdominal Heart Transplantation For Severe Mechanical 
Unloading. 
This operation was first described by Ono and Lindsey (Ono and Lindsey, 1969). This 
operation achieves virtually complete unloading of a transplanted donor heart by 
anastomosis of the donor aorta to the recipient aorta, and anastomosis of the donor 
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pulmonary artery to the recipient inferior vena cava (IVC) (Figure M-1). Blood flows 
from the recipient aorta into the aortic root of the donor, and as the donor aortic valve 
is competent, perfuses the coronaries without entering the LV. Coronary flow is 
returned to the right atrium (RA) through the venous coronary circulation and the 
coronary sinus. This blood is ejected by the right ventricle (RV) through the 
Pulmonary artery (PA) and into the venous circulation of the recipient via the IVC. 
This produces a donor LV that is virtually completely mechanically unloaded. Under 
the conditions of mechanical unloading in the LV, Thebesian veins in the LV wall 
itself open and allow a small amount of blood to directly enter the LV cavity. This 
blood is occasionally ejected through the aortic valve. This subset of operations were 
performed by Mr Manoraj Navaratnarajah, whereas I performed all the heart-lung 
transplantations (later). This model has a number of anatomical, physiologic and 
clinical considerations. 
 
 
FIGURE M-1: HETEROTOPIC ABDOMINAL HEART (LEFT) AND HEART-LUNG 
TRANSPLANTATION (RIGHT) 
These two models of provide for severe (HAHT) (left) or moderate (HAHLT) (right) mechanical 
unloading. Arrows within structures show direction of blood flow. 
 
!
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2.1.5.1 Anatomical Considerations 
Matching of the donor and graft aortic vessels’ size is imperative for proper 
anastomotic technique. The most critical component of this operation is to avoid 
kinking of the aorta and inferior vena cava (IVC). 
 
2.1.5.2 Physiological Considerations 
This operation achieves preload reduction by reducing the amount of blood flow into 
the LV. The LV occasionally fills with Thebesian blood flow which is ejected, and 
thus the LV does not experience constant afterload reduction. In performing the 
operation, the most important physiologic consideration is to avoid myocardial 
damage by achieving rapid technique and adequate cardioprotection. 
 
2.1.5.3 Clinical Considerations 
The unloading achieved by this operation is different to that achieved by LVADs in 
several important respects. LVADs act on an intra-thoracic and innervated heart, 
whereas the heterotopically transplanted heart is deinnervated and subjected to intra-
abdominal, not intrathoracic pressures. LVADs enhance coronary blood flow whereas 
heterotopic abdominal transplantation does not impact greatly on coronary blood 
flow. 
 
2.1.5.4 Recipient Preparation 
To minimise the ischaemic time of the donor heart, the recipient animal was prepared 
first. Animals were shaved from penis to xiphisternum and iodine was applied to the 
shaved skin. Animals were placed supine and limbs and tail taped down onto a 
warming blanket. Anaesthesia (1.5% Isoflurane) was administered via nose cone. 
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1. A midline laparotomy from xiphisternum to above the pubic vein was made. 
An abdominal retractor was placed. 
2. Using cotton wool buttons, the bowel was carefully retracted from the 
abdomen, and wrapped in wet gauze. 
3. Using cotton wool buttons, the retroperitoneal fascia was dissected, to reveal 
the great vessels (aorta and IVC) for a length of approximately 4cm. Using 
non-toothed Debakey forceps (World Precision Instruments, USA), the vessels 
were lifted and bluntly dissected free from surrounding structures. Any lumbar 
branches were ligated using fine sutures such as 4-0 Mersilk sutures (World 
Precision Instruments, USA). 
4. Bulldog microclamps were applied to the top and bottom of these vessels, 
leaving as much space between clamps as possible. A small hole in the aorta 
(using 30 gauge needle) was made in the middle of the longitudinal section of 
clamped aorta. 
5. The IVC was perforated. 
6. Using straight microscissors with blades of 5mm length (World Precision 
Instruments, USA) the needle holes were extended to leave an aortotomy and 
venotomy, both of which were approximately 4mm in length and were in the 
midline of the vessels. 
7. The bowel was returned to the abdomen, and wet again with saline. The level 
of Isoflurane anaesthesia was reduced to around 1% and the heating mat was 
switched off (thereby reducing the likelihood of spinal cord ischaemia) whilst 
moving onto the donor harvesting operation. 
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2.1.5.5 Harvesting The Donor Heart. 
1. An incision was extended from the jugular notch to the level of the pubic 
vein. The abdominal muscles were divided, and the great vessels were 
exposed as before. Similarly the heart was exposed in the thorax by cutting 
the sternum. A long silk suture was tied around both the abdominal aorta 
and IVC, which can be used to lift them with ease. 
2. 4000 units of heparin (LEO Labs LTD, Bucks, UK) was injected into the 
IVC via a 30-gauge needle and allowed to circulate for 1 minute. 
Clamping the great vessels ensures the abdominal aorta was distended, 
facilitating subsequent aortotomy. Then a transverse cut was made over 
the anterior surface of the abdominal aorta, sufficient to introduce a 25mm 
radial artery cannula and guide wire. The cannula was advanced to the 
level of the aortic root. The heart was arrested by administration of at least 
50ml of cold cardioplegic solution (St Thomas II) slowly through the 
abdominal aortic cannula, avoiding LV distension. 
3. Blunt dissection of the IVC, left and right SVC was performed. Exposure 
of the left SVC can be challenging, as it lies beyond the azygous vein and 
just beyond the LA. Special care must be taken here to avoid the PA and 
LA. Once all cavae were exposed they were permanently ligated using 4-0 
Mersilk (World Precision Instruments, USA). 
4. The aorta was transected, just before the brachiocephalic trunk, in one cut. 
The same applies for the PA, which was divided just below the bifurcation. 
5. Dissection in the aorta-PA window with cleaning of fat and fibrous tissue 
was helpful at this stage and aids later implantation. 
6. The pulmonary veins were then tied off en masse and the heart removed. 
7. The heart was kept in ice cold saline until ready for reimplantation. 
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2.1.5.6 Heterotopic Transplantation Of The Donor Heart 
1. The recipient vessels should not be over-cleaned, as a little fascia can be used 
to support the suture line and reduce the risk of bleeding. For the anastomosis, 
the cut ends of the donor vessels should be similar in size to the recipient 
aortotomy and venotomy. If the donor vessels were very small, a diagonal 
incision of the donor vessels was made to enlarge the relative circumference. 
If the donor vessels were excessively large, then an incision on the recipient 
vessels would be extended. Alternatively, the relative proportion of donor: 
recipient vessel circumference taken with each bite was increased, thereby 
adjusting for the discrepancy. 
2. The donor heart was positioned on the left side of the abdomen, correctly 
oriented such that the RA and RV appeared anteriorly. Correct orientation was 
crucial in order to avoid aorta and PA kinking following anastomosis. 
3. 8-0 Prolene with a 5mm round-bodied needle (Ethicon, Johnson and Johnson 
UK) was used throughout. One Prolene suture was placed at the heel and one 
at the toe of the anastomosis. A continuous suture line was made all the way to 
the opposite anchor suture and eventually tied to the short end of the opposite 
anchor suture, taking care not to purse-string the anastomosis. The easiest 
method was to suture one half of the anastomosis and then ‘flip’ the heart to 
the opposite side (i.e. from the left side of the abdomen to the right) and then 
complete the other half of the anastomosis. The ideal aortic anastomosis in rats 
of this size results in an everted intima-intima edge of approximately 0.5mm. 
Bite size should be approximately 1.5mm. 
4. Before commencing the PA-IVC anastomosis, the heart was covered in a fresh 
cold swab. The PA should be clearly visible, and the anastomosis was then 
completed as before. 
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5. Once the anastomosis was complete, it was examined for any gaps, which can 
be obliterated using a single interrupted suture. The gauze covering the heart 
was removed. First, the distal clamp was removed and the anastomoses were 
examined for any bleeding (bright red indicating arterial and dark purple 
indicating venous bleeding). 
6. The top clamp was then removed and the heart should ideally commence 
beating within 5 seconds. 
The abdomen was closed using continuous 5-0 Vicryl (NHS Supply Chain, UK) and 
the animal allowed to recover alone as for other surgical procedures. 
 
 
2.1.6 Heterotopic Abdominal Heart-Lung Transplantation For Moderate 
Mechanical Unloading  
When the lungs are left connected to the heart via the pulmonary circulation (PA and 
pulmonary veins remain connected), the LV receives blood from the pulmonary veins. 
This produces a LV which is moderately loaded with the small volume of coronary 
sinus blood returning to the left heart via the pulmonary circulation. The two models 
of heterotopic heart transplantation are shown in Figure M-1. 
 
This operation involves a single aorto-aortic anastomosis in an end-to-side fashion as 
described for the HAHT procedure. The lungs remain connected to the donor heart by 
the pulmonary artery and pulmonary veins, but do not require ventilation as they 
merely act as a vascular conduit to get the coronary sinus blood from right heart to the 
LV. It does not require operation on the IVC and PA, which are relatively fragile 
structures. However, it does require the careful handling of the pulmonary circulation 
and lungs which are prone to bleeding. In addition, it is preferable to tie off the 
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airways to avoid the collection of fluid which may lead to an inflammatory response. 
The heart-lung block should be wrapped in wet gauze during the operation. 
 
2.1.6.1 Recipient Preparation 
This is in principle the same as for the total unloading operation. Important 
differences are: 
1. No IVC incision was performed. 
2. The IVC and aorta were separated from one another by blunt dissection for 
greater access to the aorta and to reduce the risk of injuring the IVC during 
suturing of the aorta. This also allowed the vascular clamps to be placed only 
on the aorta. 
 
2.1.6.2 Harvesting The Heart-Lung Block 
Steps 1-3 were identical to the steps required to harvest the heart alone (dissect 
vessels; give Heparin through IVC; give cardioplegia through abdominal aorta). 
Dissection of the left SVC should be performed carefully to avoid damage to the PA. 
Once the heart was free from the cavae, the aorta was cut. The PA and pulmonary 
veins were left connected to the block. 
1. The trachea was cut as high as possible and pulled on whilst sharply dissecting 
behind the trachea. This frees the heart-lung block, leaving only the 
oesophagus connecting it to the animal, which should be cut. 
2. With the block on ice, any thymic tissue or fat was cleaned from the block. 
3. Because the right heart will pump against pulmonary vascular resistance, 
meticulous protection was mandatory. 
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2.1.6.3 Reimplantation Of The Heart-Lung Block. 
1. For the aortic anastomosis, and with the lungs and heart wrapped in gauze 
with ice, two anchor sutures were placed at the heel and toe of the 
anastomosis. The anastomosis was completed as described for the total 
unloading procedure. 
2. The lungs should rapidly become pink, and the heart should beat. Rarely, it 
was necessary to give short-term cardiac massage, especially to the right heart. 
3. The abdomen was closed in layers as before. 
 
2.1.7 Transplantation Of The Failing Heart 
Apart from the use of these models to understand the consequences of mechanical 
unloading on the normal heart, they have also been used to understand the effect of 
mechanical unloading on the failing heart. There are a number of considerations when 
attempting this operation. 
 
Adhesions may complicate the harvesting of the failing donor heart, following chronic 
CAL. This necessitates careful dissection which avoids trauma to the atria and the 
aorta. Adhesions may also make the aortic edge less defined, which can compromise 
the quality of the anastomosis. Elevated right heart pressures can lead to dilation of 
the pulmonary artery, which should be taken into account during the PA-IVC 
anastomosis. 
The failing heart is hypertrophic and requires a greater degree of cardioprotection. 
This may be achieved by addition of more cardioplegia during the harvesting 
operation, in conjunction with greater care in keeping the heart cool. 
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2.1.8 Echocardiographic Assessment 
 
To assess the advent of myocardial hypertrophy and subsequent HF, transthoracic 
echocardiography was used. The animal was anaesthetised as before and maintained 
on 1.5% Isoflurane. The chest hair was clipped and warm ultrasound transmission gel 
was applied to the skin surface gel (Sonogel®, AnaWiz Ltd, UK). An ACUSON 
SequoiaTM C256 (Siemens Medical Solutions, USA) echocardiography machine with 
a 14MHz phased-array transducer (15L8-S, Siemens Medical Solutions, USA) was 
used. 
 
Two modes of operation were used: two-dimensional mode and motion (M)-mode 
(Figure M-2). Scanning in the two-dimensional mode allows visualisation of the LV 
cavity and walls. It is imperative that a similar segment of the ventricle is selected for 
assessment to ensure fair comparison. To do this, a level just above the papillary 
muscles was selected. Using the draw mode, a line was placed at the border of the LV 
cavity in diastole and again in systole. This allows comparison for the calculation of 
ventricular volumes and EFs. 
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FIGURE M-2: TWO DIMENSIONAL (LEFT) AND M-MODE (RIGHT) 
ECHOCARDIOGRAPHY 
Left, two dimensional echo involves tracing the LV cavity in diastole (shown) and then in systole (not 
shown). Right, M-mode involves tracing the anterior LV wall, LV cavity and posterior LV wall in 
systole and diastole. This allows calculation of the values related to the structure and function of the 
LV. The longer line represents the LV cavity in diastole and the shorter line represents the LV cavity in 
systole. PM – Papillary muscles. 
 
M-mode echocardiography consists of scanning a line across the ventricles, which 
was tracked in time (Figure M-2). Animals undergoing CAL and TAC underwent 
echocardiography before harvesting. Echocardiography of the transplanted heart was 
technically prohibitive and the values obtained do not provide an accurate assessment 
of LV function, as the values are load-dependent. 
 
The plane of view used should be consistent because the wall dynamics differ 
significantly at different myocardial levels following myocardial infarction (Rottman 
et al., 2007). A two-dimensional short axis view just above the papillary level was 
selected to assess LV function and confirm presence of scar in the anterior wall for 
experiments involving CAL. Images were acquired at end-diastole and end-systole 
from a cine-loop and EF was calculated. M-mode images of the same level were 
!
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acquired for measuring LV wall thickness (LV posterior wall in systole (LVPWs) and 
diastole (LVPWd)), LV chamber diameter (in diastole (LVd), systole (LVs)), and LV 
function. EF was the percentage of the end-diastolic volume of blood which was 
ejected (in this case, by the LV) at end systole. The formulae which derive these 
measurements (based on M-mode echocardiography) are as below3. 
 
LV End Diastolic Volume (LVEDV) = (7.0/(2.4+LV d)) X LVd3 
LV End Systolic Volume (LVESV) = (7.0/(2.4+LV s)) X LVs3 
LV EF = ((LVEDV-LVESV)/LVEDV) X 100 
LV % Fractional Shortening (FS%) = ((LV d−LVs)/ LVd) X 100 
 
2.1.9 Knock-out Telethonin Mouse Model 
Telethonin-deficient animals were generated by replacing the coding regions of exon 
1 and 2 by a lacz-neomycin cassette to monitor endogenous gene expression using 
homologous recombination. These animals were generated by the group of Professor 
Ralph Knoll, at Imperial College London. Genotyping was performed in that 
institution (Knoll et al., 2011). 
 
2.1.10 Controls 
For transplanted normal hearts, the recipient’s own heart was used as a control. For 
CAL and TAC, Sham-operated sex and age-matched hearts were used. For KO 
animals, non-littermate age, sex and strain-matched animals were used. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!3!Echo Made Easy. Sam Kaddoura. Churchill Livingstone, Second Edition, 2009.!!
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The protocol for sham surgery was identical to TAC/CAL except for the criitical step 
of tying the suture down (whether around the left coronary artery) or the ascending 
aorta. 
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2.1.11 Harvesting The Operated Heart 
Whichever model was used, the heart must be carefully removed. This involves repeat 
anaesthesia, shaving of the animal and surgical access to the thorax or abdomen. 
Careful dissection of adhesions allows a clean cut of the aorta. This facilitates aortic 
cannulation for enzymatic digestion for the isolation of single cardiomyocytes. When 
the heart was removed, it was placed in a warm normal tyrode (NT) solution 
containing 1000 units of heparin per ml, to avoid clot formation. Subsequently, the 
heart was transferred to ice cold NT (again containing heparin) to arrest the heart. 
 
2.2 Isolation Of Single Living Cardiomyocytes 
Living single cardiomyocytes were isolated by enzymatic digestion after perfusing the 
heart with enzymes using a Langendorff setup. This involves the use of Collagenase 
(type 2), an enzyme which breaks down collagen - the major constituent of the 
extracellular matrix. In addition, Hyaluronidase was also used which degrades 
hyaluronate, another major constituent of the extracellular matrix. In these studies, 
cardiomyocyte isolation was carried out using a modification of standard enzymatic 
digestion protocols described previously (Tytgat, 1994). The aorta was cannulated 
using a 16-gauge cannula and fixed securely with one or two ligatures. The heart was 
retrogradely perfused with NT solution at 37°C, bubbled with 100% oxygen. 
Perfusion was achieved using a pump (MasterFlex® L/STM Economy Drive, Cole-
Parmer® Instrument Company Ltd., UK) and flow rate gradually increased until the 
vessels were cleared of blood and the heart was contracting well. The heart was then 
arrested by perfusion with low Ca2+ solution for 5 minutes. The hearts were then 
perfused with Buffer A, containing Type-2 collagenase (1mg/ml, Worthington 
Biochemical Corporation, USA; Product code: CLS2, 292 units/mg), and 
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hyaluronidase (0.6mg/ml, Sigma®, Sigma Aldrich Company Ltd, UK; Product code: 
H-3506, 451units/mg) for 8 minutes. Hearts were then taken off the Langendorff 
system and the atria and right ventricle were removed. 
 
For non-CAL hearts, the entire LV was used. For CAL-hearts, the scar was excised 
with a border zone and viable LV was cut into cubes, approximately 2mm3. These 
cubes were resuspended in fresh Collagenase and Hyaluronidase solution and agitated 
for five minutes in the presence of 100% oxygen in a waterbath at 37°. The digested 
tissue was gently agitated to give a single cell suspension, which was filtered through 
a nylon mesh with an average pore size of 300µm. The residue was then resuspended 
in Buffer A with fresh Collagenase and Hyaluronidase for another five minutes. The 
cell suspension was centrifuged at 500 rotations per minute (rpm) for one minute 
(Sorvall® LegendRT, Kendro Laboratory Products, Germany), and the supernatant 
was discarded and cell pellet resuspended in Buffer A without any enzymes and re-
centrifuged at 500 rpm for one minute. The supernatant was discarded again and cell 
pellet resuspended in Buffer A without enzymes, stored at room temperature and all 
cellular experiments were performed within six hours of cell isolation. This method 
provided reliable isolation of rod-shaped cardiomyocytes. 
 
For mice isolations, a smaller 24-guage cannula was used. In addition, Proteinase 
enzyme (2.7mg in 20ml Buffer A) was added to enhance enzymatic digestion at the 
Langendorff enzyme-perfusion stage for one minute prior to 
Collagenase/Hyaluronidase digestion. Collagenase/Hyaluronidase digestion lasted 
five minutes. 
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A photograph of the cell isolation setup used is shown in Figure M-3. 
 
 
 
 
 
 
FIGURE M-3: CELL ISOLATION SETUP 
The waterbath contains solutions with three lines going to each solution. An output line to the 
Langendorff setup, an input line to receive the solutions recycling in the Langendorff and an 
oxygenation line. The input/output lines are controlled by the pump. Each solution goes to its own 
bubble trap to ensure that any air bubbles do not perfuse the heart, which could cause air embolus in 
the coronaries. The heart is attached (not shown) to a cannula within the water jacket, which maintains 
physiological temperature. 
 
! 107!
2.3 Confocal Microscopy and Fluorescence 
Confocal microscopy and fluorescence form a central part of this thesis and deserve 
explanation. Fluorescence is the property of emitting a different wavelength of light 
than that at which the sample was excited. By using dyes that target specific 
molecules or structures, it is possible to detect these specific emitted fluorescence 
signals and therefore identify those structures. 
 
Confocal microscopy was invented by Minsky in 19554. He proposed a method to 
image samples on a pixel by pixel basis. The confocal microscope involves several 
key components to achieve this. First, a series of lenses focus light onto a focal point. 
To promote the collection of this light, a screen with a pinhole is added, which allows 
only light at the desired focal point through. The pinhole is conjugate to the focal 
point of the lens, providing a “confocal pinhole”. Other important components are the 
dichroic mirrors, which reflect light below a specific wavelength. The benefit of being 
able to select the light detected in this way has a drawback, in that the light which is 
let through is of low intensity. The solution is to use a laser which has sufficient 
intensity to enable detection of highly selected light. The point which is imaged is 
dictated by internal mirrors which are motorised. In this way, laser confocal 
microscopy enables point illumination and rejection of out of focus light. 
 
The Laser Scanning Microscope (LSM 510) Zeiss Axiovert inverted confocal 
microscope was used for all experiments. Cardiomyocytes were observed through a 
Zeiss EC Plan-NeoFluarTM ×40 oil-immersion objective (numerical aperture = 1.3). 
The pinhole was set to 1 Airy unit in all experiments. One Airy unit generally gives 
the best signal to noise ratio. Data was collected in 12-bit mode, with unidirectional !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!4!US Patent Number 3,013,467 in 1961!
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scanning for Di-8-ANEPPS protocols and bidirectional scanning mode for Fluo-4 
experiments to reduce the scan time. The gain and offset of the channel were kept as 
constant as possible: detector gain was set between 700-800 in all experiments, 
amplifier offset was set to 0.04, and amplifier gain was 1. Excitation was using a 
488nm Argon Laser set at 5% transmission. Emission was collected though a 505nm 
long-pass filter. 
 
2.3.1 Imaging Of The T-Tubule Network 
The t-tubules were assessed in the following ways: 
-Using Di-8-ANEPPS and confocal microscopy: during these experiments, the cell 
was imaged throughout its depth to enable three-dimensional reconstruction for the 
assessment of the density of the t-tubule network and also to calculate the cell 
volume. One plane of the cell was selected for high resolution scanning, which 
allowed assessment of the regularity of the t-tubule network. 
 
-EM: cells were fixed and embedded to allow sectioning to image the t-tubules. 
 
-Scanning Ion Conductance Microscopy: performed on single cardiomyocytes to 
provide an image of the surface of the cell membrane. 
 
2.3.2 Di-8-ANEPPS 
Di-8-ANEPPS (di-8-aminonaphthylethenylpyridinium) (Molecular Probes, 
Invitrogen, Oregon, USA) is a fluorescent, voltage-sensitive membrane binding dye. 
Di-8-ANEPPS is a zwitterionic molecule and therefore is less susceptible to 
internalization than Di-4-ANEPPS, permitting extended observation of the cell 
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membrane. The excitation maxima is 465nm and the emission maxima is 635nm. Di-
8-ANEPPS is non-fluorescent until bound to membranes. 
 
The cell membrane was stained with Di-8-ANEPPS using the following protocol. A 
cell suspension was loaded with 10µM Di-8-ANEPPS (solved in DMSO, dimethyl 
sulfoxide, Sigma-Aldrich, UK) and left for ten minutes. The supernatant was removed 
from the cell pellet and fresh Buffer A was added to wash the cells. A few drops of 
cells were added to a glass-bottom 35mm Petri dish coated with Laminin (5µl of 1 
mg/ml Laminin solution (Sigma-Aldrich, UK)) and left to attach for five minutes. 
 
Cells were selected in an orderly fashion, starting from the centre of the dish and 
working outward in a circular fashion. Any cell, irrespective of size or appearance 
was imaged, unless it met any of the following rules: 
-touches another cell 
-was not rod-shaped 
-was contracting 
-was not stuck flat 
 
The microscope was then switched to laser scanning mode, and a digital crop along 
the longitudinal axis of the cell was made. The focal plane of the cell was manipulated 
in 1µm steps until a plane was found which did not show nuclei. An initial scanning 
stack was used to define the top and bottom of the cell. Then, another scan was taken, 
where each optical slice was recorded four times and averaged to enhance the signal 
to noise ratio. After this, a single high resolution image through a chosen plane, 
averaged 16 times, was recorded. 
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Offline analysis of the t-tubule density and cell volume was performed simultaneously 
in ImageJ (using a custom-written macro (provided by Dr Mark Stagg) (U.S. National 
Institutes of Health; http://rsb.info.nih.gov/ij/)) and previously described (Stagg et al., 
2008). The steps of this macro are: 
-Conversion to 8-bit images 
-Autothresholding of the images to generate binary images. This employs serial 
divisions of the “top” and “bottom” ends of the range of foreground and background 
pixel intensities. 
-Calculation of the average percentage area of staining at every optical slice. These 
values were further divided into ten regions along the length of the cell (z1-z10). z1 
and z10 were not included as these regions show dense staining, related to the cell 
edge. 
-The mean of these values excluding the cell edge was taken as the average Di-8-
ANEPPS staining, a marker of the t-tubule density. 
 
Using a second macro, the whole intracellular space of every optical slice was stained 
and used to generate a three-dimensional reconstruction, where all optical slice 
volumes were added to provide a total cell volume. 
 
Assessment of the t-tubule regularity was performed using a custom-written macro in 
Matlab. Initially, images were prepared in ImageJ. This involved rotation of the image 
to ensure the t-tubules were aligned in the vertical direction. Using the autothreshold 
function of ImageJ, a binary image was created. A central portion of the cell 
membrane was selected, always of fixed dimensions (140 pixels in length and 25 
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pixels wide) to allow comparison between cells and cell groups of differing sizes. A 
plot profile was then generated from this binary image and exported to Matlab, where 
a standard Fourier transform was performed. This plotted the underlying frequencies 
in the image and provided a power-frequency curve. The dominant peak always 
occured at the t-tubule frequency, because the images were dominated by the regular 
t-tubules. The power of that peak, at approximately 0.5 cycles per micron (therefore 
occurring every 2 microns, approximately the length of a sarcomere) provided a t-
tubule regularity index. This methodology was adapted from published reports (Swift 
et al., 2008). 
 
2.3.3 Electron Microscopy 
Isolated cardiomyocytes were attached to coverslips using a Shandon Cytospin 2 ® 
centrifuge (Wolflabs, York, UK). This allows all the cells to align longitudinally 
along the coverslip, preventing random orientation during fixation. Coverslips were 
washed twice in 0.1M phosphate buffer, post-fixed in 1% osmium tetroxide for one 
hour and processed for transmission electron microscopy (TEM) using 2.5% 
glutaraldehyde in 0.1M phosphate buffer for 24 hours at 40°C. Ultra-thin sections 
were post-stained using 2% aqueous uranyl acetate and lead citrate for ten minutes in 
each solution and viewed with a JEOL 1200 EX microscope (Herts, UK). Digital 
micrographs were taken using Gatan digital micrograph software (Gatan, Pleasanton, 
USA) at 30000X magnification and analysed by measuring the maximum t-tubule 
diameter of transverse t-tubules (along the long-axis) and the number of t-tubules per 
optical section. 
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2.3.4 Scanning Ion Conductance Microscopy (SICM) 
SICM uses a micropipette which scans close to the cell surface to provide a non-
optical, no-contact method of imaging the cell surface. As the pipette approaches the 
cell surface, the resistance of the pipette increases, and current falls. This is measured 
through an amplifier, and a corresponding voltage is applied to prevent collision with 
the cell surface. Hopping mode was used to enable the imaging of vertical 
topographical structures (Novak et al., 2009). This means that after each approach to 
the cell surface, the micropipette returns to a preset point away from the cell surface, 
at which point a reference current is measured, and then the micropipette descends 
toward the cell surface until the current falls by 0.5 % of the reference current. The z-
position at which this 0.5 % reduction in reference current is achieved is recorded, and 
thus the changes in current produce a trace outline of the cell surface. As the 
micropipette navigates the entire cell surface, an image was constructed (Figure M-4). 
In all SICM experiments, micropipettes and the bath solution contained the same 
physiological L-15 medium (Life Technologies, Inc., Parsley, UK), so that salt 
concentration gradient potentials and liquid junction potentials were not generated. To 
quantify the data obtained during scanning, an index of the completeness of the z-
grooves on the surface of cardiomyocytes (z-groove index, Figure M-4) was used 
(Gorelik et al., 2006). The z-groove describes the domes and troughs of the surface of 
cardiomyocytes, and t-tubule openings are known to sit in these z-grooves. To 
calculate the z-groove index, the maximum extent of z-grooves observed on single 
SICM images was measured and divided by the total estimated z-groove length, as if 
they extended across the whole surface. 
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FIGURE M-4: SCANNING ION CONDUCTANCE MICROSCOPY 
(A) The cells were attached to a coverslip; a micropipette in hopping mode scans the surface by 
returning to a preset level and approaching the cell again. The current through the pipette falls as it 
approaches the cell surface. A corresponding voltage is applied to keep the pipette from touching the 
cell surface. (B) A single z-groove index is calculated by dividing the measured length of an observed 
z-groove (solid line) by the predicted length of a z-groove spanning the entire surface (dashed line).  
 
 
2.3.5 Assessment of Ca2+ Handling 
Ca2+ handling was assessed using the following techniques: 
Fluo-4 assessment of Ca2+ transients: single stimulated cells loaded with Fluo-4 were 
imaged in line scanning mode and the change in fluorescence recorded using confocal 
microscopy. 
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Fluo-4 assessment of Ca2+ sparks: single non-stimulated cells loaded with Fluo-4 
were imaged in line scanning mode and the change in fluorescence recorded using 
confocal microscopy. 
 
Whole Cell Patch Clamping: used to measure the whole cell ICa,L. Current-voltage 
relationship, activation and inactivation properties and cell capacitance can be 
recorded during these experiments. These experiments were performed by Dr Urszula 
Siedlecka. 
 
Measurement of SR Ca2+ content: Single cells labelled with the Ca2+-sensitive 
fluorescent dye, Indo-1 were rapidly superfused with caffeine and the peak of the 
fluorescence rise was taken as a measure of SR Ca2+ content. 
 
2.3.6 Fluo-4 assessment of the Ca2+ transient 
 
Fluo-4-acetoxymethyl ester (AM) (Molecular Probes, Invitrogen, Oregon, USA) is a 
non-fluorescent molecule which easily crosses the membrane and then undergoes de-
esterification to form the membrane-impermeable fluorescent dye Fluo-4. Fluo-4 
fluorescence is Ca2+-dependent and rapid allowing visualisation of the millisecond 
scale of the Ca2+ transient. Single cells were loaded with 10µM Fluo-4-AM (dissolved 
in DMSO) for 20 minutes and then washed with Buffer A. 30 minutes were allowed 
for de-esterification. 
 
Cells were plated as for Di-8-ANEPPS. During Fluo-4 experiments, the cells were 
perfused with NT containing 1mM Ca2+. The perfusion system consisted of NT 
perfusing the dish under gravity, and a suction system to remove excess solution. A 
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custom-made plastic insert was used to support the platinum wires used to stimulate 
single cells. These wires were connected to a standard bipolar stimulus generator. All 
experiments used 1V stimulus at 1Hz. The bath was kept at 37° C. 
 
The same confocal settings as for Di-8-ANEPPS were used except that during the 
Fluo-4 experiments, bidirectional scanning was used to increase the scan speed, and 
line scanning mode was used. This involves drawing a line across the longitudinal 
axis of the cell. This line was scanned continually for the duration of the scan. The 
scan therefore captures changes in time along a specific location in the cell (Figure M-
5). The changes in fluorescence provide a measure of the change in Ca2+ fluxes and 
can be analysed to provide information regarding properties of the Ca2+ transients. 
The 100 pixel horizontal bar on all experimental traces corresponds to 22 µm. 
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FIGURE M-5: LINE SCANNING CONFOCAL MICROSCOPY OF FLUO-4 LABELLED 
CARDIOMYOCYTES 
A line is drawn across the length of a rod-shaped cardiomyocyte. When stimulated, this line shows the 
Ca2+ transient. When unstimulated, Ca2+ sparks are observed. 
 
 
The analysis of the Ca2+ transients was performed according to the following 
protocol. Images were cropped to remove the cell border component of line scans. 
Custom-written Matlab Protocols (written by Dr Mark Stagg) were used to calculate 
the time to peak (from the stimulus to the peak fluorescence at each pixel), time to 
50% and 90% decline (from the peak fluorescence) and the peak change in 
fluorescence (amplitude). The calculation of the time to peak on a pixel-by-pixel basis 
allows the calculation of the variance of the time to peak. This can be inherently 
Quiescent Stimulated 
!!!!!!!!!!!!!!!!!!!!Time!!! 
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noisy, due to changes in time of a single pixel (e.g. see two-dimensional traces on 
pages 150 and 168). However, the overall effect of this noise is limited as the number 
of transients analysed becomes larger. For this reason, as many transients as possible 
were analysed.  
 
The input information required for this (and Ca2+ spark) analysis was: 
-The spacing sample, which is the ratio between a pixel and a micrometer. 
-For sparks, the detection criterium is set to 3.8 times the background value. 
-The scan time, which provides the total time required to scan one line. 
 
2.3.7 Fluo-4 Assessment Of Ca2+ Sparks 
The term Ca2+ spark originates from Cheng et al, who visualised focal Ca2+ release 
events in rat cardiomyocytes (Cheng et al., 1993). Ca2+ sparks are elementary Ca2+ 
release events that are restricted in space and time. They raise the local [Ca2+] to a 
peak of approximately 200nM, have a time to peak of approximately 10ms, and 
decline with a decay time constant (τ) of approximately 25ms (Cheng and Lederer, 
2008). 
 
The same cells (and therefore loading conditions) used for Ca2+ transients were 
employed for measurements of Ca2+ sparks. After a period of steady-state 1Hz field-
stimulation, a period of 30s quiescence was allowed before line scans were collected. 
Up to 15000 lines ranging from 500 to 963µs were scanned. Acquired x-t scans were 
exported as high-resolution tagged image file format (TIFF) digital files. 
 
Similar to the analysis of the Ca2+ transients, analysis of the collected TIFF image 
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files was performed offline using custom scripts written by Dr. Mark Stagg. These 
were used in Matlab® R2006b (MathWorks Inc. MA, USA) following the algorithm 
for automatic Ca2+ spark detection described by Cheng et al (Cheng et al., 1999). As 
for the Ca2+ transient analysis, detection criteria for Ca2+ sparks were set at 3.8 times 
the standard deviation above the mean background (Fo). The frequency of Ca2+ sparks 
was also obtained. During the Matlab macro protocol, images are generated of line 
scans with sparks labelled for identification. This allows visual assessment in case 
sparks have been double-counted or if a region of abnormally high Fluo-4 is causing 
artificial sparks. The amplitude of Ca2+ sparks is defined as the peak fluorescence 
over the background fluorescence (F/Fo). Ca2+ sparks were also analysed for their x 
and y dimensions, providing the full-width at half-maximal (FWHM) and full-
duration at half-maximal (FDHM) parameters. The output was a Microsoft Excel file. 
 
2.3.8 Measurement Of The SR Ca2+ Content 
Measurement of the SR Ca2+ content involved the use of the IonOptix system and 
loading cardiomyocytes with Indo-1-AM. Indo-1 shows maximum absorption at 
approximately 360nm. Indo-1’s maximum emission in zero Ca2+ is 495nm and goes 
toward 405nm when Indo-1 binds with Ca2+. Thus, as the [Ca2+] increases, emission 
at 405nm rises, but emission at 495nm falls. In this way, the ratio of the emission at 
405nm with that at 495nm provides a measure of [Ca2+]i (Poenie and Tsien, 1986). 
This ratiometric property makes Indo-1 a good tool for measuring SR Ca2+ content. In 
addition, it makes the measurements less sensitive to unequal loading or 
photobleaching. Indo-1 is highly selective for Ca2+ but has a low Ca2+ affinity, which 
limits its capacity to buffer Ca2+ (Grynkiewicz et al., 1985). One limitation of Indo-1 
is that its fluorescence is influenced by caffeine (O'Neill et al., 1990). 
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Fresh cardiomyocytes were loaded with 10µM Indo-1-AM (Molecular Probes, 
Invitrogen, Oregon, USA) for 20 minutes, and washed with Buffer A and allowed to 
deesterify for 30 minutes. Cells were then loaded onto a bath and imaged using an 
Olympus IX-71TM inverted microscope. Approximately 5µl of 1 mg/ml laminin 
(Sigma-Aldrich, UK) was used to promote cell sticking to the microscope dish. The 
cells were superfused with NT solution at 37°C and stimulated at 1Hz as for Fluo-4 
recordings. For each cell, pre-recording corrections for background fluorescence were 
made. Continuous recordings were used to obtain steady-state fluorescent traces. The 
stimulator was then switched off and the following perfusion protocol was 
simultaneously activated: 0 Na+/0 Ca2+ was applied for 100ms, then 0 Na+/0 Ca2+ with 
20mM caffeine for 1s, followed by NT with 20mM caffeine for 5s. This perfusion 
protocol was described in (Soppa et al., 2008a). 
 
The data was analysed in IonOptix Ion Wizard 5.0. The peak fluorescence ratio 
obtained following caffeine application was taken as a measure of SR Ca2+ content. 
 
2.4 Whole Cell Patch Clamping For Recording ICa,L 
These experiments were performed by Dr Urszula Siedlecka. ICa,L was measured 
using a MultiClamp 700A (Axon Instruments, Union City, CA, USA) in whole-cell 
patch configuration. The bath of cells was viewed using a Nikon Diaphot 200 inverted 
microscope, on a vibration-isolation table (Technical Manufacturing Corporation, 
Peabody, USA). A Faraday cage was used to minimise electrical interference 
(Technical Manufacturing Corporation). Micropipettes were made using borosilicate 
glass tubes of 0.86mm inner diameter (Harvard Apparatus, UK) in a microprocessor- 
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controlled Flaming/Brown pipette-puller (Model P97, Sutter Instruments, CA, USA). 
The pipette was manoeuvred using a Burleigh PCS-5000TM piezoelectric 
micromanipulator (EXFO Lifesciences, Ontario, Canada), aiming to place the tip of 
the pipette close to the cell membrane. The potential difference between the electrode 
and the ground (pipette offset) was then calibrated to zero. The pipette resistance and 
pipette capacitance were compensated. Suction was then applied to form a Gigaseal. 
Following this, the patch was ruptured to obtained the whole-cell configuration of the 
patch clamping technique (Sakmann and Neher, 1984). 
 
Whole cell patch clamping involves the use of a relatively large pipette, which was 
connected to the intracellular space. Because the pipette was relatively large, its 
contents may dialyse the cell over time, changing its electrophysiological properties. 
The pipette resistance was ~2–3MΩ, and the pipette-filling solution contained (in  
mM) 115 Cesium aspartate, 20 Tetraethylammonium chloride, 10 1,2-Di(2-
aminoethoxy)ethane-NNN’N’-tetra-acetic acid (EGTA), 10 HEPES, and 5 MgATP, 
pH 7.2. The external solution contained the following (in mM): 140 NaCl, 10 
Glucose, 10 HEPES, 1 CaCl2, 1 MgCl2, and 6 CsCl, pH 7.4. Current-voltage 
relationships for ICa,L were built using 450 ms depolarisation steps from a holding 
potential of ~40mV (range +40 to -40mV, in 5mV increments) at 1Hz. Then 200µM 
Cd2+ was applied and the protocol was repeated. Subtracted currents obtained were 
normalised to cell capacitance. All experiments were conducted at 37°C. 
 
2.5 Immunofluorescence To Examine Colocalisation Between DHPR 
And RyR 
In order to measure changes to the colocalisation pattern of DHPR and RyRs, 
immunolabelling of these two channels was performed in fixed single 
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cardiomyocytes. This involved the use of primary antibodies from different species, 
targeting DHPR and RyR specifically. Two secondary antibodies, each tagged with a 
different fluorescent probe, against the two primary antibody species were then used 
to label the protein distribution. The staining protocol involved pre-plating coverslips 
with laminin  (20µl of 1mg/ml laminin solution (Sigma-Aldrich, UK)) for one hour. 
1ml of cell suspension was then added and allowed to stick for two hours. It was 
important that the coverslips were kept in a humidifying chamber (a box covered with 
aluminum foil and with wet filter paper lining the bottom surface) during this process 
to avoid drying of the cell suspension. Cardiomyocytes were then fixed with 1ml cold 
acetone (4°, for 10 minutes), which was washed off three times with Buffer A (each 
wash lasting 1 minute). Cardiomyocytes were then permeabilised using 1ml of 1% 
Triton and a blocking solution of 1% Bovine serum albumin and 1% Goat serum (for 
10 minutes). Blocking solution was then left on the cells for a further one hour. Cells 
were then incubated with mouse anti-DHPR α-1 antibodies for one hour at room 
temperature (Abcam, Cambridge, UK) and after washing, were incubated with goat 
anti-mouse secondary antibodies conjugated with Alexa Fluor 488 for one hour at 
room temperature (Molecular Probes, Invitrogen, Oregon, USA). Cells were then 
incubated with rabbit anti-RyR for one hour (Santa Cruz Biotechnology Inc., Santa 
Cruz, Ca) and after washing were incubated with goat anti-rabbit antibody conjugated 
with Alexa Fluor 594 for a further hour (Molecular Probes, Oregon, USA). Between 
each antibody stage, coverslips were washed using Buffer A for 45 minutes in three 
cycles of 15 minutes each. The whole cell was imaged at high resolution using single 
direction scanning and 16 frame averaging. For Alexa 488, excitation was at 488 nm, 
with the laser at 5% transmission and emission was collected through a 500-550 nm 
band-pass filter (peak emission at 519nm). For Alexa 594, excitation was using a 543 
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nm laser at 7% transmission and emission was collected through a 535-590 nm band 
pass filter (peak emission at 617nm). Colocalisation of DHPR-RyR was assessed 
using the colocalisation threshold plug-in for ImageJ. Automatic thresholding was 
used, and confocal images were recorded using the same gain and background 
settings to avoid bias. The coefficient of colocalisation (percentage voxels above 
threshold which were colocalised) was analysed for red (RyR):green (DHPR) and 
green (DHPR):red (RyR). 
 
2.6 Statistical Analysis 
Data are represented as mean ± standard deviation. Two groups were analysed using 
the nonparametric Mann-Whitney test. The analysis was performed using Prism4 
software (GraphPad Software Inc., San Diego, CA, USA). P<0.05 was taken as 
significant. Statistical analysis of more than two groups was performed using non-
parametric one-way analysis of variance (ANOVA) (Kruskall-Wallis test). Dunn’s 
post-hoc test was used in conjunction. In graphs, one star indicates a difference of 
p<0.05, two stars indicates a difference of p<0.01 and three stars indicate a difference 
of p<0.001. 
 
Non-parametric tests are useful when two populations with unequal variances are 
compared. To test for unequal variances, the F-test for unequal variance was used.  
Non-parametric techniques do not rely on assumptions that the data belong to any 
particular probability distribution. 
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2.7 Solutions 
 
The following standard solutions were used. They are described in mM (unless 
otherwise stated). All chemicals were provided by VWR International or Sigma 
Aldrich. 
Normal tyrode (NT): 140 NaCl, 6 KCl, 10 glucose, 10 HEPES (free acid), 1 MgCl2, 
1 CaCl2, pH 7.4 
NT+Heparin: 140 NaCl, 6 KCl, 10 glucose, 10 HEPES (free acid), 1 MgCl2, 1 
CaCl2, 1000U/ml Heparin, pH 7.4 
Low Ca2+ solution (LC): 120 NaCl, 5.4 KCl, 5 MgSO4, 5 Na+ pyruvate, 20 glucose, 
20 taurine, 10 HEPES (free acid), 5 nitrilotriacetic acid, and 0.04 CaCl2, pH 6.96 
(When isolating mouse cardiomyocytes, 0.045 CaCl2 was used) 
 
Buffer A: 120 NaCl, 5.4 KCl, 5 MgSO4, 5 Na+ pyruvate, 20 glucose, 20 taurine, 10 
HEPES (free acid), and 0.2 CaCl2, pH 7.4 
 
0 Na+/0 Ca2+ solution used during measurement of SR Ca2+ content: 140 LiCl, 10 
glucose; 10 HEPES, 0.75 EGTA, 1 MgCl2, pH 7.4 (using KOH up to 6mM, thereafter 
using LiOH if necessary). 
 
St Thomas II Cardioplegia: (From NHS Supply Chain): 110 NaCl, 10 NaHCO3, 16 , 
1.2 CaCl2, pH 7.8 
 
L-15 Medium: For SICM. Listed in mg/L below. 
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SALTS  
CaCl2 140 
KCl 400 
KH2PO4 60 
MgCl2 93.70 
MgSO4 97.67 
NaCl 8000 
Na2HPO4 190 
OTHER    
D+ Galactose 900 
Na+ Pyruvate 550 
Phenol Red 10 
AMINO ACIDS   
DL-Alpha Alanine 450 
L-Arginine 500 
L-Asparagine 250 
L-Cysteine 120 
L-Glutamine 300 
Glycine 200 
L-Histidine 250 
DL-Isoleucine 250 
L-Leucine 125 
L-Lysine 75 
DL-Methionine 150 
DL-Phenylalanine 250 
L-Serine 200 
DL-Threonine 600 
L-Tryptophan 20 
L-Tyrosine 300 
DL-Valine 200 
VITAMINS   
D-Ca2+ Pantothenate 1 
Choline Chloride 1 
Folic Acid 1 
I-Inositol 2 
Niacinamide 1 
Pyridoxine Hydrochloride 1 
Riboflavin 5'-Phosphate, Na+ 0.10 
Thiamine hydrochloride 1 
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2.8 Experimental Scheme 
 
The general experimental scheme for the subsequent Chapters is described below. 
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FIGURE M-6: SCHEME OF EXPERIMENTS IN CHAPTERS 4 TO 6 
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FIGURE M-7: SCHEME OF EXPERIMENTS IN CHAPTER 7 
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Chapter 3 
Characterisation Of Animal Models Of Cardiac Mechanical 
Load Variation At The Level Of The Whole Heart 
 
 
In this Chapter, the models of mechanical overload (TAC), unloading (HAHLT) and 
HF (post-CAL) used in subsequent Chapters were validated using clinical, 
echocardiographic and heart weight data. 
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3.1 Introduction 
The animal models of myocardial mechanical load variation and HF used in the 
studies described in the following Chapters are extensively used in the cardiovascular 
sciences and accepted as suitable substrates for the study of relevant physiological 
processes (Abarbanell et al., 2010). However, it is possible to produce models of 
widely different clinical states and physiological conditions depending on the 
operative technique used and therefore these models require validation and 
characterisation. 
 
The most practical and effective means to validate these models differ. CAL surgery 
results in progressive HF as evidenced by echocardiography (Schwarz et al., 1998). 
TAC surgery produces physiological hypertrophy and eventually HF and can also be 
assayed using serial echocardiograms (Del Monte et al., 2002). The models of 
mechanical unloading are more difficult to evaluate. Echocardiographic assessment 
can be used to exclude graft failure and provide some measure of cardiac dimensions, 
but cannot be used for functional assessment due to the technical difficulty and 
because echocardiography provides only load-dependent parameters. LV weight and 
cardiomyocyte volume provide an index of atrophy (a concept which will be 
discussed below), indicating the impact of mechanical unloading. 
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3.2 Materials and Methods 
The operative technique for these models, the basis of echocardiographic assessment 
and general animal husbandry has been detailed in the Methods. The number of 
animals shown in this Chapter is not always the number of animals used in the 
experimental groups in following Chapters. The number of animals used per 
experimental group is detailed in the Methods of each specific Chapter. 
 
3.2.1 Kaplan–Meier Curves 
Kaplan-Meier curves provide a running estimate of survival after an intervention 
(Bland and Altman, 1998). Animals would be withdrawn from the study for a number 
of reasons, for example by developing a complication that causes them to be 
incomparable to other members of the experimental group. A typical case is the 
development of aortic regurgitation in a post-operative HAHT or HAHLT animal. 
These subjects are censored (removed from the rolling analysis) with a new estimated 
survival. Censoring is a declaration that the final outcome for that subject is not 
known and therefore they are excluded from the analysis. 
 
When there is no censoring, the Kaplan-Meier statistic for a given point in time 
estimates survival beyond that point and is obtained by subtracting the deaths at a 
time point from the observed survival directly before that time (n), divided by n. 
When there is censoring, n is adjusted for the lost number of cases no longer observed 
(Leung et al., 1997). 
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Kaplan-Meier curves are given for CAL, TAC and HAHLT in Figure C3-1. All these 
operations were performed by myself. They exclude the series of TAC performed in 
mice by Dr Mutsuo Harada (Chapter 6), the heart-only transplantations performed by 
Dr Manoraj Navaratnarajah (Chapter 3 and 4) and the operations performed during 
the learning curve of these operations. The issue of learning curves is discussed 
below. There were no deaths for Sham operations in any group. 
 
3.2.2 Heart Weight 
The heart weights reported were measured directly after harvesting and removing the 
oesophagus, lungs, descending aorta and any excess thymic tissue or fat. 
 
3.2.3 Functional Assessment 
Hearts were assessed using echocardiography as described in the Methods. Unloaded 
hearts underwent echocardiography for dimensions but not for functional assessment. 
 
3.2.4 Statistical Analysis 
Statistical analysis was performed using non-parametric one-way ANOVA (Kruskall-
Wallis test). Dunn’s post-hoc test was used to test for differences between groups. 
The analysis was performed using Prism4 software (GraphPad software Inc., San 
Diego, CA, USA). P<0.05 was taken as significant. 
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3.3 Results 
 
3.3.1 Survival 
The survival of animals following TAC (Chapter 6), CAL (Chapter 5) and HAHLT 
(Chapter 6) is shown in Figure C3-1.  Early mortality occurred within the first day and 
usually peri-operatively or immediately postoperatively and accounts for the majority 
of deaths in all three animal models. This early mortality was largest for CAL surgery 
and lowest for HAHLT. The causes of deaths for CAL are listed in the first five 
practice series of experiments in Table C3-1. Table C3-1 also shows the significant 
learning curve involved in generating CAL models, with a mortality of 50% in the 
first series compared to approximately 10-20% in later series. All perioperative or day 
1 deaths in the TAC group were secondary to severe pulmonary oedema, where 
animals were unable to tolerate the significant aortic pressure gradient generated and 
suffered acute HF. All perioperative or day 1 deaths in the HAHLT group were due to 
bleeding from the anastomosis. 
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TABLE C3-1: CAUSE OF DEATH IN FIVE INITIAL CAL SERIES 
Mortality Causes of Death 
Series 1 7/14 Anaesthetic error (3) 
Bleeding (2) 
Surgical Error (2) 
Series 2 5/15 Acute HF/VF (3) 
Bleeding (2) 
Series 3 3/16 Acute HF/VF (3) 
Series 4 6/23 Acute HF/VF (4) 
Bleeding (1) 
Surgical Error (1) 
Series 5 2/8 Bleeding (2) 
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FIGURE C3-1: KAPLAN-MEIER CURVE ESTIMATION OF SURVIVAL IN CAL, TAC AND 
HAHLT 
The figure shows Kaplan-Meier analysis of survival following CAL, TAC and HAHLT. 
 
Late mortality occurred following CAL surgery only. The mechanisms for this are not 
known but could be ischaemia-related arrhythmia or arrhythmia due to the presence of 
scar tissue. Other possible causes include HF. 
 
The HAHLT curve also shows the incidence of graft failure, which was low. Graft 
failure was defined as cessation of contraction, presence of large LV clot, significant 
aortic valve regurgitation (evidenced on echocardiography or by dilation of the 
ventricle), or infection. 
CAL TAC 
HAHLT 
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3.3.2 Heart Weight 
Heart weights after CAL and TAC are shown in Figure C3-2. The TAC experiments 
show that heart weight increased as the duration of overload was increased. This 
increase in heart weight was associated with cardiomyocyte hypertrophy, as will be 
demonstrated in following Chapters, but other mechanisms including increases in 
extracellular matrix components such as collagen may also play a role. This 
hypertrophic response occurs in response to pressure overload in a number of studies 
(Wei et al., 2010, Del Monte et al., 2002). 
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FIGURE C3-2: MECHANICAL LOAD VARIATION AND HEART FAILURE MODULATED 
HEART WEIGHT 
Pre-digestion heart weights are shown. To avoid a large number of statistical comparison bars, 
significant differences are as follows: CAL vs HF-UN (p<0.05), CAL vs HAHLT 4wks (p<0.01), CAL 
vs HAHLT 8wks (p<0.05), CAL vs HAHT 4wks (p<0.001), HAHLT 4wks vs TAC 6 weeks (p<0.05), 
HAHLT 4wks vs TAC 10 weeks (p<0.01), HAHT 4wks vs TAC 6 weeks (p<0.01), HAHT 4wks vs 
TAC 10 weeks (p<0.001). Abbreviations: HAHT 4wks - normal heart 4 weeks following HAHT; 
HAHLT - normal heart following HAHLT; HF-UN - failing (12 week post CAL) heart 4 weeks 
following HAHT; CAL - 12 weeks post CAL. N numbers are as follows: Sham=8; CAL=8; HF-UN=8; 
HAHLT 4wks-6; HAHLT 8wks-5; HAHT 4wks-5; TAC 6wks-5; TAC 10wks-6. 
 
Conversely, reductions in mechanical load have been shown to induce reductions in 
cardiac mass (Klein et al., 1990). In a previously normal heart, mechanical unloading 
resulted in a time-dependent reduction in heart weight, of approximately 75%, 4 
weeks following HAHLT (Figure C3-2). Partial mechanical unloading induced by 
HAHLT resulted in slower and less profound reductions in heart weight. Mechanical 
unloading of a failing heart (post-CAL HAHT) induced a regression of whole heart 
hypertrophy, indicating that the determination of cardiac mass is dependent at least 
partly on load and is reversible. 
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3.3.3 Functional Assessment 
 
Functional assessment consisted of echocardiography as described in the Methods. 
These data provide information on dimensions of the LV cavity and wall as well as 
LV wall functional properties, except in the case of the mechanically unloaded heart 
where functional assessment is meaningless as the heart is not equally loaded as a 
normal heart (discussed below). 
 
Serial echocardiographic assessment of hearts following CAL is shown in Figure C3-
3 (single, not averaged values from individual animals). Data obtained at 1, 6 and 12 
weeks post-operatively are shown. The initial part of the reduction in contractility is 
due to loss of cardiomyocytes and later due to remodelling of the chronically-
overloaded remaining myocardium (Pfeffer and Braunwald, 1990). At the early stage, 
it was possible to identify and exclude a population of animals who suffered 
myocardial infarction that was not extensive enough to result in a large drop in EF 
(Figure C3-3). Remodelling of the remaining myocardium results in a more slowly 
progressing reduction in contractility, primarily due to pressure overload. Animals 
used showed echocardiographic features of HF, including dilation of the ventricle and 
impaired contractility with an EF of 40%. 
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FIGURE C3-3: ECHOCARDIOGRAPHIC ASSESSMENT OF CAL 
The figure shows LV EF at 1, 6 and 12 weeks following CAL. 1 wk vs 12 week, P<0.05. 
 
Final echocardiograms were performed three times and the average values were used 
for each single animal. The overall average is provided in Table C3-2. 
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TABLE C3-2: EJECTION FRACTION OF VARIOUS ANIMAL MODELS 
This table shows the final average value based on n number of animals in each group. Each animal 
undergoes three echocardiograms and the average value is used. * indicates a significant difference 
(p<0.05) from normal. Note that the n numbers here only include those animals who went on to be 
included in an experimental group, unlike for Figure C3-2. 
 
Echocardiographic assessment of TAC animals shows an increase in EF and FS 
(Table C3-2). FS was likewise increased. This was associated with a reduction in the 
ventricular dimensions (LVs and LVd) due to concentric hypertrophy. The LV 
posterior wall was thicker than normal at 6 and 10 weeks, correlating with the 
increased heart weight. 
 
The table includes echocardiographic assessment of normal hearts following HAHLT. 
These show that mechanical unloading was associated with a reduction in the size of 
the ventricular cavity and thinning of the LV posterior wall, possibly indicating 
atrophy. This correlates with the reduction in heart weight above. 
 EF% FS% LVs (cm) LVd (cm) LVPWd 
(cm) 
Normal (n=12) 
HAHLT 4 week 
(n=4) 
HAHLT 8 week 
(n=3) 
74±8 
 
45±9 
 
0.39±0.08 
0.45±0.13 
0.34±0.05 
0.65±0.1 
0.47±0.13* 
0.46±0.04 
0.22±0.1 
0.17±0.04 
0.15±0.04 
TAC 6 week (n=5) 81±13 47.6±8.4 0.34±0.1 0.53±0.15 0.25±0.3 
TAC 10 week (n=6) 82±8.9 46.8±7.8 0.35±0.07 0.55±0.1* 
 
0.28±0.2* 
 
CAL (n=8) 39±2.3* 20.6±4.3* 0.81±4.2* 0.92±3.4* 0.20±3.8 
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3.4 Discussion 
This validation study shows that models of mechanical overloading and unloading 
and HF can be generated in a reproducible manner, with low mortality and evidence 
of clinically-relevant functional characteristics. 
 
3.4.1 Survival 
Survival is dependent on a number of factors related to the injury of the surgery itself 
and the physiological consequences of the model. In the case of CAL, the surgery 
itself could result in dehydration, bleeding, trauma to the heart or lungs and chest wall 
trauma, which could result in the animal dying in the peri-operative or early post-
operative period. Myocardial infarction in itself has a significant mortality due to low 
CO, arrhythmia and pulmonary oedema. Likewise, TAC results in pressure overload 
and can cause lethal pulmonary oedema. The severity of these insults can be modified 
to achieve a balance between models of advanced severity and a practical survival 
rate. This was achieved by selecting the level at which to ligate the left coronary 
artery in the case of CAL, where ligation toward the origin of the left coronary results 
in a greater loss of myocardium (and a more severe model), but this risks a higher 
mortality. In the case of TAC, the degree of band tightening can be adjusted to induce 
more severe overload, but this risks a higher acute mortality. The learning curve 
involved in generating the animal models affects not only mortality but also the 
consistency of the model. This highlights the importance of rejecting initial survivors 
to achieve a consistent animal model. 
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3.4.2 Heart Weight 
Increases in heart weight are an independent risk factor for mortality in man (Lorell 
and Carabello, 2000). Heart weight is determined by genetic and environmental 
factors, as well as their interaction through epigenetic changes (McDermott-Roe et al., 
2011, Post et al., 1997). Hypertrophy is a uniform response to increases in mechanical 
load (Gaasch and Zile, 2011) and enables the heart to cope with the increased 
workload. Likewise, reductions in cardiac mass are thought to be a uniform response 
to mechanical unloading, and the reduction in cardiac workload (Baskin and 
Taegtmeyer, 2011). 
 
The term cardiac atrophy is complex and ill-defined. Strictly, it refers to diminutions 
of size below the normal range or below the starting, pre-disease value. It may be 
measured in a number of ways, including in single cells (Yacoub, 2001), standard 
morphometric analysis of tissue sections (Dipla et al., 1998) and other techniques 
(Terracciano et al., 2004). The term ‘atrophy’ however, implies a functional 
deterioration. However, the link between heart weight, cell size and function is not 
straightforward. Thus, even though hypertrophy is associated with dysfunction (Lorell 
and Carabello, 2000), increased mass is not always pathological and may be 
physiological, for example after endurance training (Ellison et al., 2012). 
Furthermore, LVAD-induced mechanical unloading of the failing heart results in 
regression of cardiomyocyte hypertrophy, but this occurs in both those patients who 
show sufficient cardiac improvement to allow explantation of the LVAD without 
requiring cardiac transplantation, and those who did not and required maintenance of 
circulatory support until transplantation (Terracciano et al., 2004). Therefore, it is 
more accurate to describe the relationship between cardiac mass and function as 
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operating within a range of normal loading conditions. Deviations outside this range 
at either the positive or negative end may lead to deterioration of function. 
 
3.4.3 Functional Assessment 
The purpose of functional assessment of animal models is to understand the extent to 
which they reflect a specific clinical syndrome. In this case, echocardiography was 
used. 
 
In the case of CAL, progressive remodelling as well as the initial loss of myocardium 
drive the response to myocardial infarction (Pfeffer and Braunwald, 1990). Serial 
echocardiography reveals a large drop in myocardial contractility initially with a 
slower decline over time. Anversa et al showed that acutely after CAL, side-to-side 
slippage of cardiomyocytes, as well as increases in cardiac dimensions, leads to 
reduced CO (Anversa et al., 1991). They also showed that the hypertrophic response 
to CAL in the remaining viable myocardium was insufficient to maintain cardiac 
function, nor to reduce wall stress. This overload sustains the progression to HF. Only 
animals with an EF below 40% were included in the final study, indicating a ‘severe’ 
HF phenotype. 
 
It is important to understand that the diagnosis of HF in man is clinical, based on 
symptoms and functional abilities, in conjunction with echocardiographic and 
biomarker assessment. These animals reside in a restricted space with free access to 
food and water and therefore do not experience stressful exercise. It is impossible to 
correlate the human syndrome of HF with CAL in rats, but this model does replicate 
the myocardial changes observed, primarily defective contractility. Previous studies 
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have documented increased myocardial fibrosis, arrhythmia and death following CAL 
(Anversa et al., 1991). It is important that this model specifically replicates the 
derangements in excitation-contraction coupling observed in the failing heart. This 
will be addressed in Chapter 5. 
 
In the case of TACs, ventricular remodelling is driven by overload, which progresses 
more slowly than in CAL. This leads to a HF phenotype at approximately 24 or more 
weeks (Del Monte et al., 2002). However, cellular remodelling, and specifically t-
tubule remodelling, precedes whole heart dysfunction (Wei et al., 2010). The 
mechanisms mediating the compensatory phase of hypertrophy and its transition to 
cardiac failure are mediated by numerous factors, including the severity and duration 
of the onset of pressure overload (Frohlich and Susic, 2012). The model used here 
provides (at 10 weeks) a model of compensated hypertrophy with preserved 
contractility. The cellular phenotype associated with this is investigated in Chapter 6. 
 
Echocardiography is a convenient method of checking the viability of a transplanted 
cardiac graft. It cannot be used to assess cardiac contractility, since the heart is 
mechanically unloaded and lies on a different part of the Starling curve than the 
normal heart, and therefore has a different mechanical stimulus to contract (Frank, 
1990). It is useful to exclude aortic regurgitation, however, as outlined in the 
Methods. A better method to assess contractility in a load-independent manner would 
have been the use of pressure-volume analysis (Pacher et al., 2008). 
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3.4.4 Summary 
This Chapter suggests that the surgical models described are able to produce HF and 
mechanical load variation.  
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Chapter 4 
Prolonged Mechanical Unloading Altered Cardiomyocyte 
Excitation-Contraction Coupling, T-Tubule And Cell 
Surface Structure 
 
In this Chapter, the effect of prolonged mechanical unloading on cardiomyocyte t-
tubule, cell and surface structure was studied. Ca2+ transients, Ca2+ sparks, ICa,L and 
AP morphology were assessed. A summary of the materials and methods is provided. 
 
This Chapter tested the hypothesis that the t-tubule network of LV cardiomyocytes is 
altered by prolonged mechanical unloading, with consequences for CICR. 
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4.1 Introduction 
The beneficial effects of LVAD therapy on myocardial function appear to diminish 
after prolonged mechanical unloading and the clinical recovery obtained is 
insufficient for device explantation in most patients (Maybaum et al., 2007, Mancini 
et al., 1998). It is thought that this may be due to atrophic remodelling - a set of 
changes triggered by excessive mechanical unloading. 
 
In experimental models of LVAD therapy, prolonged mechanical unloading can result 
in detrimental effects on cardiac function (Oriyanhan et al., 2007) and this may be 
partly mediated by deranged excitation-contraction coupling (Soppa et al., 2008b). 
Soppa et al showed that prolonged mechanical unloading in normal hearts resulted in 
impaired single cell contractility, mediated by reduced myofilament sensitivity to 
Ca2+ and reduced SR Ca2+ content due to lower SR Ca2+ reuptake. This points to 
changes in excitation-contraction coupling being a major feature of the remodelling 
which occurs after prolonged mechanical unloading. 
 
There is abundant evidence that alterations in t-tubule structure are an important cause 
of deteriorations in cardiomyocyte function in a range of cardiac disease states 
(reviewed in (Brette and Orchard, 2003)). In agreement with their role in guaranteeing 
efficient Ca2+ release, areas of impaired Ca2+ release are spatially colocalised to 
regions of t-tubular disruption (Meethal et al., 2007) and the degree of t-tubular 
disruption correlates with the severity of impaired Ca2+ release (Louch et al., 2004). 
There is evidence that this derangement is caused by a structural uncoupling of LTCC 
and RyR due to defects in the t-tubule network (Song et al., 2006). 
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It is not known whether the t-tubule network is sensitive to mechanical unloading, but 
a recent report suggests that the t-tubules are regulated by stretch-sensitive molecules 
(Zhang et al., 2009). This suggests that t-tubule defects may underlie the functional 
impairment of the chronically unloaded heart.  The aim of this Chapter was to 
characterise the effect of chronic mechanical unloading on t-tubule and cell surface 
structure and on local CICR. To test the hypothesis that the t-tubule network of LV 
cardiomyocytes is altered by prolonged mechanical unloading, with consequences for 
CICR, hearts were mechanically unloaded using HAHT and single cells were 
characterised for local CICR and t-tubule structure. 
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4.2 Materials and Methods 
 
4.2.1 Animal Models 
Syngeneic male Lewis rats (10 - 12 weeks old, approximately 220g) were used in all 
the experiments. Four animals were used in each group. 
 
HAHT. The heart was harvested from the thorax and heterotopically transplanted into 
the abdomen of an age-matched syngeneic recipient, as described in the Methods. 
Hearts were harvested four weeks following transplantation. 
 
After cell isolation, the following experiments were performed: 
 
-Ca2+ transient and Ca2+ spark recordings (with help from Dr Abeer Al Masri) 
-Cell and t-tubule imaging using Di-8-ANEPPS 
-Cell surface imaging using SICM (with help from Dr Alexey Moshkov) 
-ICa,L recordings (Dr Urszula Siedlecka) 
-AP Recordings (Dr Cesare Terracciano) 
 
4.2.2 Statistical Analysis 
Statistical analysis was performed using non-parametric one-way ANOVA (Kruskall-
Wallis test). Dunn’s post-hoc test was used to test for differences between groups. 
The analysis was performed using Prism4 software (GraphPad software Inc., San 
Diego, CA, USA). P<0.05 was taken as significant. 
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4.3 Results 
4.3.1 Prolonged Unloading Reduced Cell Size 
The most profound effect of mechanical unloading is a reduction in cell volume. 
Using three-dimensional volume reconstruction of Di-8-ANEPPS-stained cells, an 
estimate of cell volume was obtained. The volume of cardiomyocytes from unloaded 
hearts was 56.5% smaller than control. This reduction in cell size was confirmed by a 
reduced cell capacitance measured during the electrophysiological experiments 
(Figure C4-1). This result indicates that absolute cell surface area was reduced with a 
reduction in cell size. 
 
 
FIGURE C4-1: PROLONGED MECHANICAL UNLOADING REDUCED CELL SIZE 
(A) Unloaded cell volumes were significantly smaller compared to control cells. (B) Cell capacitance 
measurements showed a reduction in cell capacitance after chronic unloading. 
 
4.3.2 The Ca2+ Transient Was Altered By Prolonged Unloading 
The peak amplitude of the whole cell Ca2+ transient was significantly smaller in cells 
from the chronically unloaded heart compared to control cells  (Figure C4-2). In 
addition, the average time to peak was significantly longer, as was the time to 50% 
decline, compared to control cells. The variance of time to peak of the Ca2+ transient 
was significantly increased in cardiomyocytes from the unloaded heart, suggesting 
that the synchronicity of Ca2+ release was disrupted. Possible causes for this impaired 
A B 
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Ca2+ release include altered ICa,L, altered RyR function or an uncoupling of the 
CICR machinery. These possibilities are examined in subsequent sections.
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Figure!C4,2:!Prolonged!Mechanical!Unloading!Disrupted!The!Ca2+!Transient!
(A) Two representative traces showing that the whole cell Ca2+ transient was less synchronous in unloaded compared to control cells. (B) The time to peak of the Ca2+ 
transient is increased in unloaded cells. (C) The amplitude of the Ca2+ transient is decreased in unloaded cells. (D) The time to 50% decline in the Ca2+ transient is increased 
in unloaded cells. (E) The variance of the time to peak of the Ca2+ transient is increased in unloaded cells. The colour chart is a normalised scale of fluorescence intensity. 
The vertical scale bar represents 100 ms and the horizontal scale bar represents 100 pixels. (F) Two dimensional representation of the Ca2+ transient of control and unloaded 
cells.
A 
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4.3.3 ICa,L Was Unaffected 
There was no difference in the ICa,L density between cardiomyocytes from control or 
unloaded hearts (Figure C4-3). However, the fast-inactivation of ICa,L was 
significantly slower in unloaded cardiomyocytes compared to control. Thus the 
trigger for SR Ca2+ release was not altered by prolonged mechanical unloading under 
voltage-clamping conditions. 
 
 
FIGURE C4-3: PROLONGED MECHANICAL UNLOADING DID NOT ALTER THE ICA,L 
DENSITY 
(A) Raw traces of ICa,L elicited by a voltage clamp step from −40 to 0mV. (B) ICa,L density was 
unaffected by mechanical unloading. (C) The fast phase of ICa,L inactivations was significantly slower 
in cardiomyocytes from the unloaded heart. 
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4.3.4 The Action Potential Was Unaffected 
 
As the synchronicity of the Ca2+ transient may be affected by AP morphology, the AP 
was recorded from cardiomyocytes from unloaded and control hearts. The resting 
membrane potential was unaffected by prolonged mechanical unloading. The time to 
50% repolarisation was similarly unchanged, as was the time to 90% repolarisation. 
Thus chronic mechanical unloading did not alter the AP of LV cardiomyocytes 
(Figure C4-4). 
 
Taken together, these results suggest that there is a local disruption of CICR in 
unloaded cardiomyocytes, which is not due to altered ICa,L. To investigate the basis 
of this impaired Ca2+ release, the components of the local CICR process, which 
include RyR and the t-tubular structure, were assessed. 
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FIGURE C4-4: THE ACTION POTENTIAL WAS UNAFFECTED BY MECHANICAL 
UNLOADING 
(A) AP morphology was unchanged after unloading. (B). Resting membrane potential was unchanged 
after unloading. (C) Time to 50% repolarisation was unchanged after unloading. (D) Time to 90% 
repolarisation was unchanged after unloading. 
 
4.3.5 Prolonged Mechanical Unloading Altered Ca2+ Spark Frequency And 
Morphology 
Cardiomyocytes from the unloaded heart showed a significantly higher Ca2+ spark 
frequency than control  cardiomyocytes (Figure C4-5). Mechanically unloaded 
cardiomyocytes also showed increased Ca2+ spark width and duration, and decreased 
Ca2+ spark peak. These results indicate an altered activity of the RyR. It has been 
previously reported that the SR Ca2+ content is unchanged after prolonged mechanical 
unloading for four weeks in rats (Soppa et al., 2008b). These changes to Ca2+ sparks 
might be due to alterations at the level of the structural coupling of the RyR and 
LTCC at the t-tubules. 
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FIGURE C4-5: CA2+ SPARK PROPERTIES WERE ALTERED BY PROLONGED 
MECHANICAL UNLOADING 
(A) Representative images of Ca2+ sparks. Cells from the chronically unloaded heart had more frequent 
Ca2+ sparks (B) which were smaller in amplitude (C) longer in duration (FDHM) (D) and wider 
(FWHM) (E). The vertical scale bar represents 768ms. The horizontal scale bar represents 100 pixels. 
The colour chart is a normalised scale of fluorescence intensity. 
 
 
4.3.6 Prolonged Mechanical Unloading Disrupted The T-Tubules 
The t-tubule network in cells from the chronically unloaded heart was investigated 
because changes in SR Ca2+ release have been associated with t-tubule disruption (as 
extensively reviewed in Introduction). To do this, cardiomyocytes were stained with 
the membrane-staining dye Di-8-ANEPPS (Figure C4-6). Unloading did not alter the 
density of the t-tubule network, consistent with an unchanged ICa,L, but significantly 
reduced its regularity, with fewer t-tubules lying in their ordinary position. 
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FIGURE C4-6: PROLONGED MECHANICAL UNLOADING DISRUPTED T-TUBULE 
STRUCTURE 
(A) Representative images of Di-8-ANEPPS stained cardiomyocytes from chronically unloaded and 
control hearts. Binary images of the central area indicated that the t-tubules of unloaded cells were 
significantly disrupted. (B) The density of the t-tubule network was unchanged by unloading. (C and 
D) Fourier analysis of the binary images of Di-8-ANEPPS images indicated that the t-tubules were 
irregular. The length of the yellow box is 25µm. 
 
4.3.7 Prolonged Mechanical Unloading Disrupted The Cell Surface 
To image the external membrane structure and its relationship with the t-tubule 
network at high resolution in living cells, SICM was used. SICM imaging of unloaded 
cells showed changes on the cardiomyocyte surface with a decrease in the z-groove 
index compared with control cells (Figure C4-7), as previously described (Gorelik et 
al., 2006). 
!!
Unloaded Control 
Control (n=56) Unloaded (n=57)
0
5
10
15
20
25
***
P
ow
er
 (x
10
5 )
0.0 0.5 1.0 1.5 2.0
0
5
10
15
20
25
Unloaded
Control
cycles/micron
po
w
er
 (
x1
05
)
Control (n=59) Unloaded (n=90)
10
20
30
40
50
60
70
D
i-
8-
A
N
E
P
P
S
 s
ta
in
ed
 a
re
a 
 (
%
)
A 
C B D 
! 156!
 
 
FIGURE C4-7: CARDIOMYOCYTE SURFACE STRUCTURE WAS DISRUPTED BY 
PROLONGED MECHANICAL UNLOADING 
SICM images from the surface of cardiomyocytes isolated from control (A) and unloaded (B) hearts. 
(C & D) are high power views of the same cells. (E) z-groove index for cells from control hearts and 
unloaded hearts, indicating a disrupted cell surface structure. 
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4.4 Discussion 
The results presented here show that cardiomyocytes from chronically unloaded 
hearts have impaired, markedly asynchronous Ca2+ release despite intact Ca2+ triggers 
(normal ICa,L). Cells from chronically unloaded hearts also showed disrupted t-tubule 
structure, with a normal density but abnormal pattern. The disrupted, asynchronous 
Ca2+ release events can be explained by a functional uncoupling of the RyRs and 
LTCC (Song et al., 2006). This is a fundamental mechanism for impaired contractility 
and arrhythmia in HF, and these results show that this is of relevance in the 
chronically unloaded heart. This mechanism may explain the regression of improved 
contractility observed initially in patients treated chronically with LVADs. 
 
One unexpected result was that despite alterations to the Ca2+ transient, the AP was 
not changed (duBell et al., 1991). In addition, ICa,L is a major determinant of phase 
two of the cardiac AP. Prolonged Ca2+ dependent fast inactivation might also be 
expected to prolong the AP and Ca2+ transient. As the changes observed to the Ca2+ 
transient were small, they may have been too small to alter the AP. 
 
4.4.1 CICR Uncoupling 
There is accumulating evidence that t-tubule disruption produces an uncoupling of 
LTCCs and RyRs during mechanical overload (Song et al., 2006, Gomez et al., 1997, 
Brette and Orchard, 2003, Louch et al., 2004, Heinzel et al., 2002, Heinzel et al., 
2008, Lenaerts et al., 2009). The ‘orphaned’ RyRs no longer respond to LTCCs 
opening as they are functionally uncoupled by their distance, which leads to lower 
ICa,L-induced activation. The present results indicate that this is also the case in the 
chronically unloaded heart. This uncoupling is evidenced by the increased variance in 
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the time to peak of the Ca2+ transient and the increased Ca2+ spark frequency. A 
structural basis is suggested by the disruptions to the t-tubule network. The changes to 
the parameters of Ca2+ spark mass (FWHM and FDHM) may be dependent on a 
number of mechanisms, including properties of Ca2+ diffusion through the cell and 
altered opening features of individual RyR in each cluster (Zima et al., 2008, Xu et 
al., 2007, Song et al., 2006, Sham et al., 1998). 
 
The suggestion that the deranged Ca2+ release is due to a structural abnormality in the 
t-tubules is supported by evidence that the points of delayed Ca2+ release spatially 
relate to defects in the t-tubule network in other studies (Meethal et al., 2007). 
Whether there is RyR-LTCC uncoupling at those points is unknown but this is likely 
to be the case (Song et al., 2006). Interestingly, when the t-tubule network is 
disrupted, increased Ca2+ spark frequency occurs in areas of delayed activation, 
indicating possible RyR-LTCC uncoupling (Biesmans et al., 2011). 
 
An important question is how t-tubule disruption leads to increased Ca2+ spark 
frequency, since displacement of the LTCC might be expected to reduce (not 
enhance) RyR activation. First, it is important to note that while spontaneous sparks 
localise to the t-tubules (Meethal et al., 2007), this does not appear to be due to the 
presence of LTCC, as block of the ICa,L in rat atrial cardiomyocytes does not 
diminish the elevated Ca2+ spark frequency close to the membrane (Woo et al., 2003). 
Moreover, the addition of BayK (an LTCC agonist) in the absence of Ca2+ influx, 
activates Ca2+ sparks (Katoh et al., 2000). Indeed, the addition of cardiac DHPR loop 
II-III peptide to the patch pipette solution lowers Ca2+ spark frequency by 50%. This 
indicates that the normal relationship between the t-tubule membrane, LTCC and Ca2+ 
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spark frequency is due to factors more complex than simple Ca2+ influx through ICa,L 
(Li and Bers, 2001). Rather, the interaction between LTCC and RyR, regulated 
heavily by the t-tubules, appears to be critical. Thus, complex consequences of t-
tubule irregularities might be expected, and not necessarily reduced Ca2+ spark 
frequency. Following myocardial infarction, Ca2+ spark frequency appears to increase 
in areas of delayed activation during the Ca2+ transient, where t-tubules would be 
disrupted (Biesmans et al., 2011). Irregularities in the t-tubule membrane might result 
in mislocalisation of NCX also, which could locally elevate [Ca2+]i and promote Ca2+ 
sparks through either directly activating RyR or via CaMKII (Song et al., 2008). This 
mislocalisation of NCX could also account for the increased length of Ca2+ sparks 
(Biesmans et al., 2011). 
 
ICa,L was unchanged in density but fast (Ca2+ dependent) inactivation was prolonged. 
The mechanisms mediating fast Ca2+ dependent inactivation are complex. ICa,L 
inactivates with two time constants, one fast (between 7-50ms, Ca2+ dependent) and 
one slow (65-400ms, voltage-dependent) constant (Grandi et al., 2010).  The fast Ca2+ 
dependent inactivation depends on both the Ca2+ entering through the channel and on 
the Ca2+ released from the SR. One possible cause for delayed fast inactivation could 
be slower Ca2+ release from the SR. 
 
There might be a number of other factors, other than t-tubule irregularity and dyadic 
uncoupling, which could result in altered Ca2+ spark frequency and diminished Ca2+ 
transient amplitude. Foremost amongst these is altered phosphorylation. Schwoerer et 
al reported that mechanical unloading reduced phosphorylation of Phospholamban  
(Phospholamban is an inhibitor of SERCA2a in the unphosphorylated state, but 
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inhibition is reduced upon Phospholamban phosphorylation) by approximately 50% 
(Schwoerer et al., 2008). This could inhibit SERCA2a activity, which ought to reduce 
the SR Ca2+ content, and would be expected to reduce the Ca2+ transient amplitude 
and spark frequency. Further studies are needed to address this issue. 
 
4.4.2 T-Tubule Physiology 
The t-tubule is the structural basis of LTCC-RyR coupling. T-tubule disruption also 
correlates with the degree of HF (Wei et al., 2010). There appears to be a tight 
connection between disrupted t-tubule structure and defective Ca2+ handling. This has 
been demonstrated as an important mechanism after pathological insults to the 
myocardium (reviewed in the Introduction). These results in this Chapter suggest 
chronic unloading could be added to the list of stressors to which the t-tubule structure 
is sensitive. 
 
The pathological alterations to the t-tubules observed here as a result of prolonged 
mechanical unloading appear to be different in nature to those after myocardial 
overload and HF. Mechanical unloading appears to induce a relatively limited loss of 
regularity, rather than the loss of t-tubule density observed in HF (Louch et al., 
2010c). This could be related to the time-point, as t-tubule remodelling begins with 
irregularity and progresses to frank t-tubule loss during overload (Wei et al., 2010, 
Ritter et al., 2000). Given that these results suggest that load variation alters t-tubule 
structure, further studies are needed to examine the nature of that load sensitivity with 
respect to alterations to the degree and duration of load variation on t-tubule structure 
and local CICR. This will be addressed in the following Chapters. 
 
! 161!
4.4.3 Short-Term And Long-Term Unloading 
Short-term mechanical unloading has been associated with improved myocardial 
function in normal (Ritter et al., 2000) and failing hearts (Oriyanhan et al., 2007). 
Improved myocardial function has also been demonstrated clinically (Maybaum et al., 
2007, Mancini et al., 1998, Birks et al., 2006). The mechanisms mediating improved 
function span the spectrum of cardiac physiology and include improved Ca2+ handling 
(Terracciano et al., 2004). The following Chapter will address whether the initial 
functional improvements after mechanical unloading are mediated in part by effects 
on the t-tubule network. 
 
Prolonged unloading is associated with impaired function and Ca2+ handling in the 
normal (Ito et al., 2003) and failing heart (Oriyanhan et al., 2007, Ogletree-Hughes et 
al., 2001). These data correlate with the observed biphasic response of cardiac 
function after LVAD implantation in HF patients (Maybaum et al., 2007). Maybaum 
et al show that the cardiac function (EF) is initially increased, as the overload is 
removed. However, with prolonged unloading cardiac function begins to decrease 
again. The mechanisms mediating this are not clear, but a clinical report highlights 
initial improvements in Ca2+ cycling (after LVAD therapy in patients with HF), 
including the expression of a number of Ca2+ handling proteins, followed by 
subsequent impairment in Ca2+ homeostasis with prolonged unloading (Ogletree-
Hughes et al., 2001). 
 
It is difficult to compare the period of mechanical unloading investigated here with 
those that would be used clinically, as the timecourse of the response is very different. 
Previous studies indicated that an atrophic response was produced in four weeks, 
using HAHT (Soppa et al., 2008b). Soppa et al. described the functional impairment 
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of chronically unloaded normal hearts and identified reduced myofilament sensitivity 
to Ca2+ as an important mechanism (Soppa et al., 2008b). 
 
4.4.4 Clinical Implications 
These results provide support to the hypothesis that chronic mechanical unloading 
alone results in an atrophic derangement of contractile function in cardiomyocytes. T-
tubule disruption appears to play a role in this phenomenon. How this interacts with 
the remodelling described in HF will be addressed in the following Chapter (Chapter 
5). 
 
4.4.5 Summary 
Prolonged mechanical unloading of normal hearts impairs CICR in cardiomyocytes 
due to impairment of the SR Ca2+ release process. T-tubular disarray may be the 
structural basis of the impaired CICR observed. These results may explain the 
deleterious effects of prolonged mechanical unloading in experimental studies and the 
regression of functional improvements in clinical studies. 
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Chapter 5 
Mechanical Unloading Reversed T-tubule Remodelling and 
Normalised Local Ca2+-induced Ca2+ Release in a Rodent 
Model of Heart Failure 
 
In this Chapter, the effects of treating failing hearts with mechanical unloading on 
CICR were investigated. Cellular Ca2+ transients, Ca2+ sparks, cell and t-tubule 
structure were studied. To assess DHPR-RyR colocalisation directly, 
immunofluorescence was used. 
 
The experiments described in this chapter test the hypothesis that mechanical 
unloading of chronically failing hearts can restore t-tubule structure with important 
consequences for local CICR.  
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5.1 Introduction 
The evidence presented in the Introduction suggests that t-tubule loss is a common 
mechanism of cellular dysfunction in HF. Furthermore, the experiments described in 
Chapter 4 suggest that the t-tubules are also sensitive to mechanical unloading; 
specifically, they suggest that prolonged mechanical unloading can disrupt the t-
tubule system. This raises the possibility that there is a physiological range of loads 
which are compatible with normal t-tubule structure and CICR. Assuming that 
mechanical load variation activates specific subcellular signalling pathways which 
result in t-tubule structural abnormalities, normalising mechanical load could result in 
‘retubulation’ with improved Ca2+ handling. This may be one mechanism mediating 
the improved function of failing hearts treated with LVADs, as discussed in the 
Introduction. 
 
Chapter 4 showed that prolonged mechanical unloading of normal hearts distorted the 
t-tubules, which resulted in dysfunctional Ca2+ handling. Clinical trials suggest that 
mechanical unloading induces initial functional improvements in the failing heart, 
which regress after prolonged mechanical unloading (Maybaum et al., 2007). LVAD 
therapy improves a number of features of cellular structure and function, but whether 
reverse remodelling of the t-tubules is an element of this is not known. 
 
To test the hypothesis that t-tubule dysfunction of HF is reversible by mechanical 
unloading (HF-UN) and that this improves cellular Ca2+ handling, the structural and 
functional properties of failing rat cardiomyocytes were studied four weeks after 
HAHT. 
! 165!
5.2 Materials and Methods 
Syngeneic male Lewis rats (10 - 12 weeks old, approximately 220g) were used in all 
the experiments. Four animals were used in each group. 
 
5.2.1 HF Model 
HF was induced by ligation of the left coronary artery. HF was defined as an EF of 
40% or less at 12 weeks. Hearts were harvested at 12 weeks after ligation. Sham-
operated animals were used as controls. 
 
5.2.2 Heterotopic Abdominal Heart Transplantation. 
The failing heart was harvested from the thorax and heterotopically transplanted into 
the abdomen of an age-matched syngeneic recipient, as described in the Methods 
(HF-UN). Briefly, the donor aorta was anastomosed to the recipient abdominal aorta 
and the donor pulmonary artery to the recipient inferior vena cava. Hearts were 
harvested 4 weeks following transplantation. LV cardiomyocytes were isolated and 
the following experiments were performed: 
 
-Ca2+ transient and Ca2+ spark recordings 
-SR Ca2+ content measurements 
-Cell and t-tubule imaging using Di-8-ANEPPS 
-Cell surface imaging using SICM (with help from Dr Alexey Moshkov) 
-ICa,L recordings (Dr Urszula Siedlecka) 
-Immunofluorescence imaging of RyR-DHPR colocalisation 
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5.2.3 Statistical Analysis 
Statistical analysis was performed using non-parametric one-way ANOVA (Kruskall-
Wallis test). Dunn’s post-hoc test was used to test for differences between groups. 
The analysis was performed using Prism4 software (GraphPad software Inc., San 
Diego, CA, USA). P<0.05 was taken as significant. 
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5.3 Results 
5.3.1 Ca2+ Transient Features Were Improved After Mechanical Unloading 
Single cardiomyocyte Ca2+ transients were studied in Sham, HF and HF-UN. 
Compared to Sham, HF cells showed a depressed Ca2+ transient amplitude, which 
improved in HF-UN to Sham levels (Figure C5-1). An important determinant of the 
Ca2+ transient amplitude is SR Ca2+ content. This parameter was depressed in HF 
compared to Sham and increased towards Sham values in HF-UN ((Indo-1 ratio units) 
Sham 0.212 ±0.07 n=53, HF 0.162 ± 0.04 n = 20, HF-UN 0.238 ± 0.05 n=47, Sham 
vs HF, p=0.01, HF vs HF-UN, p=0.001). HF cells showed a prolonged time to peak of 
the Ca2+ transient compared to Sham.  Mechanical unloading achieved a significant 
reduction in time to peak. The time to 50 and 90 % decline in the Ca2+ transient were 
prolonged in HF compared to Sham. Mechanical unloading reduced these values 
towards Sham levels (Figure C5-1). The variance of the time to peak of the Ca2+ 
transients measured at each pixel was taken as an index of CICR synchronicity. HF 
cells showed a significant decrease in synchronicity of Ca2+ release (increase in 
variance of the time to peak), compared to Sham cells (Wasserstrom et al., 2009, 
Kapur et al., 2010) (Figure C5-1). Mechanical unloading induced a normalisation of 
the Ca2+ transient synchronicity (Figure C5-1). This suggests that the stimulus 
activates Ca2+ release throughout the cell uniformly. There are a number of possible 
causes for this normalisation of CICR including changes to ICa,L or normalised RyR 
function. Another possibility is that coupling between these trigger and release sites, 
which partly sets the gain of the positive feedback component of CICR, is reduced 
after HF and improved by mechanical unloading.  
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FIGURE C5-1: MECHANICAL UNLOADING INDUCED A NORMALISATION OF CA2+ TRANSIENT PARAMETERS 
(A) Line scans of Sham, HF and HF-UN cells. (B-E) The time to peak, decay to 50% and decay to 90% of the Ca2+ transient were prolonged in HF. Mechanical unloading 
normalised these parameters. The amplitude of the Ca2+ transient was depressed in HF and normalised by mechanical unloading. (F) The variance of the time to peak, an 
index of CICR synchronicity, was increased in HF and normalised by mechanical unloading. The vertical scale bar represents 200ms. The horizontal scale bar indicates 100 
pixels (Sham n=40, HF n = 34, HF-UN n=29). The colour chart is a normalised scale of fluorescence intensity. (G) Two dimensional representation of Ca2+ transients from 
Sham, HF and HF-UN cells.  
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5.3.2 Raised Ca2+ Spark Frequency In HF Was Reduced By Mechanical 
Unloading 
To assay SR Ca2+ release function, Ca2+ sparks were recorded. Ca2+ spark frequency 
was increased in HF cells compared to Sham (Figure C5-2). Mechanical unloading 
reduced Ca2+ spark frequency to Sham levels. HF cells had significantly higher Ca2+ 
spark peak amplitude compared with Sham cardiomyocytes, but unloading did not 
change Ca2+ spark peak amplitude. Ca2+ spark width and duration were increased by 
HF and increased further by mechanical unloading (Figure C5-2). 
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FIGURE C5-2: MECHANICAL UNLOADING REDUCED CA2+ SPARK FREQUENCY 
(A) Quiescent Fluo-4 labelled LV cardiomyocytes were imaged in line scans. (B) HF cells showed a 
higher Ca2+ spark frequency, (C) peak, (D) width and (E) duration. Mechanical unloading normalised 
Ca2+ spark frequency and increased width and duration. Mechanical unloading did not influence Ca2+ 
spark peak. The vertical scale bar indicates 280ms, and the horizontal scale bar indicates 100 pixels 
(Sham n=45, HF n = 34, HF-UN n=36). The colour chart is a normalised scale of fluorescence 
intensity. 
 
5.3.3 Mechanical Unloading Caused A Regression Of Cellular Hypertrophy 
To assess the volume of single cardiomyocytes, three-dimensional reconstructions of 
Di-8-ANEPPS stained cardiomyocytes were obtained. HF cells were larger than Sham 
on average, although the overall range of sizes was similar. Mechanical unloading 
induced a regression of hypertrophy, with average cell volume below that of Sham. In 
HF-UN, a new population of smaller cells appeared and the population of larger cells 
was lost (Figure C5-3, left panel). The appearance of a new population of smaller 
cells has led some investigators to suggest that mechanical unloading leads to the 
HF)UN HF Sham A B C 
D E 
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appearance of a cardiac stem cell pool (Yacoub and Terracciano, 2011). This will be 
addressed in the discussion below. Cell capacitance provides a measure of cell area 
and was recorded during the electrophysiological experiments to record the ICa,L 
density (Figure C5-3, right panel). The value of the cell capacitance changes as a 
result of altered surface sarcolemma and and/or t-tubule area. The increase in cell 
capacitance in HF can be attributed to an increased surface sarcolemma area 
accompanying hypertrophy. This regressed with mechanical unloading and was 
sufficient to decrease the cell capacitance. 
 
FIGURE C5-3: MECHANICAL UNLOADING CAUSED A REGRESSION OF CELLULAR 
HYPERTROPHY 
(A) Cell volumes were analysed from three dimensional reconstructions of isolated LV cardiomyocytes 
stained with Di-8-ANEPPS. Mechanical unloading caused a regression of the cellular hypertrophy 
observed in HF, to below Sham levels. (B) The cell capacitance, a measure of cell area, was recorded 
during the recordings of ICa,L. The cell capacitance was increased in HF and reduced by mechanical 
unloading. (For cell volume, Sham n=39, HF n = 40, HF-UN n=47; For cell capacitance, Sham n=33, 
HF n = 26, HF-UN n=35). 
 
5.3.4 Depressed ICa,L Was Rescued By Mechanical Unloading 
HF showed depressed ICa,L compared to Sham (Figure C5-4). HF-UN normalised the 
ICa,L density to Sham levels (Figure C5-4). The rate of activation of ICa,L was 
unaffected by either HF or HF-UN (data not shown). The fast, Ca2+-dependent 
A B 
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inactivation of ICa,L was faster in HF and showed to Sham levels after mechanical 
unloading. 
 
 
FIGURE C5-4: MECHANICAL UNLOADING RECOVERED THE DEPRESSED ICA,L 
DENSITY OBSERVED IN HEART FAILURE 
(A) The ICa,L density was reduced in HF and normalised by mechanical unloading (Sham n=33, HF n 
= 26, HF-UN n=35). (B) Fast inactivation was faster in HF and not different compared to Sham after 
mechanical unloading. (C) Raw traces of ICa,L are shown. Cells were held at - 40mV and voltage 
clamped to +5mV.  
 
5.3.5 Mechanical Unloading Restored Normal T-Tubule Structure 
HF reduced the t-tubule density significantly compared to Sham, with the appearance 
of a new population of cardiomyocytes with very low t-tubule density and the loss of 
the middle and top of the range of cardiomyocyte t-tubule densities (Figure C5-5). 
HF-UN increased the t-tubule density to Sham levels (Figure C5-5). The deterioration 
A 
B C 
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in the regularity of the t-tubule system in HF, as measured by the power of the 
dominant frequency of the Fourier transform, was also partially normalised by HF-
UN (Figure C5-5). These results indicate that mechanical unloading can normalise t-
tubule structure. The impact of this on DHPR-RyR coupling and microarchitecture 
was investigated below. 
 
FIGURE C5-5: MECHANICAL UNLOADING RESTORED THE T-TUBULE DENSITY AND 
REGULARITY 
(A) Single LV cardiomyocytes stained with Di-8-ANEPPS are shown. HF resulted in a reduced t-
tubule density and (B &C) a lower power of the dominant peak of the Fourier transform of the t-
tubules. Mechanical unloading improved t-tubule density and regularity. (Sham n=40, HF n = 32, HF-
UN n=27). 
 
5.3.6 T-Tubule Improvements After Mechanical Unloading Were Accompanied 
By Improved Cell Surface Structure 
In Sham cells, clearly defined z-grooves were present which contain the t-tubule 
openings. This is in common with all ventricular mammalian cardiomyocytes studied 
to date. The cell surface is characterised by a high z-groove index, which provides a 
Sham 
HF 
HF)UN 
A 
B C D 
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measure of the actual z-groove over the predicted z-groove. The cell surface was 
flattened and distorted in HF, with a reduction in the z-groove index. SICM of cells 
from failing hearts after HF-UN showed the reappearance of a normal cell surface 
structure with clear striations (Figure C5-6). This was accompanied by a 
normalisation of the z-groove index. Therefore the cell surface undergoes profound 
remodelling in HF and reverse remodelling following mechanical unloading. 
 
 
FIGURE C5-6: MECHANICAL UNLOADING RESTORED NORMAL CELL SURFACE 
ARCHITECTURE 
(A-C) SICM shows the cell surface of isolated ventricular cardiomyocytes. (D) The z-groove index is 
an index of the regularity of the cell surface. This was reduced in HF and normalised by mechanical 
unloading. (Sham n=14, HF n = 25, HF-UN n=17). 
 
5.3.7 Mechanical Unloading Restored Normal T-Tubule Microarchitecture 
T-tubule microarchitecture was assessed using transmission EM of single 
cardiomyocytes, which were stuck flat along their long-axis using a Cytospin system, 
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described in the Methods. Only optical sections in which the sarcomere length was 
between 1.6-2.0µm were used. The lumen of single t-tubules could be observed close 
to the z-disk. T-tubule lumen were reduced in density (measured as number of lumen 
per optical section) and were dilated in HF. Mechanical unloading normalised these 
parameters towards Sham levels (Figure C5-7). 
 
FIGURE C5-7: MECHANICAL UNLOADING RESTORED T-TUBULAR 
MICROARCHITECTURE 
(A-C) Optical sections of TEM of isolated ventricular cardiomyocytes are shown. (D) HF cells showed 
fewer total t-tubules per optical section which were dilated. (E) Mechanical unloading caused a 
regression of t-tubular dilation, and a restoration of their normal density. Black scale bars indicate 1µm 
(80 optical sections were analysed in each animal in each group). 
 
5.3.8 Mechanical Unloading Restored DHPR-RyR Coupling 
To test the hypothesis that the Ca2+ handling improvements observed here were the 
result of recoupling of DHPR-RyR, immunofluorescence was used to quantify the 
Sham HF HF)UN 
Sham HF HF-UN
0
2
4
6
8
10
12
***
***
N
o 
of
 T
-t
ub
ul
es
/O
pt
ic
al
S
ec
ti
on
Sham HF HF-UN
0.00
0.25
0.50
0.75
***
***
*
R
at
io
 o
f 
Tr
an
sv
er
se
: 
Lo
ng
it
ud
in
al
T-
tu
bu
le
s
Sham HF HF-UN
0.000
0.025
0.050
0.075
0.100
0.125
0.150
0.175 *** ***
T-
tu
bu
le
 D
ia
m
et
er
 (
µ
m
)
Sham HF HF-UN
0
2
4
6
8
10
12
***
***
N
o 
of
 T
-t
ub
ul
es
/O
pt
ic
al
S
ec
ti
on
Sham HF HF-UN
0.00
0.25
0.50
0.75
***
***
*
R
at
io
 o
f 
Tr
an
sv
er
se
: 
Lo
ng
it
ud
in
al
T-
tu
bu
le
s
Sham HF HF-UN
0.000
0.025
0.050
0.075
0.100
0.125
0.150
0.175 *** ***
T-
tu
bu
le
 D
ia
m
et
er
 (
µ
m
)
!! !
A B C 
D E 
! 176!
degree of DHPR-RyR overlap. In cells from Sham-operated animals, the DHPR-RyR 
staining overlapped, resulting in a pattern of colocalised pixels which was ordered 
into regular striations. In HF, the degree of colocalisation was reduced as the t-tubular 
disruption caused loss of and disruption to the DHPR-RyR staining. Unloading 
normalised the pattern of DHPR and RyR staining and increased DHPR-RyR 
colocalisation, towards Sham levels (Figure C5-8). 
 
 
FIGURE C5-8: MECHANICAL UNLOADING RECOUPLED ORPHANED RYR WITH DHPR 
(A-C) Examples of DHPR (green), RyR (red) and colocalised pixels (CP, white) are shown. In normal 
ventricular cardiomyocytes, there is a high degree of DHPR-RyR colocalisation with a clear striated 
pattern of DHPR-RyR interaction. (B,D,E) In HF, DHPR-RyR colocalisation is reduced with a loss of 
the striated pattern of colocalised pixels. Mechanical unloading significantly improves DHPR-RyR 
colocalisation. (Sham n=63, HF n = 49, HF-UN n=42). 
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5.4 Discussion 
The experiments described in this Chapter suggest that mechanical unloading of 
failing hearts results in regression of a number of pathologic cellular properties 
observed in HF including the amplitude, time to peak and decay of the Ca2+ transient 
and the synchronicity of the Ca2+ release from the SR. Mechanical unloading 
normalised the Ca2+ spark frequency, t-tubule density and regularity all of which were 
altered in HF. Unloading also normalised ICa,L and SR Ca2+ content. Chronic 
mechanical unloading recovered the t-tubule system structure with improvements in 
CICR, and recoupling of DHPR-RyR. Such DHPR-RyR recoupling likely underlies 
the cellular Ca2+ handling improvements identified. 
 
5.4.1 Ca2+ Handling Improvements 
There is considerable evidence that HF cardiomyocytes have disrupted synchronicity 
of Ca2+ release during the Ca2+ transient (Song et al., 2006, Louch et al., 2010c, 
Louch et al., 2006, Louch et al., 2004). This Chapter showed similar results, with 
Ca2+ transients severely disrupted in HF and with multiple points of delayed SR Ca2+ 
release across the cell compared to Sham. This study did not attempt to colocalise 
defects in the t-tubule system and the Ca2+ transient, but other studies show that points 
of delayed SR Ca2+ release are localised to gaps in the t-tubule system (Song et al., 
2006, Louch et al., 2004). SR Ca2+ release is initiated at t-tubules but propagates more 
slowly to activate RyR in regions devoid of t-tubules (Louch et al., 2010c). The RyR 
distribution was partially affected in HF, although to a significantly lesser degree than 
for DHPR. The reappearance of regular t-tubules following mechanical unloading 
likely accounts for the improvements in Ca2+ release synchronicity by improving 
DHPR-RyR coupling. 
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SR Ca2+ content, which was also found reduced in HF, is a critical determinant of 
Ca2+ transient amplitude and rate of release. The SR Ca2+ content increased after 
mechanical unloading, which may contribute to the improvement in the Ca2+ transient 
amplitude. Recent evidence from studies in HF rats treated with SERCA2a adenovirus 
is helpful in understanding what impact this alone could have (Lyon et al., 2012). 
Lyon et al. also showed that cell surface and t-tubule density underwent significant 
reverse remodelling after SERCA2a adeno-associated virus infection. This resulted in 
β2-AR redistribution and recompartmentalisation of cAMP signalling. Ca2+ transient 
synchrony was also enhanced after SERCA2a therapy, in a similar fashion to the 
results observed here. Lyon et al also showed that SERCA2a gene therapy, for a 
period of 4-6 weeks, was sufficient to improve LV systolic function measured by 
pressure-volume loop analysis. Another important study in this regard is an 
investigation of the electrophysiological properties of cardiomyocytes from patients 
who recovered following LVAD implantation and those who did not. Terracciano et 
al showed that clinical recovery was associated with an enhanced SR Ca2+ content 
specifically (Terracciano et al., 2004). Whether the increase in SR Ca2+ content 
brought about by gene therapy approaches is sufficient to induce functional recovery 
is not known in the clinical setting. Ogletree-Hughes et al (Ogletree-Hughes et al., 
2001) showed that short term LVAD support resulted in enhanced SERCA2a 
expression and improved contractility, but that longer duration support resulted in a 
reversion of these properties to failing levels. This supports the notion that 
physiological cellular Ca2+ handling is dependent on a normal range of mechanical 
load and that deviation in either positive or negative directions results in subnormal 
performance. 
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Changes to the RyR phosphorylation status and AP morphology are features which 
were not investigated, but which may contribute to the changes in the Ca2+ transient. 
With respect to AP changes, Chapter 4 suggests that mechanical unloading alone does 
not influence the AP morphology but whether this is true in the context of the failing 
heart is not known. Recent computational studies (Louch et al., 2010a) suggest that 
AP changes per se are not primarily responsible for dyssynchronous Ca2+ release in 
HF, and that other changes, including t-tubule abnormalities, may be more important 
for small species; in man, however, AP morphology certainly would play a role in 
dyssynchronous Ca2+ release. 
 
One way of investigating RyR function is to examine Ca2+ spark properties. In HF, 
spontaneous Ca2+ sparks occur more frequently at gaps in the t-tubules, suggesting 
that they are generated by uncoupled RyRs (Meethal et al., 2007). This uncoupling is 
caused by disruptions to the t-tubule system (Heinzel et al., 2002, Heinzel et al., 2008, 
Song et al., 2006) and could explain the finding that global Ca2+ spark frequency was 
raised in HF, and that it was normalised by the reappearance of t-tubules after 
unloading. 
 
Evidence was presented in the previous Chapter to support the notion that coupling 
between DHPR and RyR stabilises the RyR and reduces Ca2+ spark frequency. This is 
supported by this Chapter, which shows that uncoupled, relatively detubulated 
cardiomyocytes show increased Ca2+ spark frequency, and that Ca2+ spark frequency 
was reduced when the t-tubules reappear. Exposure of RyR to the cardiac DHPR II-III 
loop peptide can inhibit RyR open probability in bilayers (Li and Bers, 2001). When 
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included in a dialysing patch pipette this peptide reduces Ca2+ spark frequency by 
50% in voltage clamp mode (Li and Bers, 2001). Thus it could be possible that 
retubulation results in recoupling, which directly inhibits RyR. More work is needed 
to clarify this question. 
 
The Ca2+ spark amplitude, duration and width are determined by mechanisms which 
are incompletely understood, but include the SR Ca2+ content, the functional status of 
RyR, the buffering properties of the cytoplasm and possibly the activity of NCX 
(Jordan et al., 2010, Neco et al., 2010). Recent evidence suggests that the increase in 
Ca2+ spark duration observed in HF might be due to misplacement of NCX, which 
leads to persistently raised local Ca2+ (Biesmans et al., 2011). β-adrenergic 
stimulation may also affect the Ca2+ spark amplitude (Ramay et al., 2011). All these 
elements are affected in HF and their interaction sets the Ca2+ spark amplitude, which 
was increased in this model, despite reduced SR Ca2+ content. Direct effects of 
phosphorylation on RyR open probability, due to involvement of CaMKII (Mishra et 
al., 2010) or accessory proteins (Marx et al., 2000) in HF, may occur but whether 
these aspects contribute to the Ca2+ spark changes observed here is not known, and 
further studies are required. Chapter 4 demonstrated that mechanical unloading of 
normal hearts resulted in cardiomyocytes with longer and wider Ca2+ sparks, which 
suggests that mechanical unloading in either the setting of HF or normal hearts could 
result in increased Ca2+ spark width and duration. No previous studies have examined 
the effect of unloading on Ca2+ spark properties and future studies should examine 
whether this could be due to altered cytoplasmic buffering, or post-translational 
regulation of RyR, for example by phosphorylation. 
 
! 181!
5.4.2 Regression Of Cellular Hypertrophy 
Mechanical unloading induces a regression of cellular hypertrophy (Zafeiridis et al., 
1998). Compared with mechanical unloading of normal hearts described in Chapter 4, 
mechanical unloading of failing hearts does not cause as large a reduction in cell size. 
Although profound reductions in cell volume, atrophy, may induce dysfunction, there 
is no direct relationship between cell size and CICR, although it is clear that profound 
increases or reductions in cell size are associated with altered function (Oriyanhan et 
al., 2007, Welsh et al., 2001).  Importantly, in a study of the effect of LVAD therapy 
on failing cardiomyocytes, cells from patients who showed clinical recovery showed 
enhanced SR Ca2+ content, reduced AP duration and improved inactivation properties 
of ICa,L (Terracciano et al., 2004). That is to say that the regression of cellular 
hypertrophy occurred in both those who recovered and those who did not, while the 
cardiomyocytes of those who showed clinical recovery showed specific 
electrophysiological features. 
 
5.4.3 ICa,L Changes 
 
ICa,L density is reduced in some HF models (Soppa et al., 2008b), while other studies 
do not show a depressed ICa,L (Schroder et al., 1998). ICa,L depends on both the 
number and the activity of LTCCs. Since there was a reduction in the t-tubule density 
in our model, it is likely that the number of channels was reduced. Typically, 
investigators have explained reports of unchanged ICa,L between Sham and HF as 
due to increased single channel activity and likely to be altered by the overall severity 
of the model of HF (Brette et al., 2004b, Brette et al., 2006, Brette et al., 2004a, Chen 
et al., 2002, Yang et al., 2000). This study shows normalisation of ICa,L with 
unloading, which suggests that either the new t-tubules contain LTCCs or the same 
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channels have improved conductance. Further studies are required to clarify these 
issues. 
 
Fast, Ca2+ dependent inactivation time was reduced (faster) in HF and normalised 
after mechanical unloading. In Chapter 4, mechanical unloading alone resulted in a 
slowing of fast, Ca2+ dependent inactivation. The mechanisms for this may be linked 
to SR Ca2+ release and merit further study. 
 
5.4.4 T-Tubule Physiology 
This study confirms the deterioration in t-tubule structure observed by many 
investigators (reviewed in (Louch et al., 2010c)) in models of HF (He et al., 2001, 
Gomez et al., 1997, Song et al., 2006) and in diseased human myocardium (Lyon et 
al., 2009). The nature of this disruption appears to be different depending on the 
animal model. HF models in large animals appear to show drastic reductions in the t-
tubule density, also confirmed in man, and are associated with a reduction in the 
regularity of the remaining t-tubules. In small animal models, the dysfunction is 
dominated by a reduction in the regularity of this system, in the absence of large 
reductions in t-tubule density.  However, in our model there is a modest but 
significant reduction in t-tubule density, which likely reflects the severity of HF 
obtained in these animals. 
 
This Chapter is the first study to show a recovery of the t-tubule system in post-
ischemic cardiomyopathy by reducing mechanical load. Only one study, using 
exercise in murine diabetic cardiomyopathy, has previously shown that this recovery 
is possible (Stolen et al., 2009). 
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The mechanisms mediating the load-dependence of the t-tubule structure are poorly 
defined, and further studies are needed to dissect the molecular mechanisms. These 
studies will assess the therapeutic potential of the t-tubules. Such molecules include 
Tcap, which has recently been shown to be both stretch-sensitive and involved with 
orderly t-tubule formation (Zhang et al., 2009). The regulators of other proteins, such 
as BIN1, which is involved in t-tubule biogenesis and the shuttling of LTCCs to the 
membrane, is not known (Lee et al., 2002, Hong et al., 2012). It was also recently 
demonstrated that JPH2, a protein thought to promote dyad coupling, was reduced as 
cardiac hypertrophy developed into HF (Wei et al., 2010). How these molecular 
pathways interact in health and disease is a central question for future studies. Recent 
evidence has come from the study mentioned previously on SERCA2a gene therapy 
in the failing heart (Lyon et al., 2012). This study showed that the recovery of t-tubule 
density and cell surface structure was associated with enhanced expression of BIN1 
and Tcap protein, but not JPH2. Whether these are causally related to the recovery of 
the t-tubule system is untested. Chapter 7 will address the role of Tcap in t-tubule 
structure and function. 
 
5.4.5 Summary 
This Chapter shows that mechanical unloading of failing hearts produces recovery of 
the t-tubule structure with improvements to local CICR, likely as a result of enhanced 
DHPR-RyR coupling. These changes may constitute a subcellular mechanism for the 
initial improvements in cardiac function seen after LVAD therapy in patients with 
HF. 
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Chapter 6 
Cardiomyocyte Ca2+ Handling And Structure Are Regulated 
By Degree And Duration Of Mechanical Load Variation 
 
In this Chapter, the effect of chronic mechanical load on local CICR and t-tubule 
structure is examined using a model of chronic mechanical overload (TAC) and 
moderate mechanical unloading (HAHLT). Results are then compared with those 
presented in Chapter 4, which employed a model of severe mechanical unloading, 
heterotopic abdominal heart-only transplantation. Cellular Ca2+ transients, Ca2+ 
sparks, cell and t-tubule structure were studied. 
 
These experiments assessed the following hypothesis: the t-tubule network and local 
CICR are sensitive to the degree and duration of mechanical load. 
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6.1 Introduction 
T-tubule dysfunction is a major feature of HF in human cardiomyocyes (Lyon et al., 
2009), and in animal models of overload, myocardial infarction and arrhythmia 
(reviewed in the Introduction), which was also found in Chapter 5. HF is driven by a 
wide range of insults to the myocardium, including inflammation and altered systemic 
signalling, and it is advantageous to study the effect of isolated chronic mechanical 
overload. Chronic mechanical overload alone, prior to the advent of HF, may lead to 
disruption of the t-tubule system (Wei et al., 2010). Prolonged mechanical unloading 
of the normal heart can also disrupt t-tubule structure and impair local CICR, as found 
in Chapter 4. In addition, mechanical unloading can promote reverse functional and 
ultrastructural remodelling in HF (Chapter 5) but unloading-induced improvements 
regress and prolonged unloading can cause further dysfunction (Oriyanhan et al., 
2007). Reducing the degree of unloading could prevent these long-term negative 
effects and possibly favour a stable myocardial recovery, but this has not been 
thoroughly investigated (Wang et al., 2008, Wang et al., 2009). These studies raise 
the question of the nature of the load sensitivity of the myocardium. Specifically, it is 
not clear whether there is an optimal range of degrees and durations of load variation, 
and the nature of the transition to a non-physiological range is not understood. 
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6.2 Materials and Methods 
Syngeneic male Lewis rats (10 - 12 weeks old, approximately 220g) were used in all 
the experiments. 
6.2.1 Mechanical Unloading 
Moderate mechanical unloading (UN) was obtained by transplanting a heart-lung 
block from a donor animal into the abdomen of a syngeneic recipient (HAHLT). 
Briefly, the ascending aorta of the donor was anastomosed to the recipient abdominal 
aorta. Coronary blood flow is directed to the right heart via the coronary sinus, 
through the pulmonary circulation and then to the LV. Therefore, the LV only ejects 
the coronary and not the systemic return, and is moderately mechanically unloaded. 
Severe, full unloading (S-UN) (as used during Chapters 4 and 5) was obtained by 
using the heterotopic abdominal heart only transplantation, which completely 
abolishes blood return to the LV via the pulmonary veins. Data from the experiments 
performed in Chapter 4 are compared with the moderate unloading data generated in 
these experiments in Table C6-1. The recipient’s native heart acted as a control in 
these experiments. 
 
6.2.2 TAC Model 
The TAC model was used to overload the heart by increasing afterload. A right 
thoracotomy was made, and the ascending aorta exposed. A suture was looped around 
the aorta and tied over a 0.9mm bar placed between the ascending aorta and the 
suture. The suture was tied tightly and the needle removed. Sham-operated rat hearts 
acted as a control. 
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6.2.3 Duration Of Mechanical Load Variation And Cell Isolation 
UN hearts and normal recipient hearts were harvested after 4 or 8 weeks. The 4-week 
moderate unloading results are compared with the 4-week severe unloading results 
generated in Chapter 4. Mechanically overloaded hearts were harvested after 6 or 10 
weeks. The number of animals studied in each group were as follows: UN 8 weeks 
n=3, UN 4 weeks n=4, Control n=7, TAC 6 weeks n=5, TAC 10 weeks n=6. 
 
Single LV cardiomyocytes were isolated as described previously (Siedlecka et al., 
2008). All experiments were conducted at 37°C. 
 
Following cell isolation, the following experiments were performed: 
 
-Ca2+ transient and Ca2+ spark recordings 
-SR Ca2+ content measurements 
-Cell and t-tubule imaging using Di-8-ANEPPS 
-Cell surface imaging using SICM (with help from Dr Sergiy Tokar) 
-ICa,L recordings (Dr Urszula Siedlecka) 
 
 
6.2.4 Statistical Analysis 
Statistical analysis was performed using Prism4 software (GraphPad software Inc., 
San Diego, Ca, USA), and the non-parametric Kruskal-Wallis test was used to assess 
statistical differences. Dunn’s post-hoc test was used to compare groups. As no 
statistical differences were detected between sham-operated controls (for the TAC 
group) and native recipient heart controls, these two groups were pooled in a single 
control group for clarity. In the comparison section with Chapter 4, values were 
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normalised to their controls by dividing each value by the mean control value. These 
data are reported in ratio units (Table C6-1). 
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6.3 Results 
6.3.1 Chronic Mechanical Load Variation Altered LV Weight and 
Cardiomyocyte Volume 
4 weeks UN significantly reduced cardiomyocyte volume by 25.7%, but did not cause 
a reduced LV weight (Figure C6-1). After 8 weeks UN, cell volume was further 
reduced (a 60.1% reduction compared to control, Figure C6-1), as was LV weight. 
Interestingly, as UN progressed with time, the spread of cell volumes became smaller, 
as well as the mean. UN at 4 weeks showed a range of cell volumes within that of the 
control group. At 8 weeks a population of smaller cells, with a cell volume below the 
minimum range of the control group, were documented. 
 
FIGURE C6-1: CHRONIC MECHANICAL LOAD VARIATION ALTERED LV WEIGHT 
AND CARDIOMYOCYTE VOLUME 
(A) LV weight of moderately unloaded and overloaded hearts (UN 8 n=3, UN 4 n=4, Control n=7, 
TAC 6 n=5, TAC 10 n=6) (B) Cell volume of Di-8-ANEPPS stained LV cardiomyocytes from hearts 
subjected to chronic mechanical load variation of different periods (UN 8 n=80, UN 4 n=50, Control 
n=136, TAC 6 n=60, TAC 10 n=42). 
 
Mechanical overload for 6 weeks caused significant LV but not cardiomyocyte 
hypertrophy (Figure C6-1). Mechanical overload for 10 weeks caused significant LV 
and cardiomyocyte hypertrophy (23.6% increase in cardiomyocyte volume compared 
A B 
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to Sham, Figure C6-1). The mismatch between LV weight and cell volume might be 
artefactual and is discussed below. It is notable that the range of cell volumes did not 
change after mechanical unloading, but the mean did, owing to shifts in the relative 
distribution of cell volumes within the same range. 
 
6.3.2 The Ca2+ Transient Was Affected By Degree And Duration Of Mechanical 
Load Variation 
 
4 weeks UN did not influence the time to peak of the Ca2+ transient, which was 
prolonged by 17.4% at 8 weeks unloading (Figure C6-2). 4 weeks UN did not affect 
the amplitude of the Ca2+ transient, but 8 weeks significantly reduced this (Figure C6-
2). Both 4 and 8 weeks UN increased the time to 50% and time to 90% decline of the 
Ca2+ transient. The variance of the time to peak of the Ca2+ transient was increased 
after 8 weeks but not 4 weeks UN (Figure C6-2). 
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FIGURE C6-2: THE CA2+ TRANSIENT WAS AFFECTED BY DEGREE AND DURATION OF MECHANICAL LOAD VARIATION 
(A) Ca2+ transients of control, (B) unloaded and (C) overloaded cardiomyocytes. (D) Variance of the time to peak of the Ca2+ transient. (E) Time to peak, (F) 
amplitude, (G) time to 50% decline and (H) time to 90% decline of the Ca2+ transient were assessed (UN 8 n=50, UN 4 n=46, Control n=141, TAC 6 n=34, TAC 
10 n=21). The vertical scale bar represents 100ms and the horizontal scale bar represents 100 pixels. The colour chart is a normalised scale of fluorescence 
intensity. 
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Time to peak of the Ca2+ transient was unaffected by the duration of mechanical 
overload used in this study (Figure C6-2). After 6 and 10 weeks of mechanical 
overload, the amplitude of the Ca2+ transient was larger and the decline of the Ca2+ 
transient was faster compared with controls. 6 weeks of mechanical overload reduced 
the variance of the time to peak of the Ca2+ transient, which was then increased to 
control levels at 10 weeks (Figure C6-2). SR Ca2+ content was augmented at 10 weeks 
of mechanical overload compared to controls (Control: 0.39±0.1 ratio units, n=30 vs 
TAC 10 weeks: 0.47±0.1 ratio units, n=29, p<0.0001).  In summary, UN 
progressively slowed and reduced the amplitude of the whole cell Ca2+ transient but 
the two overloading conditions induced responses which resembled physiological 
adaptation to stress. 
 
6.3.3 Ca2+ Spark Frequency And Morphology Were Affected By Degree And 
Duration Of Mechanical Load Variation 
 
8 but not 4 weeks UN increased Ca2+ spark frequency. 4 weeks UN increased the Ca2+ 
spark peak amplitude, which was reduced at 8 weeks UN compared to control (Figure 
C6-3). 4 and 8 weeks UN increased Ca2+ spark width and duration.  
 
10 but not 6 weeks of mechanical overload increased Ca2+ spark frequency (Figure 
C6-3). 6 and 10 weeks of mechanical overload increased Ca2+ spark peak and width. 
Again, although these were statistically significant, they were small in magnitude and 
possibly of limited functional relevance. 6 weeks of mechanical overload reduced 
Ca2+ spark duration, which was increased at 10 weeks compared to control. These 
results indicate that Ca2+ sparks are affected by the direction, degree and duration of 
chronic mechanical load.
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FIGURE C6-3: CA
2+
 SPARK FREQUENCY AND MORPHOLOGY WERE AFFECTED BY DEGREE AND DURATION OF MECHANICAL LOAD 
VARIATION 
(A) Representative traces of quiescent cardiomyocytes taken in line-scan mode to measure Ca
2+ 
spark features in control, (B) unloaded and (C) overloaded 
cardiomyocytes. Graphs show (D) Ca
2+
 spark frequency (UN 8 n=75, UN 4 n=73, Control n=173, TAC 6 n=50, TAC 10 n=28), (E) peak, (F) width and (G) duration (UN 
8 n=359, UN 4 n=242, Control n=447, TAC 6 n=152, TAC 10 n=513). The vertical scale bar represents 768ms and the horizontal scale bar represents 100 pixels. The 
colour chart is a normalised scale of fluorescence intensity. 
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6.3.4 T-Tubule Structure Is Sensitive To Degree And Duration Of Mechanical 
Load Variation 
 
Neither 4 nor 8 weeks UN altered the t-tubule density, as was found in Chapter 4 
(Figure C6-4). 8 but not 4 weeks UN reduced the t-tubule regularity, measured as the 
peak of the Fourier transform. At 6 weeks of mechanical overload, neither t-tubule 
density nor regularity were affected (Figure C6-4). However, 10 weeks of mechanical 
overload depressed both t-tubule density and regularity. Interestingly, all the data 
points of the experimental groups lie within the spread of the control data. The 
significant differences in the mean are the result of a different distribution of cell 
volumes within the same range. These data show that t-tubule structure is 
progressively disrupted by either chronic unloading or overloading of the 
myocardium.
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FIGURE C6-4: T-TUBULE STRUCTURE IS SENSITIVE TO DEGREE AND DURATION OF MECHANICAL LOAD VARIATION 
(A) T-tubule density was measured in cardiomyocytes from hearts undergoing chronic load variation (UN 8 n=80, UN 4 n=50, Control n=157, TAC 6 n=61, TAC 10 
n=31). (B) T-tubule regularity was recorded using Fourier transforms of (C) unloaded and (D) overloaded cardiomyocytes (UN 8 n=82, UN 4 n=53, Control n=151, TAC 
6 n=42, TAC 10 n=33). (E) Representative images of Di-8-ANEPPS stained LV cardiomyocytes from control, (F) unloaded and (G) overloaded hearts. Inset shows binary 
images of central portions of the cardiomyocytes. 
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6.3.5 Severe But Not Moderate Mechanical Unloading At 4 Weeks Is Associated 
With Pathological Remodelling Of Local CICR, T-Tubule And Cell Structure 
 
To examine the impact of moderate versus severe mechanical unloading, the results 
obtained after 4 weeks UN (as used throughout above) were compared with the results 
obtained using a model of severe unloading (S-UN), previously used in Chapter 4 and 
5. S-UN was associated with significantly smaller cell volume than UN (Table C6-1). 
Neither severe nor moderate unloading affected the t-tubule density with respect to 
control, although UN was surprisingly associated with lower t-tubule density 
compared to S-UN. While 4 weeks of UN did not alter t-tubule regularity, S-UN was 
associated with significant loss of regularity of the t-tubule system (Table C6-1). 
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TABLE C6-1: COMPARISON OF SEVERE UNLOADING (HAHT) VERSUS 
MODERATE UNLOADING (HAHLT) 
Values were obtained by dividing each value from the experimental group in question by the mean 
control value. This represents the effect of either S-UN or UN compared to its respective control. These 
values were then compared using a non-parametric t-test. TTP – time to peak; T50 – time to 50% 
decline; T90 – time to 90% decline. VTTP – variance of the time to peak. In the case of ICa,L, the peak 
current density was used. 
All values are ratio of 
control 
UN 4 S UN 4 p value 
Cell Volume 0.63 ± 0.04 (n=59) 0.43 ± 0.02 (n=90) *** 
T-tubule Density 0.89 ± 0.03 (n=50) 1.03 ± 0.02 (n=90) *** 
T-tubule Regularity 1.10 ± 0.08 (n=53) 0.13 ± 0.01 (n=49) *** 
z-groove index 0.93  ± 0.15 (n=6) 0.47 ± 0.03 (n=17) 0.064 
    
Ca
2+
 Transient TTP 1.12 ± 0.05 (n=46) 1.35 ± 0.08 (n=42) * 
Ca
2+
 Transient 
Amplitude 
0.99 ± 0.04 (n=46) 0.71 ± 0.04 (n=42) *** 
Ca
2+
 Transient T50 1.24 ± 0.03 (n=46) 1.66 ± 0.12 (n=42) ** 
Ca
2+
 Transient T90 1.24 ± 0.02 (n=46) 1.36 ±0.07 (n=42) 0.997 
Ca
2+
 Transient VTTP 1.15 ± 0.07 (n=46) 1.80 ± 0.16 (n=42) ** 
ICa.L Peak Current 0.77 ± 0.06 (n=26) 1.04 ± 0.04 (n=15) ** 
    
Spark Frequency 1.18 ± 0.17 (n=73) 3.85 ± 0.65 (n=87) *** 
Spark Peak 1.12 ± 0.02 (n=297) 0.96 ± 0.01 (n=459) *** 
Spark Width 1.03 ± 0.02 (n=242) 1.23 ± 0.02 (n=410) *** 
Spark Duration 1.23 ± 0.04 (n=242) 1.74 ± 0.06 (n=410) *** 
! 198!
S-UN increased the variance, prolonged the mean of the time to peak and time to 50% 
decline and reduced the amplitude of the Ca2+ transient compared to S-UN (Table C6-
1). The ICa,L was unaffected by either form of mechanical unloading compared to 
control, but UN was associated with lower peak ICa,L compared with S-UN. Given 
that with respect to their individual controls, there is no change to ICa,L, it appears 
that ICa,L is not affected by mechanical unloading. The Ca2+ spark frequency, width 
and duration were higher in S-UN compared to UN (Table C6-1). Ca2+ spark peak 
amplitude was lower in S-UN. 
 
To assess the impact of different degrees of unloading on the cell surface, SICM was 
used. S-UN appeared to induce some changes to the cell surface but this effect was 
not significantly different to the effect of UN (Table C6-1). In summary, these 
experiments show that the effects on CICR and t-tubules are graded by the severity of 
mechanical unloading. 
 
 
 
 
 
 
 
 
 
 
! 199!
 
6. 4 Discussion 
These results show that severe chronic increases or decreases in load are associated 
with significant changes in local CICR and t-tubule structure of normal LV 
cardiomyocytes. There were limited effects on these parameters by changes in load 
that are less severe or maintained for a shorter time period. 
 
6.4.1 Effect Of The Degree Of Mechanical Unloading 
The differential impact of the two models for severe and moderate unloading has been 
corroborated in previous studies (Wang et al., 2009). This Chapter shows that 
reduction of cell size obtained with moderate/short periods of unloading is 
accompanied by preserved cell function, supporting the notion of physiological 
hypotrophy, similar, but opposite in direction, to physiological hypertrophy (Figure 
C6- 5). This is distinct from pathological atrophy, which is observed after prolonged 
and severe unloading and is associated with dysfunction. Mechanical unloading using 
LVADs can produce major reverse remodelling and promote cardiac recovery (as 
reviewed in the Introduction) but prolonged unloading-induced atrophy may be a 
major impediment. One possible approach to prevent atrophic remodelling of the LV 
is the use of moderate mechanical unloading (Wang et al., 2008). The data presented 
in this study supports the concept that pathological atrophic remodelling is delayed 
with the use of moderate mechanical unloading. CICR remodelling is a central defect 
in failing cardiomyocytes and reversal of these changes is specifically associated with 
cardiac recovery (Terracciano et al., 2004). However, prolonged mechanical 
unloading can impair CICR, as documented in Table C6-1. 
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6.4.2 Alterations In Cell Volume And Myocardial Hypertrophy 
Both mechanical overload and unloading resulted in changes to the cell volume and 
LV weight. LV weight and cardiomyocyte volume did not necessarily change 
together, with a significant reduction in cell volume but not LV weight at 4 weeks of 
mechanical unloading, and a significant increase in LV weight but not cell volume at 
6 weeks of mechanical unloading (Figure C6-1). The mechanisms of this are unclear. 
The measurement of LV weight occurs after enzymatic digestion on the Langendorff 
perfusion system, but while the LV is still relatively intact, and prior to dissection of 
the tissue into smaller pieces and isolation of single cardiomyocytes. As LV weighing 
occurs at this early stage it is possibly less vulnerable to confounding factors. The 
spread of the data might also play a role in preventing statistical significance. A 
greater number of experimental replicates could help to overcome the problem of 
spread of the data. 
 
6.4.3 Load Variation And Local CICR 
The Ca2+ transient undergoes pathological remodelling in mechanical unloading, and 
was depressed in amplitude and delayed in its time course at 8 weeks of mechanical 
unloading. Shorter term unloading did not result in such changes. Severe mechanical 
unloading resulted in significantly more Ca2+ transient remodelling than moderate 
unloading, indicating a graded effect of degree of unloading. Mechanical overload 
resulted in an augmented Ca2+ transient amplitude and faster decline at 6 and 10 
weeks. These changes are likely to be a part of the physiological compensation to 
mechanical overload, and it is known that such physiological responses can be 
maintained up to 24 weeks after the institution of chronic mechanical overload (Del 
Monte et al., 2002). HF and the maladaptive response are heralded by abnormal 
cellular structure and function. The variance of the time to peak of the Ca2+ transient 
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was increased after 8 weeks of mechanical unloading, indicating greater CICR 
dyssynchrony, related to the disruption of the t-tubule structure. Interestingly, the 
variance of the time to peak of the Ca2+ transient was reduced (better synchrony) at 6 
weeks of mechanical overload, possibly indicating enhanced cellular activation due to 
the augmented Ca2+ transient. This effect was lost at 10 weeks of mechanical 
overload, which accompanied t-tubule loss and disorganisation. While shorter-term 
mechanical overload is within a physiological range and associated with preserved t-
tubule structure, as in physiological hypertrophy of exercise (Stolen et al., 2009), 
prolonged overload likely represents the beginning of a maladaptive response. The 
enhanced SR Ca2+ content observed at 10 weeks mechanical overload could account 
for the fact that, despite the loss of the t-tubule network, relatively normal Ca2+ 
transients were observed. The increased SR Ca2+ content could mitigate the reduced 
LTCC-RyR coupling, allowing an early stage of compensated T-tubule dysfunction. 
ICa,L was unchanged compared to control in both moderate and severe unloading. 
 
Increased Ca2+ spark frequency, an indication of SR Ca2+ leak which is observed in 
HF (Venetucci et al., 2008), occurs at the extremes of both mechanical overload and 
mechanical unloading. The enhanced SR Ca2+ content could also contribute to the 
increased Ca2+ spark frequency in the 10 week TAC group. Mechanical unloading, 
whether moderate or severe, of a normal or failing heart (Chapter 5), uniformly 
increased Ca2+ spark duration. The mechanisms mediating this are unclear, but may 
include altered phosphorylation of RyR clusters (Bers, 2006b). Changes to the width 
of the Ca2+ sparks may be related to altered Ca2+ diffusion and buffering properties of 
these cells. The mechanisms mediating altered Ca2+ spark duration during unloading 
were discussed in previous Chapters. 
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This Chapter was focused on examining the impact of chronic mechanical load 
variation on local CICR and its structural substrate, the t-tubule network. This system 
exists in a wider system, of excitation-contraction coupling elements including the 
NCX, the AP, SERCA2a (Louch et al., 2010c). The assessment of these elements is 
an important point for future studies. 
 
6.4.4 T-Tubule System As A Load-Sensitive Regulator Of CICR 
Mechanical unloading appears to induce subtle disorder of the t-tubules, without 
reduction in their density. These changes are dependent on both the degree and 
duration of unloading (Figure C6-5). Mechanical overload appears to impair their 
density and regularity. 
 
While there were multiple cellular examples of physiological adaptation in this study, 
including augmented Ca2+ transient amplitude, and the novel finding of enhanced 
variance of the time to peak, there was no evidence of enhanced t-tubule density. 
Kemi et al used exercise training to examine the effect of physiologic hypertrophy 
alone and as a possible therapy for post-myocardial infarction pathological 
hypertrophy (Kemi et al., 2011). They found that the induction of physiological 
hypertrophy alone did not influence the t-tubule density, in agreement with the 
present findings. Interestingly, they showed that the induction of physiological 
hypertrophy could reverse the detubulating effect of pathological, post-infarct 
hypertrophic remodelling. This indicates that it is not only the degree of hypertrophy 
(by measures of heart weight or cell volume) but also its quality and timecourse, 
which is presumably signalled by separate pathways (Heineke and Molkentin, 2006). 
The pace of load variation may also be important since the gradual, intermittent 
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increase in cardiac load induced by exercise is quite different to the sudden increase in 
cardiac load induced by myocardial infarction or TAC. 
 
The mechanisms mediating the load sensitivity of the t-tubule system are not clear, 
but a number of candidates are emerging including BIN-1, Tcap, JPH2 and others (for 
a detailed review, see Introduction). In particular, JPH2 expression appears to 
decrease as TAC-induced hypertrophy progresses, possibly mediating t-tubule 
disruption (Wei et al., 2010). 
 
6.4.5 Limitations And Questions For The Future 
One limitation of this study is that not all the parameters were measured for every 
group. SR Ca2+ content measurements were only performed for the Sham and 10 
week TAC groups to address the specific question of the aetiology of preserved Ca2+ 
transient amplitude in the light of t-tubule disruption. It was only possible to use 
SICM to examine the 4 week moderate unloading cells, and the effect of longer term 
8 week moderate unloading has not been studied. The nature of the sensitivity to the 
degree of load was addressed for mechanical unloading, using models of moderate 
and severe unloading. These data suggest that more severe unloading brings about 
rapid cellular remodelling. Future studies should examine whether the same is true of 
mechanical overload, using different band tightness as well as using different 
durations of load increase. In this regard, it is noteworthy that most studies describe 
the degree of stenosis in a way which is not meaningful. The gauge of a cannula or 
needle is not a guarantee of fixed external diameter, but internal diameter. It is 
preferable to use the external diameter, and ideal to provide a pressure gradient, but 
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this was not possible in this study. Also, it is important to control the size of the aorta, 
which can be attempted by using animals within a small body weight range. 
 
6.4.6 Clinical Relevance 
Partial mechanical unloading is being suggested as a means to prevent mechanical 
unloading-induced atrophic remodelling in patients and these results and those of 
others (e.g. (Wang et al., 2008)) support the concept that lower grade unloading 
delays or prevents adverse remodelling during treatment with LVADs. 
 
6.4.7 Summary 
Mechanical overloading and unloading result in graded changes to the t-tubule 
network and local CICR. This supports the notion that the t-tubule system is load-
sensitive in both degree and duration and that there is a range of physiological loading 
conditions that allow normal t-tubule structure. Importantly, this study supports the 
notion of a physiological reduction in load that can be associated with normal 
cardiomyocyte structure and function. 
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Chapter 7 
Telethonin Regulates T-Tubule Structure And Function In 
The Mammalian Heart 
 
 
 
In this Chapter, the role of Tcap in regulating t-tubule structure and function during 
physiological conditions and during chronic mechanical overload (TAC) was studied. 
To do this, Tcap KO mice were used. Cellular Ca2+ transients, Ca2+ sparks, cell 
surface and t-tubule structure were studied. 
 
These experiments assessed the following hypothesis: Tcap is a regulator of t-tubule 
structure, which is especially important during mechanical overload. 
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7.1 Introduction 
T-tubule dysfunction is a major feature of cardiac diseases, and occurs early in 
overload-induced HF (Wei et al., 2010). A major biophysical regulator of t-tubule 
structure appears to be chronic mechanical load, with both increases and decreases in 
mechanical load altering the t-tubule structure, as investigated in Chapters 4-6. 
Treatment of HF-induced overload with mechanical unloading can reverse t-tubule 
dysfunction (Chapter 5), indicating that normalisation of mechanical overload results 
in normalisation of the t-tubule structure and function. Therefore, the t-tubule system 
is tightly regulated by load variation in both health and disease. 
 
Tcap is a 19KDa protein of the sarcomeric z-disk, which is involved in a class of 
muscular dystrophies (Valle et al., 1997, Markert et al., 2010). Recent work has 
suggested that one mechanism by which Tcap mutations result in such muscular 
dystrophies is by disruption to the t-tubule system (Zhang et al., 2009). Tcap KO has 
been studied previously (Markert et al., 2010, Knoll et al., 2011). These studies show 
that while Tcap is not essential for skeletal or cardiac muscle development, contractile 
and stretch-sensing defects occur in Tcap KO. In the heart, Tcap KOs show no gross 
cardiac disease spontaneously, but its signalling with p53 results in profound 
apoptosis after the institution of mechanical overload, with contractile failure (Knoll 
et al., 2011). 
 
As has been discussed previously, a number of molecules are likely to be involved in 
regulating t-tubule structure and function (Table I-4). Tcap is a candidate load-
dependent regulator of t-tubule structure because (i) it is a part of the stretch-sensitive 
complex of the cardiomyocyte z-disc (Hayashi et al., 2004, Knoll et al., 2002); (ii) it 
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links this stretch-sensitive complex with proteins localised in the t-tubule membrane 
(Furukawa et al., 2001); (iii) it is stretch-sensitive in expression, and is required for 
normal t-tubule development in zebrafish skeletal muscle (Zhang et al., 2009) and (iv) 
is mutated in a manner which increases stretch-sensitivity in HOCM and reduces 
stretch-sensitivity in DCM (Hayashi et al., 2004), conditions where t-tubule 
abnormalities also exist (Lyon et al., 2009). Recent evidence shows that in Tcap KOs 
cardiac overload results in pronounced apoptosis (Knoll et al., 2011). 
 
Based on these studies, it is timely to test the hypothesis that Tcap is a load-dependent 
regulator of t-tubule structure in the heart. This was done using a Tcap KO mouse, 
which was studied at 3 and 8 months, and following 4 weeks of TAC performed in 3 
month old mice. Single cardiomyocytes were then isolated and assessed in terms of 
local CICR, t-tubule and cell structure. 
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7.2 Materials and Methods 
All procedures were performed according to the guidance of the UK Home Office 
following ethical review. 
 
7.2.1 Tcap Knock-Out Mice 
Tcap KO animals were generated on a C57BL/6 background by replacing the coding 
regions of exon 1 and 2 by a lacz-neomycin cassette to monitor endogenous gene 
expression using homologous recombination as described previously (Knoll et al., 
2011). These animals were provided by Professor Ralph Knoll, Imperial College 
London. Four animals were used in each group. 
 
The whole heart phenotype of this specific model has been described previously 
(Knoll et al., 2011). Using echocardiography in 3 to 4 month old KO mice, Knoll et al 
were unable to identify any defect in contractility or heart dimensions under 
spontaneous conditions. In addition, electrocardiogram analyses revealed no 
abnormalities. (Knoll et al., 2011) 
 
In this Chapter, to investigate the status of the t-tubule system and local CICR at a 
young and mature stage, animals were studied at 3 months of age (3mKO) and at 8 
months of age (8mKO). Age- and sex-matched C57BL/6 non-littermate wild-type 
(WT) controls were used. 
 
7.2.2 TAC 
To investigate the impact of chronic mechanical overload, TAC was performed in 
animals at 8-12 weeks of age. A small portion of the second rib was excised to 
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provide access to the transverse thoracic aorta. A band of 7-0 Prolene was placed 
under the aorta and tied around a blunted 26-gauge needle, which was later removed. 
The animals were studied 4 weeks after TAC. Sham-operated matched animals were 
used as controls. These operations were performed by Dr Mutsuo Harada at South 
Kensington Campus, Imperial College London, due to an infection which prohibited 
their entrance to the bioscience unit in Harefield. 
 
7.2.3 Cell Isolation 
LV cardiomyocytes were isolated as described previously in the Methods. All 
recordings were performed at 37oC with cells superfused with NT unless otherwise 
indicated. 
 
Following cell isolation, the following experiments were performed: 
 
-Ca2+ transient and Ca2+ spark recordings 
-T-tubule imaging using Di-8-ANEPPS 
-Cell surface imaging using SICM (largely by Dr Anamika Singh) 
-ICa,L recordings (Dr Urszula Siedlecka) 
-AP recordings (Dr Christopher Rao) 
 
 
7.2.4 Statistical Analysis 
Statistical analysis was performed using non-parametric one-way ANOVA (Kruskall-
Wallis test). Dunn’s post-hoc test was used to test for differences between groups. 
The analysis was performed using Prism4 software (GraphPad software Inc., San 
Diego, CA, USA). P<0.05 was taken as significant. 
! 210!
7.3 Results 
7.3.1 Lack Of Tcap Caused Progressive Ca2+ Handling Defects 
In isolated LV cardiomyocytes, the whole cell Ca2+ transient was assessed during 
aging. 3 month old mice were studied, corresponding to young mice that were 
previously described (Knoll et al., 2011), as well as 8 months of age. 
 
In 3mKO, the Ca2+ transients had a normal time to peak, amplitude, and time to 50 
and 90% decline, as previously shown by Knoll et al (Knoll et al., 2011). Only the 
variance of the time to peak, a measure of the synchrony of Ca2+ release across the 
cell, was increased (Figure C7-1). This indicated a reduced Ca2+ transient synchrony, 
which may be due to altered AP morphology or t-tubule disruption. 
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FIGURE C7-1: TCAP KO WAS ASSOCIATED WITH PROGRESSIVE CA2+ TRANSIENT 
DEFECTS 
(A) The figure shows line scans of stimulated LV cardiomyocytes from 3 month old or 8 month old 
WT and KO hearts. (B) Variance of the time to peak of the Ca2+ transient, (C) amplitude of the Ca2+ 
transient; (D) time to 50% decline of the Ca2+ transient, (E) time to 90% decline of the Ca2+ transient, 
(F) time to peak of the Ca2+ transient. 3mWT n=40, 3mKO n=48, 8mWT n=48, 8mKO n=43. The 
vertical scale bar represents 100 pixels and the horizontal scale bar represents 100ms. The colour chart 
is a normalised scale of fluorescence intensity. 
 
In 8mKO, the time to peak and time to 90% decline were also prolonged, indicating 
progression of Ca2+ handling abnormalities. It is important to note that the functional 
status of 8mKO animals at the whole heart level has not been described. It was not 
possible to assess these for regulatory reasons concerning infection with a benign 
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7.3.2 Tcap KO Was Associated With Progressive Ca2+ Spark And LTCC Defects 
Ca2+ sparks are the functional constituents of the Ca2+ transients. In 3mKO and 
8mKO, there was an elevated Ca2+ spark frequency, with a small but significant 
reduction in Ca2+ spark peak amplitude (Figure C7-2).  This indicates impaired SR 
Ca2+ release function, which could be due to altered ICa,L, dyadic disruption or 
primary changes to the RyR. 
 
 
FIGURE C7-2: TCAP KO WAS ASSOCIATED WITH PROGRESSIVE CA2+ SPARK AND 
LTCC DEFECTS 
(A) Line scans of quiescent LV cardiomyocytes from 3 month or 8 month WT and KO hearts. Ca2+ 
spark (B) frequency, (C) peak, (D) width and (E) duration. 3mWT n=40, 3mKO n=48, 8mWT n=48, 
8mKO n=43. (F) The ICa,L density is shown. 3mWT n=24, 3mKO n=25, 8mWT n=16, 8mKO n=20. 
The vertical scale bar represents 768ms and the horizontal scale bar represents 100 pixels. The colour 
chart is a normalised scale of fluorescence intensity. 
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There was no difference in ICa,L density in 3mKO cardiomyocytes; however, 
cardiomyocytes from 8mKO had a significant reduction in ICa,L density (Figure C7-
2). The shape of the current-voltage curve was not affected at any timepoint. 
 
7.3.3 Loss Of Tcap Did Not Influence The Action Potential 
The AP was unchanged in amplitude or time to 50 and 90% depolarisation (Figure 
C7-3).  These results indicate that at 3 months of age, the triggers for SR Ca2+ were 
unaffected. The results at 8 months need to be interpreted in light of the loss of t-
tubule density, as the LTCC is concentrated in the t-tubule membrane (Gu et al., 
2002). 
 
 
FIGURE C7-3: THE ACTION POTENTIAL WAS UNAFFECTED IN TCAP KO 
The figure shows the (A) amplitude and (B) time to 50 and (C) 90% repolarisation in the AP at 1 Hz. 
Similar recordings were made at 3 and 5Hz. 3mWT n=25, 3mKO n=26, 8mWT n=9, 8mKO n=10. 
 
7.3.4 The T-Tubule System Was Disrupted In Tcap KO 
The isolated loss of Ca2+ transient synchronicity in cardiomyocytes from 3mKO could 
be due to pathological changes to the t-tubule system. In 3mKO, there was a normal 
density of the t-tubules, but the regularity of the t-tubules, measured by the power of 
the dominant peak of the Fourier transform, was significantly depressed (Figure C7-
4).
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FIGURE C7-4: T-TUBULE STRUCTURE WAS DISRUPTED IN TCAP KO 
(A) Single Di-8-ANEPPS stained cardiomyocytes from which t-tubule density (B) and regularity (C & D) are calculated. This provides a power-frequency curve, 
the peak of which is taken as an index of t-tubule regularity. 3mWT n=30, 3mKO n=32, 8mWT n=45, 8mKO n=44. 
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In 8mKO, the t-tubule abnormalities progressed, with loss of both t-tubule density and 
regularity (Figure C7-4). 
 
7.3.5 The Cell Surface Was Initially Unaffected by Tcap KO 
To study the structure of the cell surface, SICM was used. 3mKO had a normal cell 
surface structure with a typical pattern of fine membrane striations (z-grooves) in 
which orderly t-tubules reside (Figure C7-5). However, in 8mKO there was loss of the 
fine membrane architecture with a reduced z-groove index (Figure C7-5). 
 
FIGURE C7-5: CELL SURFACE STRUCTURE WAS DISRUPTED IN TCAP KO 
(A) Low (top images) and high (bottom images) power views of the cell surface of 8m WT and KO 
cells are shown. (B) The z-groove index is reduced in 8mKO, indicating loss of cell surface 
organisation. 3mWT n=7, 3mKO n=16, 8mWT n=30, 8mKO n=20. 
 
7.3.6 Mechanical Overload Caused Marked Ca2+ Transient Abnormalities In 
Tcap KO 
After chronic mechanical overload induced by TAC for 4 weeks in 3 month old mice, 
both WT and KO cells showed prolongation of the time to peak (WT increased by 
16%, KO increased by 19%) of the Ca2+ transient (Figure C7-6). Both WTs and KO 
!
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showed an increase in the variance of the time to peak of the Ca2+ transient than WT 
(WT increased by 34%, KO by 25%, with respect to control), and additional 
prolongation of the time to 50  (WT increased by 11%, KO increased by 40%) and 
90% (WT increased by 5%, KO increased by 15%) decline of the Ca2+ transient. 
 
 
FIGURE C7-6: MECHANICAL OVERLOAD CAUSED SEVERE CA2+ TRANSIENT 
DEFECTS IN TCAP KO 
(A) Line scans of stimulated LV cardiomyocytes from Sham or TAC, WT and KO hearts. (B) Time to 
peak of the Ca2+ transient, (C) amplitude of the Ca2+ transient, (D) time to 50% decline of the Ca2+ 
transient, (E) time to 90% decline of the Ca2+ transient, (F) variance of the time to peak of the Ca2+ 
transient. WT-Sham n=34, WT-TAC n=32, KO-Sham n=31, KO-TAC n=34. The vertical scale bar 
represents 100 pixels and the horizontal scale bar represents 100ms. The colour chart is a normalised 
scale of fluorescence intensity. 
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7.3.7 Mechanical Overload Caused Marked Increases In Ca2+ Spark Frequency 
In Tcap KO 
To understand the mechanisms involved in the Ca2+ transient abnormalities in 
response to TAC, Ca2+ spark properties were studied. KO, but not WT, cells showed 
increased Ca2+ spark frequency (Figure C7-7). There was also a prolongation of the 
Ca2+ spark duration in both WT and KO cells after TAC. The Ca2+ spark duration was 
increased in the KO-Sham group, compared to the WT-Sham group. This was not 
observed in the study using 3 and 8 month old animals above. 
 
There was no change to ICa,L after mechanical overload in KO or WT (Figure C7-7). 
This was different to the finding in the ageing study above (Figure C7-2), and will be 
discussed below. 
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FIGURE C7-7: MECHANICAL OVERLOAD ALTERED CA2+ SPARK FREQUENCY IN 
TCAP KO BUT NOT WT AND DID NOT AFFECT LTCC 
(A) Line scans of quiescent ventricular cardiomyocytes from 3 month or 8 month WT and KO hearts. 
Ca2+ spark (B) frequency, (C) peak, (D) width and (E) duration. WT-Sham n= 34, WT-TAC n= 32, 
KO-Sham n= 31, KO-TAC n= 34. (F) ICa,L density is shown in lower graph. WT-Sham n=11, WT-
TAC n=16, KO-Sham n=13, KO-TAC n=14. The vertical scale bar represents 768ms and the 
horizontal scale bar represents 100 pixels. The colour chart is a normalised scale of fluorescence 
intensity. 
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7.3.8 The Action Potential Was Unaffected by Loss of Tcap Following TAC 
The AP was also unaffected in amplitude or time to 50% or 90% depolarisation at all 
stimulation frequencies studied (1Hz (shown) 3Hz and 5Hz) (Figure C7-8). 
 
FIGURE C7-8: THE ACTION POTENTIAL WAS UNAFFECTED BY OVERLOAD IN WT 
AND KO CELLS 
The figure shows the (A) amplitude and (B) time to 50 and (C) 90% repolarisation in the AP at 1Hz. 
Similar recordings were made at 3 and 5Hz. WT-Sham n=16, WT-TAC n=13, KO-Sham n=24, KO-
TAC n=23. 
 
7.3.9 Pronounced T-Tubule Loss And Disorder Following Mechanical Overload 
In Tcap KO 
It is known that chronic mechanical overload induces loss and disorder in the t-tubule 
system, and this was confirmed by comparing Sham and TAC WT cells (Figure C7-9) 
Tcap KO showed a profound loss of t-tubule density and regularity, which was greater 
than the loss which occurred in WT cells (density was reduced by 27% in WT and by 
30% in KO).
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FIGURE C7-9: PROFOUND T-TUBULE LOSS OCCURRED AFTER MECHANICAL OVERLOAD IN TCAP KO 
(A) Single Di-8-ANEPPS stained cardiomyocytes from which t-tubule density (B) and regularity (C) are calculated. WT-Sham n= 31, WT-TAC n= 28, KO-Sham n= 30, KO-
TAC n= 34. 
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7.3.10 The Cell Surface Was Disrupted By Mechanical Overload in Tcap KOs 
 
The cell surface was examined using SICM and found that TAC induced pathological 
remodelling of the cell membrane surface with loss of the z-grooves (Figure C7-10). 
 
 
 
FIGURE C7-10: CELL SURFACE STRUCTURE WAS DISRUPTED IN TCAP KO 
FOLLOWING MYOCARDIAL OVERLOAD 
(A) The cell surface of Tcap KO Sham and TAC cardiomyocytes is shown, from which the z-groove is 
calculated (B). KO-Sham n=16, KO-TAC n=14. 
KO-Sham KO-TAC 
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7.4 Discussion 
This study shows that loss of Tcap from cardiomyocytes is associated initially with an 
isolated t-tubule defect, with minor Ca2+ handling changes and normal heart and 
cellular function, suggesting that this effect is primary to the t-tubule. This defect 
becomes worse with ageing and is associated with significant changes in Ca2+ cycling. 
During mechanical overload, there is pronounced t-tubule loss and remodelling 
indicating that Tcap is necessary to maintain t-tubule structure and function, 
especially after mechanical overload. 
 
7.4.1 T-Tubule Regulation 
The t-tubules are regulated by a number of molecules, each acting at different levels, 
as discussed in the Introduction (Table I-4). A major biophysical regulator of the t-
tubule system is mechanical load variation, as both increased and reduced mechanical 
load can disrupt t-tubule structure when prolonged (as shown in Chapters 4-6). Zhang 
et al identified Tcap as a load-dependent promoter of t-tubule formation in response 
to stretch in zebrafish skeletal muscle (Zhang et al., 2009). It was recently reported 
that during HF Tcap expression declines, then recovers after SERCA2a gene therapy-
induced reverse remodelling, correlating with observed loss and reappearance of the t-
tubules(Lyon et al., 2012). In this present study, Tcap is identified as a molecular 
mechanism governing t-tubule structure and function in the mammalian heart. 
Importantly, lack of Tcap results initially in isolated abnormal t-tubule structure, with 
few Ca2+ handling changes (discussed below). This is suggestive of a direct t-tubule 
regulatory role by Tcap. In the absence of Tcap, mechanical overload results in a 
more pronounced t-tubule dysfunction, with major implications for CICR. Taken 
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together, these data suggest that Tcap is involved in the regulation of t-tubule 
structure, especially after mechanical overload. 
 
7.4.2 Electrophysiological Abnormalities 
The AP morphology was unaffected by either lack of Tcap or mechanical overload. 
The AP was unaffected despite a reduced ICa,L. This may be due to the enhancement 
of other currents such as the NCX current. Further, the changes in ICa,L may have 
been too small to influence the AP. 
 
The effect on ICa,L reported in this Chapter is complex. In 8mKO, where t-tubule 
density was depressed, the ICa,L density was also significantly depressed. Such ICa,L 
depression could result in smaller increases in the dyadic [Ca2+], resulting in slower 
Ca2+ release from the SR and therefore less activation of the contractile apparatus. 
Indeed, the time to peak and time to 90% decline of the Ca2+ transient were prolonged 
in 8mKO. During conditions of overload in both WT and KO cells, where t-tubule 
density was also depressed, ICa,L was unaffected. There are two possible 
explanations for this discrepancy. First, ICa,L density is a normalised measure to cell 
capacitance, which depends on the membrane area. Therefore, if the membrane area 
were to decrease to the same extent as loss of LTCCs, the overall ICa,L density 
measure would be the same. Secondly, there could be a compensatory increase in 
LTCCs to counter the loss through detubulation, (whether driven by proteins linked to 
the t-tubule biogenesis such as BIN1, or independent) which results in a relatively 
normal ICa,L:membrane area measurement. Whether these or other mechanisms 
explain this finding is an important question for future studies. Lastly, most studies do 
not report depression of ICa,L after models of overload and HF (Bers, 2006a), and it 
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could be that the t-tubule loss induced by ageing is distinct (driven by distinct 
molecular pathways) from that driven by overload-induced HF; this also needs to be 
addressed by future studies. 
 
In 3mKO, as previously reported (Knoll et al., 2011), the amplitude and duration of 
the whole cell Ca2+ transient were not different from control cardiomyocytes. 
However, using confocal microscopy, it was possible to perform an additional 
examination of CICR synchronicity, and it was found that this was significantly 
disrupted in 3mKO. The points of delayed Ca2+ release spatially colocalise to defects 
in the t-tubule system, indicating that these areas of dysynchrony are caused by 
delayed RyR activation due to LTCC-RyR uncoupling (Louch et al., 2004, Meethal et 
al., 2007). T-tubule morphology is not the only regulator of CICR synchrony, but 
given that Ca2+ handling appears intact at this stage, t-tubule remodelling is likely the 
cause of this loss of synchrony. In 8mKO, in addition to loss of synchronous CICR, 
there was also prolongation of the time to peak and time to 90% decline of the Ca2+ 
transient. This was accompanied by loss of t-tubule density, which would further 
uncouple CICR. 
 
After mechanical overload, Ca2+ transient remodelling occurs with a prolongation of 
the time to peak, loss of Ca2+ release synchrony and prolongation of time to 50% and 
90% decline in the Ca2+ transient. In cardiomyocytes lacking Tcap, mechanical 
overload-induced additional prolongation of the Ca2+ transient occurred. One 
explanation for this effect is that pronounced t-tubule defects in this group resulted in 
altered interaction between ion channels responsible for efficient CICR, resulting in 
Ca2+ transient remodelling. Interestingly, despite longer Ca2+ spark duration after 
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TAC, the Ca2+ transient decline was faster in KO compared to WT Shams. The 
reasons for this are unknown and could be related to Tcap interactions with other 
receptors and ion channels which were not studied, including NCX. 
 
SR Ca2+ release function was assayed by measuring Ca2+ sparks. In 3mKO, Ca2+ 
spark frequency was elevated. The mechanisms governing Ca2+ spark properties are 
complex, but this could be due to uncoupling of LTCC and RyR, which can induce 
destabilisation of the RyR. Increased Ca2+ spark frequency occurs in HF where the t-
tubules are abnormal or missing (Meethal et al., 2007) and this increased Ca2+ spark 
frequency is spatially localised to gaps in the t-tubule system. Ca2+ spark frequency 
was elevated in KOs but not WT after TAC, possibly due to the pronounced t-tubule 
loss, resulting in LTCC-RyR uncoupling. The Ca2+ spark duration was prolonged in 
both WT and KO after TAC. One mechanism which could mediate this is 
displacement or loss of NCX, which is concentrated in the t-tubules. Loss of NCX 
could delay the extrusion of Ca2+, resulting in prolonged Ca2+ sparks (Biesmans et al., 
2011). KO Sham cells showed longer Ca2+ spark duration compared to WT Sham.  
Ca2+ spark duration is a complex parameter and depends on factors promoting Ca2+ 
leak, altering Ca2+ diffusion properties throughout the cytoplasm and Ca2+ extrusion 
from the cytoplasm (Cheng et al., 1999). 
 
7.4.3 Changes To The Cell Surface 
In 3mKO, the cell surface was not altered but in 8mKO, cell surface remodelling 
occured After mechanical overload, the cell surface was also disrupted. The 
implications for CICR of z-groove loss is not clear, although in all conditions studied 
so far, where z-groove remodelling has occurred, there have also been CICR defects 
(Lyon et al., 2009). Importantly, the intact cell surface structure of 3mKO indicates 
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that these cells were not in a state of general pathological remodelling and that their 
gross structural features were intact. Together with previous reports (Zhang et al., 
2009), this supports the notion that the t-tubule changes in these cells were an 
isolated, primary defect. 
 
7.4.4 Molecular Mechanism Mediating Tcap-T-Tubule Interaction 
In the heart, Tcap interacts with a number of proteins to form a stretch-sensing 
complex (Knoll et al., 2002), Figure C7-11. Importantly, Tcap also binds minK, the 
regulatory β-subunit of the delayed rectifier K+ current channel that resides in the t-
tubules (Furukawa et al., 2001), providing a possible molecular mechanism for the 
findings observed in this study. This suggests a role for Tcap in coupling stretch-
sensation with the t-tubule membrane. Zhang et al showed in zebrafish that t-tubule 
development, which corresponds to body twitch initiation, is dependent on normal 
Tcap expression (Zhang et al., 2009). Reduction of body movement by anaesthesia 
delayed t-tubule development. The authors concluded that Tcap could be regulating 
the t-tubule system in response to changes in stretch. One way in which Tcap could 
perform mechanosensation functions might be using the integrin-linked kinase 
system, which should be tested in future studies (Knoll et al., 2007). 
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FIGURE C7-11: TELETHONIN BINDS WITH A NUMBER OF MOLECULES IN THE Z-
DISK 
The binding partners and arrangement of Tcap  (Telethonin) in the z-disk is shown. This 
includes minK, present in the t-tubule membrane of the ventricular muscle cells. Figure from 
(Zou et al., 2006). 
 
Given the large body of evidence showing that the t-tubule system is load-sensitive in 
both myocardial overloading and unloading (Chapters 4-6), it was hypothesised that 
Tcap would regulate the t-tubule system of mammalian ventricular cardiomyocytes in 
response to load. In this study, it was shown that cardiomyocytes lacking Tcap have 
deranged t-tubule structure with limited other defects to the CICR system, suggesting 
Tcap has a primary role in regulating the t-tubule structure. When subjected to 
mechanical overload, the t-tubule system undergoes even more profound remodelling, 
indicating a failure of load-dependent regulation. This supports the hypothesis that 
Tcap is a critical, load-dependent regulator of t-tubule structure. Further studies are 
required to elucidate the precise mechanisms mediating the biochemical interactions 
between Tcap and the t-tubule membrane.
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Chapter 8 
General Discussion 
 
“Truth in science can be defined as the working hypothesis best suited to open the 
way to the next better one.” 
Konrad Lorenz (1903-89), Austrian founder of Ethology [Nobel prize for Medicine, 1973] 
 
 
In this Chapter, the evidence presented in respect of the general hypothesis that 
mechanical load affects t-tubule structure and function in LV cardiomyocytes in a 
graded and reversible manner via specific molecular mechanisms is synthesised and 
evaluated. 
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8.1 Summary 
8.1.1 Whole Heart 
The studies in this thesis were aimed at evaluating t-tubule structure and local CICR 
during various loading conditions. The evaluation of the whole heart was limited to 
the validation of the animal models through the measurement of heart weight and 
echocardiography. 
 
Heart weights increased in proportion to the degree of mechanical overload, 
secondary to CAL or TAC (Chapter 3, 5 and 6). Likewise, heart weights were reduced 
following mechanical unloading (Chapter 3 and 6). 
 
Echocardiographic assessment was employed for functional analysis of CAL and 
TAC, and for measurement of wall and cavity dimensions in the case of mechanical 
unloading. HF was assessed as an EF of below 40%, representing a class of 
functionally very impaired patients, who would be candidates for mechanical 
circulatory support (Stewart and Givertz, 2012), although the CAL model does not 
result in any detectable functional symptoms or signs of HF. CAL was accompanied 
by dilation of the LV cavity (Chapter 3). The contractility of the TAC model was 
enhanced, indicating compensated hypertrophy (Chapter 3). Mechanical unloading 
was associated with thinning of the LV wall and a smaller LV cavity.  No whole heart 
functional assessment of the mechanically unloaded heart was performed. 
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These results indicate that mechanical load variation results in myocardial 
hypertrophy or atrophy. Overload resulted in a compensated hypertrophy and CAL 
caused clinically-relevant HF. 
 
8.1.2 Whole Cell 
A summary of cellular findings and what was not studied, for each group of 
experiments is given in Figures C8-1 to C8-5. 
Cell volume generally mirrored the changes in whole heart weight, with hypertrophy 
in response to CAL and TAC and reductions in response to mechanical unloading. 
The cellular hypertrophy after CAL was associated with cell volumes in the order of 6 
x104 µm3, while 10 weeks after TAC the cell volume reached approximately 5 x104 
µm3. Cells from the TAC 10 week group showed some preserved functional 
properties (e.g. Ca2+ transient amplitude) and some signs of deterioration (e.g. raised 
Ca2+ spark frequency and altered t-tubule structure). This may represent a transitional 
period between compensated hypertrophy and HF. 
 
Mechanical unloading results in reductions in cell volume (Chapter 4, 5 and 6). It was 
shown that while severe mechanical unloading, induced by heart-only transplantation 
resulted in major diminution of cell volume, moderate mechanical unloading resulted 
in graded reductions in cell volume. The regression of hypertrophy (Chapter 5) was 
associated with enhanced cellular function. However, very low cell volumes (Chapter 
4) were associated with deterioration in function. 
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This thesis reveals that the relationship between cell volume and function is complex, 
with very high or low volumes associated with dysfunction and a physiologic 
intermediate range. 
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FIGURE C8-3: SUMMARY OF CHANGES REPORTED IN HEART FAILURE 
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FIGURE C8-5: SUMMARY OF CHANGES REPORTED IN TCAP KO 
 
8.1.3 The Cell Surface 
The cell surface is a highly sophisticated structure which interacts with the 
extracellular matrix and the milieu of extracellular signaling molecules (Louch et al., 
2010c). It is a communication hub, sensing external stressors, and containing 
microdomains of β-adrenergic and other cell signalling centres (Nikolaev et al., 
2010), which shift during disease. 
 
Using SICM, the cell surface was shown to be modulated by mechanical unloading in 
Chapters 4 and 6. Its disruption during HF was confirmed in Chapter 5, which showed 
for the first time that these changes were reversible. Chapter 6 showed that the degree 
of mechanical unloading might influence the cell surface, but more evidence is 
needed to reach a conclusion. 
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The method used to characterise the cell surface provides a general picture of the cell 
surface microarchitecture (Gorelik et al., 2006). It is now routinely combined with 
assessment of the functional ion channel constituents of these membrane fractions 
(Gu et al., 2002) and assessment of the β-adrenergic response of these fractions 
(Nikolaev et al., 2010). These additional features will provide a much more detailed 
understanding of the dynamic regulation of the cell surface in response to various 
physiological and pathological stimuli. 
 
This thesis supports the notion that mechanical load variation, in particular 
mechanical unloading, may impact the cell surface and highlights it as an important 
target for new studies. In particular, the relationship between the structural regulation 
of the membrane and the t-tubules needs to be investigated. 
 
8.1.4 The T-Tubule System Or Network 
This thesis was focused on understanding the response of the t-tubule system to 
altered physiological and pathological loading conditions. T-tubule structure is a 
major determinant of cellular Ca2+ handling, as has been demonstrated by many 
studies and perhaps most powerfully by a series of seminal papers using the 
detubulating agent formamide (Brette et al., 2002, Chase et al., 2010, Chase and 
Orchard, 2011, Despa et al., 2003, Fowler et al., 2007, Kawai et al., 1999, Komukai 
et al., 2002, Yang et al., 2002). This thesis has confirmed the tight relationship 
between t-tubule structure and subcellular Ca2+ handling. 
 
This thesis used advanced surgical models to test the relationship between chronic 
mechanical load and the t-tubule system. Chapter 4 showed that prolonged 
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mechanical unloading could alter the t-tubule structure. Chapter 5 furthered the 
concept of mechanical load as a regulator of the t-tubules by showing that 
normalisation of mechanical load restored the t-tubule structure. What is more, the 
study reported in Chapter 5 was the first demonstration of recovery of loss of t-tubule 
density after a pathological insult. This shows that not only are t-tubule structural 
properties regulated by mechanical load, but that t-tubule formation is also regulated 
by mechanical load, and the phenomenon is reversible. Chapter 6 refined these 
findings, showing that graded, slower decreases in mechanical load can be consistent 
with normal t-tubule structure, as can graded increases in mechanical load. The 
molecular mechanisms mediating the load-dependent regulation of the t-tubule 
structure are certainly multiple. Tcap became a target of interest due to its load-
sensitivity and apparent role in load-dependent t-tubule regulation (Zhang et al., 
2009). 
 
Chapter 7 showed that Tcap is essential for normal t-tubule structure at rest. What is 
remarkable is that there is no cardiac dysfunction at the earliest time point studied, 
and also no stigmata of abnormal cellular Ca2+ handling, indicating, as far as possible, 
that the defect is primary to the t-tubule. However, it is pertinent that overload-
induced t-tubule dysfunction occurs prior to the advent of overt myocardial failure in 
rats (Wei et al., 2010). As such, it cannot at this stage be ruled out that Tcap acts on 
the t-tubule membrane via another, as yet undiscovered, mechanism. Such a 
mechanism x could not be found after rigorous biochemical analysis (Knoll et al., 
2011). This investigator therefore submits, with some reservations, that Tcap has a 
primary role in t-tubule regulation. The load-dependence of Tcap expression, and the 
profound t-tubule disruption observed when the heart is challenged in its absence, 
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supports the notion that Tcap is particularly important during load-variation (although 
it is important to note that the percentage reduction of t-tubule density following TAC 
in WT and KO is approximately the same [27% and 30%, respectively]). Several 
questions remain unanswered, and will be outlined below. 
 
8.1.5 Local CICR 
Local CICR is profoundly dependent on t-tubule structural integrity. That is not to say 
that a physiological stimulus, such as mechanical load variation – which alters the t-
tubule structure – cannot independently influence the determinants of local CICR. 
This is a problem when interpreting the influence of mechanical load variation on a 
system whose function is determined by multiple elements. 
 
The whole cell Ca2+ transient was dyssynchronous when the t-tubules were also 
impaired (Chapter 4, 5, 6, 7).  Other investigators used double-staining experiments 
(with membrane-staining and Ca2+ sensitive dyes) to colocalise the gaps in the t-
tubule system with inhomogeneous Ca2+ transient (Louch et al., 2004, Louch et al., 
2006, Louch et al., 2010c). The finding that synchrony improved following 
restoration of normal t-tubule structure in Chapter 5 was suggestive of a direct 
relationship. However, other factors, especially the AP, play a role in regulating Ca2+ 
release synchrony (Louch et al., 2010a) and should be investigated in future studies. 
 
The Ca2+ transient amplitude was depressed in HF, and recovered following 
mechanical unloading (Chapter 5). Prolonged mechanical unloading of the normal 
heart depressed the Ca2+ transient amplitude (Chapter 4). Moderate unloading 
achieved the same effect, over twice the duration (Chapter 6). Mechanical overload 
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enhanced the Ca2+ transient amplitude, as expected for a compensated hypertrophy 
picture (Chapter 6). In some cases, these results could be explained by alterations to 
the SR Ca2+ content. 
 
The timecourse of the Ca2+ transient was also affected by mechanical unloading 
alone, which induced prolongation of the time to peak and time to 50% and 90% 
decline. This may be related to the loss of the normal t-tubule architecture, which 
separates the normally close interaction with LTCC and the RyR (Chapter 4). The t-
tubules also contain Ca2+ extrusion pathways, including NCX, which help to 
determine the transient. HF-induced prolongation of the time to peak and decay 
parameters of the transient was reversed following mechanical unloading, at least 
partly driven by the reappearance of the t-tubule network (Chapter 5). The 
physiologic hypertrophy induced by mechanical overload did not influence the time to 
peak, but caused reduction of the time to 50% and 90% decline (Chapter 6). Moderate 
mechanical unloading induced a slowing of the Ca2+ transient, over a longer duration 
of unloading than severe mechanical unloading. Together, these results imply that all 
the features of the Ca2+ transient can be regulated by mechanical load. There is thus 
substantial evidence which ties these changes to alterations in t-tubule structure. 
Further experiments which simultaneously map the changes in Ca2+ transients and t-
tubule structure in the same cells will be helpful in understanding this link in greater 
detail. 
 
The Ca2+ spark properties are regulated by a number of factors and have been 
discussed in the preceding chapters. The cardinal sign of altered SR Ca2+ release 
function, in particular enhanced RyR leak, is Ca2+ spark frequency. Prolonged 
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mechanical unloading increased the Ca2+ spark frequency, in line with altered t-tubule 
structure which may uncouple the RyR and LTCC. This was also found in the failing 
heart, where t-tubule density was reduced. In support of the notion that disruption of 
the t-tubule membrane can result in increased Ca2+ spark frequency, when the t-tubule 
density was enhanced following mechanical unloading, the Ca2+ spark frequency was 
reduced (Chapter 5). Chapter 6 showed that Ca2+ spark frequency was raised at either 
end of prolonged mechanical unloading and mechanical overload. These conditions 
were accompanied with t-tubule aberrations. In addition, Ca2+ spark frequency was 
increased in young Tcap KOs, where there appeared to be isolated t-tubule 
irregularity. These results may present a challenge to the current paradigm of the 
functional consequences of LTCC-RyR interaction. It would be expected that LTCC-
RyR uncoupling would reduce the Ca2+ spark frequency. Evidence against this was 
summarised in the preceding Chapters. 
 
There was no evidence that the ICa,L or AP were affected by mechanical unloading. 
HF depressed the ICa,L and mechanical unloading restored this. 
 
8.2 What Remains To Be Discovered? 
 
This thesis has served to highlight the dynamism of the t-tubule network’s structure 
and function in relation to various physiologic and pathologic stimuli. It has shed light 
on the details of this interaction, but raised a number of questions of importance. 
 
First, to what extent precisely can the corollaries of mechanical unloading (altered 
phosphorylation, metabolic changes and so on) explain the changes which have been 
ascribed to the t-tubule network? 
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In particular, denervation may have considerable consequences on the transplanted 
heart. The main consequence of denervation appears to be abolition of the fine 
extrinsic neuroendocrine regulation (Kent and Cooper, 1974), necessary for the 
feedforward anticipatory changes which contribute to the response to increased 
cardiac workload. This leaves intrinsic mechanisms to cope, mainly Starling’s law. 
This is augmented by catecholamine surges which stimulate a number of subcellular 
phosphorylation pathways to augment excitation-contraction coupling. In the absence 
of vagal tone, turning off of these responses is mediated by the termination of the 
catecholamine surge and reduced cardiac workload. The importance of these effects in 
an unloaded heart is uncertain.  
 
Second, what mechanisms govern the impact of Tcap’s loss on the t-tubule network’s 
structure? 
 
Third, it is necessary to understand the functional consequences of LTCC and RyR 
interactions to a more sophisticated extent than this thesis has achieved. 
 
Finally, it is necessary to use the substantial data which has amassed in the last fifteen 
years to tackle the major, but neglected, question of what the purpose of (or survival 
advantage of) t-tubule restructuring, loss and reappearance is. It may be a bystander 
effect, simply a consequence of a ruined dyadic neighbourhood (Louch et al., 2010c). 
But might it be of physiological benefit to impair contractility in an energy-deplete 
system? There are two approaches that could help to answer this major question. 
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First, it is relevant to compare physiological with pathological hypertrophy (Kemi et 
al., 2011). To the extent that this has been possible, it appears that physiological 
hypertrophy is not associated with t-tubule density changes, while this parameter is 
reduced in pathological hypertrophy. What do these terms mean, however, if the cell 
sizes compared (e.g. (Kemi et al., 2011)) are so wildly different? Is it possible to have 
a physiological hypertrophy of the order of magnitude reported for pathological 
conditions? The same is true of mechanical unloading and atrophic hearts, where the 
cell volumes compatible with normal function are significantly larger than those that 
are damaged. This is a major problem which needs to be addressed. 
 
Second, the perhaps more fruitful avenue is to address the molecular mechanisms 
governing these changes. By understanding the molecular pathways governing the 
change in t-tubule density, perhaps it will be possible to better understand its 
aetiology. Is it perhaps a consequence of reversion to a foetal gene programme? Is it 
part of a wider energy-conserving programme? These approaches may allow us to 
understand the purpose and first-cause of the reported changes in t-tubule structure 
and function. 
 
8.3 Clinical Implications 
The phenomenon of significant myocardial mechanical unloading is essentially 
confined to the relatively rare setting of LVADs. That is not to understate the 
significance of understanding the physiological mechanisms mediating the response 
to myocardial unloading. It represents one half of a cycle which is understudied. It is 
impossible to understand how the heart responds to load variation without studying 
mechanical unloading. Nonetheless, the prime motivation of this work is to 
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understand the spectrum of effects of mechanical unloading because of the advent of 
the LVAD. In that regard, this thesis has contributed original knowledge to three 
major clinical questions. 
 
First, what mechanisms explain the regression of the improvement to myocardial 
function in the setting of prolonged mechanical unloading? This thesis suggests that 
subcellular Ca2+ handling defects, likely the result of structural dysregulation of the t-
tubules, may play a role in so-called atrophic remodelling. 
 
Second, what mechanisms explain the improved function following mechanical 
unloading of the failing heart? This thesis suggests that one mechanism (of many) is 
restitution of the normal tight LTCC-RyR coupling mediated by the t-tubule. 
 
Third, can a shorter duration or less severe degree of mechanical unloading influence 
the enhancement of bridge to recovery? This thesis suggests that the heart is sensitive 
to the degree and duration of mechanical unloading; in particular, that mechanical 
unloading of a lesser degree can preserve the structure and function of the t-tubule 
system. 
 
8.4 General Conclusion 
Chronic mechanical load variation influences t-tubule structure and function in a 
time- and degree-dependent manner. The degradation of the t-tubule system is 
reversible by reducing mechanical load. Tcap is a regulator of t-tubule structure, 
which is especially important during mechanical overload. 
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These results support a general model of t-tubule regulation by mechanical load 
variation, where a physiological range exists, beyond which t-tubule abnormalities 
occur and local CICR is disturbed. This thesis has highlighted a potentially critical 
molecule involved in the load-dependent regulation of t-tubule structure, Tcap. 
Further work will reveal the details of the specific pathways which link the 
physiological processes described here with their molecular regulators. 
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